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ABSTRACT

It is estimated that this year more than 200,000 women in the United States will
be diagnosed with breast cancer. Treatment for most occurrences of breast cancer will
often include surgical removal of the tumorigenic tissue, resulting in a soft tissue defect
within the subcutaneous tissue of the skin. Post-surgical reconstruction methods are
often sought by patients to restore the aesthetic function of the breast via cellular or noncellular methods; however, because of complications associated with currently used
methods for breast reconstruction, researchers are investigating tissue engineering
methods to produce viable autologous adipose tissue for breast reconstruction.
Previous research in our laboratory has focused on the development of an
injectable composite system for breast reconstruction that uses injectable microcarrier
beads as support scaffolds for cellular growth. In vitro and in vivo studies of this system
have shown that the polymeric microcarriers not only support cellular attachment, but
also facilitate proliferation and differentiation of adipose cells, and yield biocompatible
tissue response in an in vivo host. Successful clinical implementation of this system, like
many other adipose tissue engineering methods, has been limited by an inability to
engineer adipose tissue of sustained volume long-term. It is hypothesized that more
optimal in vitro culturing methods for adipose cells could yield populations of fat cells
capable of differentiating to adipocytes and retaining their capacity for lipid-filing over
time. The goal of this work, therefore, was to evaluate specific factors that influence
adipose cell differentiation in an attempt to create a more successful injectable composite
system for breast reconstruction. While adipogenesis is influenced by many factors, for
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this work, we investigated two specific areas: 1) the influence of adipose cell-mammary
epithelial cell interactions and 2) the influence of fatty acids on adipose cell
differentiation in vitro.
A series of conditioned media studies were first performed to determine how
adipogenesis of primary adipose cells from bovine, murine, and human tissue samples
was influenced by mammary epithelial cell-conditioned media. Depending on the source
of conditioned media and the species of adipose cell, adipose cell differentiation was
either positively or negatively influenced by the conditioned media as evidenced by
increased or decreased triglyceride production and lipid accumulation in the twodimensional cultures.

Characterization of the components of the conditioned media

samples showed that mammary epithelial cell-conditioned media contains measurable
quantities of factors that influence adipogenesis.
To investigate the influence of fatty acids on adipose cell differentiation, a series
of studies were performed to identify an optimal concentration of fatty acid and an
optimal culture time for supplementing adipose cells with a fatty acid that would
stimulate fatty acid uptake and subsequent lipid filling of the cells. Exogenous fatty acids
in cell culture medium were found to influence adipogenesis.

Microcarrier beads

containing fatty acids were then manufactured and used in three-dimensional cell culture
experiments to determine if microcarrier beads could be used for fatty acid delivery while
simultaneously supporting adipose cell growth and differentiation.
Results of the studies performed in this work suggest that fatty acids as well as
specific factors produced by mammary epithelial cells will influence adipogenesis,
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suggesting that these factors may be used to enhance the in vitro culturing of adipose
cells for the injectable composite system. Methods to more optimally culture the adipose
cells in vitro could be used to identify strategies that could then reduce the concerns of
tissue resorption and volume-reduction that have limited the success of breast tissue
engineering strategies clinically. Ideally, the incorporation of fatty acids and/or cellular
components into the injectable composite would allow immediate delivery of a cellular
implant without the need for in vitro cultivation.
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PREFACE

Many methods for post-surgical reconstruction of breast tissue following tumor
resection exist. There are, however, complications associated with these methods which
influence the successful reconstruction of the patients’ breast tissue. For this reason,
researchers are investigating strategies to engineer adipose tissue that would allow
autologous, natural tissue sources to be used for breast reconstruction. To date, the
successful implementation of these methodologies into clinical practice has been limited
primarily because researchers have yet to develop methods that yield sufficiently
vascularized large volumes of tissue that remain viable and retain volume over time.
Previous work in our lab has focused on the development of an injectable
composite system for breast reconstruction that uses injectable microcarrier beads as
support scaffolds for cellular growth. In vitro and in vivo studies of this system have
shown that the polymeric microcarriers not only support cellular attachment, but also
facilitate proliferation and differentiation of adipose cells, and yield biocompatible tissue
response in an in vivo host. While these results have been promising there are still facets
of this system that must be further understood to successfully engineer adipose tissue
using this system. The long-term goal of this work, therefore, is to evaluate factors that
modulate adipogenesis for breast tissue engineering.
To accomplish the goals set forth for this project, five specific aims were
identified:
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1. Investigate the relationship between mammry epithelial cells and primary
adipose cells in two-dimensional (2-D) culture
2. Evaluate adipose cell behavior in three-dimensional (3-D) cultures with
mammary epithelial cells
3. Evaluate the influence of exogenous fatty acid on adipose cell
differentiation in 2-D in vitro cultures
4. Evaluate the influence of 3-D fatty acid-loaded substrates on adipose cell
differentiation
5. Evaluate fatty acid influence on adipose cell-breast cancer cell interactions
in vitro
The studies in Aim 1, as detailed in Chapter 2, were designed to investigate the
relationship between mammary epithelial cells and primary adipose cells in 2-D culture.
In long-term application of our proposed system, beyond the scope of this research,
adipose cells will be implanted into the mammary microenvironment which largely
consists of mammary epithelial cells. It is therefore important to understand the influence
that mammary epithelial cells have on adipose cell behavior.

To evaluate this

relationship, conditioned media from mammary epithelial cells was used in the culture of
primary adipose cells from bovine, murine, and human tissue samples. Three types of
conditioned media were used for analysis, and the influence of each type on adipose cell
behavior was evaluated to determine if there was any difference in cell behavior, and if
so, if it was dependent on the cell or medium species. Additionally, the influence of
conditioned media on adipose gene expression was assessed, and the conditioned media
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components were assessed with an adipokine protein array and ELISAs specific for TGFβ and PAI-1.
The Aim 2, as detailed in Chapter 3, was conducted to evaluate the behavior of
adipose cells co-cultured with mammary epithelial cells in a 3-D environment. This work
evaluated the effect of culturing primary human adipose cells on polymer microcarriers,
made of a chitosan-gelatin blend, in conjunction with human mammary epithelial cells.
This in vitro study allowed us to observe how adipose cell viability and differentiation
were influenced by 3-D conditions and served as an indicator of how cells included in the
injectable composite system might behave in vivo.
The studies performed to address Aim 3, as detailed in Chapter 4, were designed
to evaluate the influence of exogenous fatty acids on adipose cell behavior in 2-D
cultures. The breast microenvironment is very complex by nature. The large presence of
adipose tissue in the breast means that there are also factors, such as fatty acids, released
by fat tissue, that are present within the breast. We hypothesized that supplementation of
adipose cell cultures with fatty acids would enhance the lipid-filling capacity of adipose
cells for breast tissue engineering, such that the cells would retain volume over time.
Aim 4 studies, as described in Chapter 5, evaluated the influence of 3-D fatty
acid-loaded polymer substrates on adipose cell behavior. One advantage of the injectable
composite system is the ability to tailor the polymeric microcarrier for multiple uses. In
addition to serving as cellular supports, the microcarriers can serve as delivery vehicles
for growth factors, drugs, media supplements, or in this case, fatty acid delivery. Aim 4
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studies included devising methods of sterilely producing chitosan-gelatin microcarriers
loaded with linoleic acid.
Aim 5 studies, as described in Chapter 6, include the evaluation of fatty acid
influence on adipose cell and breast cancer cell interactions in vitro. Fatty acids present
in the body have been shown to influence the behavior of both normal and cancerous
cells. The addition of fatty acids to the bead component of our injectable composite
systems lead us to wonder, if by chance there were residual cancer cells within a postsurgical patient, how the addition of fatty acids would influence the behavior of cancer
cells. Additionally, fatty acids have been shown to influence the effectiveness of cancertreating drugs. Here, we evaluated the influence of fatty acid supplemented beads on
breast cancer cell behavior. Chitosan-gelatin beads with and without incorporated fatty
acids produced and cultured with human primary adipose cells.

These cellular

microcarriers were co-cultured with MCF-7 breast cancer cells and then treated with an
anti-cancer drug, tamoxifen.

xix

CHAPTER 1
INTRODUCTION

1.1 Clinical Significance
Cases of traumatic injury, congenital defect, or tumor resection often result in soft
tissue defects, where loss or removal of volumes of adipose tissue, within the
subcutaneous layer of skin, results in alterations of the skin’s normal contour [1]. Soft
tissue defects are repaired clinically using plastic and reconstructive procedures to restore
the missing volume of adipose tissue. Clinical procedures used to repair such defects
include autologous fat tissue grafts and tissue flap transfers, implants, or injectable fillers
that reconstruct and fill the void space. While many options for soft tissue reconstruction
are used in clinical application, there is, however, not one strategy that is useful for the
wide range of defects that may exist. Additionally, the methods currently used for soft
tissue reconstruction are limited in their success due to complications, such as tissue
resorption, resulting in loss of tissue volume over time [1-6]. Researchers are therefore
working to develop methods for engineering autologous adipose tissue that may be used
to fill soft tissue defects.
Breast cancer is one of the most commonly diagnosed cancers among women in
the United States. For many women undergoing surgical treatments for this disease,
some form of reconstructive procedure is subsequently performed to restore the aesthetic
function of the breast. In the case of tissue-based reconstruction options, autologous fat
tissue transplantation has been largely unsuccessful as a means for breast reconstruction.
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To date, tissue engineering strategies have led to the development of various methods that
appear to be promising starting points for researchers working to successfully engineer
autologous adipose tissue for breast reconstruction.

The structural and functional

complexity of the human breast, however, has limited progress developing a successful
means for engineering breast tissue. This dynamic organ is comprised of multiple tissue
types and their associated secretory factors that play key roles in the developmental
processes of the breast throughout the stages of female maturation [7]. The complexity of
the breast must therefore be considered when investigating strategies for engineering
breast tissue; however, a complete understanding of the specific interactions that occur
between the stromal cells and epithelial cells of the breast remains limited.

1.2 Anatomy and Structure of the Human Breast
The female mammary gland or breast is composed of two primary tissue types:
epithelial tissue and stromal tissue.

The epithelial tissue of the breast is primarily

glandular tissue that plays a role in lactation and milk production. The stromal tissue of
the breast consists primarily of adipose tissue and its associated vascular network. The
tissue of the breast lies over the pectoral or chest muscle of the body and typically
extends from the collarbone to the breastbone midway of the sternum [8, 9].
Structurally, the breast is divided into 15 to 20 sections called lobes (Figure 1.1).
At the extension of these lobes are lobules with acini that produce milk during lactation.
The lobes are interconnected by thin tubes called ducts that function to transport the
produced milk from the lobules to the nipple of the breast. Within the spaces between the
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lobular and ductal structures is stromal tissue which provides the structural framework
and support for the breast.

Figure 1.1: The structural anatomy of the human breast which is made up primarily of
epithelial and stromal tissues [10].

Adipose tissue fills the interstitial spaces and provides the most significant
proportion of the breasts’ volume, accounting for approximately one-third of the breasts’
volume at specific stages of female maturation [11-16]. The breasts are connected
systemically to other parts of the body via its associated vascular network and the
lymphatic system [17]. The primary source of blood supply to the breast is from the
internal mammary artery, accounting for approximately 60%; however, the mammary
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branch of the thoracic artery provides an additional 30% of blood to the breast [8]. Veins
of the breast drain into the internal mammary vein, which is the primary vein that
facilitates blood flow from the breast [15]. The lymphatic vessels carry lymph fluid, or
cellular waste, away from the breast. Most lymphatic vessels in the breast connect to the
axillary nodes. Lymph fluid drains from the breast to the axillary nodes first and then
second to the internal mammary nodes. The internal mammary lymph nodes are located
within the chest, and the supraclavicular or infraclavicular nodes are located around the
collar bone and connect to the breast. The connection of the breasts to the lymphatic
system is important to note because the spreading of metastatic breast cancers often
occurs via the lymphatic vessels to the lymph nodes [15, 17].

1.3 Normal Development of the Female Breast
The human breast is a dynamic organ that undergoes morphological and
developmental changes throughout the stages of female maturation, as shown in Figure
1.2 [15, 18]. Changes in the size, shape, and function of the breast occur in response to
puberty, pregnancy, lactation, and menopause. The most significant changes in growth of
the breast, however, occur following puberty [17]. Following birth, the mammary gland
is composed primarily of adipose tissue, with small ductal structures present forming
breast tissue that remains immature until the onset of puberty. At puberty, growth of the
breast, signified by increased cellular growth of the epithelial ducts, is stimulated by the
hormones estrogen and growth hormone produced by the ovaries and pituitary gland,
respectively [7]. In addition to increased deposition of adipose tissue in the breasts, the
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ducts stretch, elongate, and become more branched, creating a more defined ductal
network [8, 19-23]. The formation of lobules at the end of the ducts also occurs. As the
female ages, during the course of menstruation, the growth of a mature network of ducts
and lobules is formed, with slight growth apparent until approximately age 35 when the
growth of the breast reaches its maximum.

Figure 1.2: The mammary gland undergoes morphological and structural changes
throughout its normal developmental stages (Adapted from [24]).

While a mature network of ductal and lobular structures is formed over time,
complete development of the breast tissue does not occur unless pregnancy and childbirth
are experienced [8, 25]. Growth of the mammary gland is stimulated by production of
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progesterone hormones during pregnancy. During pregnancy, significant extension and
branching of the breast ductal system, accompanied by growth of glandular tissue, leads
to maximal development of the breast whereby the lobules increase in both size and
number.

Systemic reproductive hormones, specifically progesterone and prolactin,

stimulate the expansion and differentiation of the mammary epithelium into milkproducing cells [7]. Lactation, or the production of milk, is the point where the breast
reaches its complete functional capacity due to these functional changes of the glands,
which now secrete milk.

Following lactation, the breast undergoes involution, a

regression of the tissue most notably caused by a collapse or folding of lobular structures
and a narrowing of the ducts. A similar type of tissue remodeling is observed following
menopause when hormones levels, particularly estrogen levels, decrease and glandular
tissue atrophies, leaving larger proportions of fat tissue, stromal connective tissue, and
skin [8, 9, 15, 19-22, 25].

1.4 Breast Cancer Development and Tumor Progression
Healthy cells in the body undergo a balanced, controlled pattern of growth; both
signals that promote cell growth and signals that limit cell growth remain in balance with
each other for ordered proliferation and, ultimately, differentiation of cells. When this
balance is interrupted, the cells will become cancerous [26, 27]. Cancers of the body
occur when cells abnormally divide and proliferate outside the body’s normal control.
Cancerous cells often result from DNA damage that leads to constitutively activated
oncogenes (genes that initiate cell proliferation and differentiation) and inactivated tumor
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suppressor genes (genes that inhibit growth and progression in the cell cycle). Tumor
formation, or tumorigenesis, occurs when the cells cluster together to form large masses
which or may not be malignant. Benign tumors are not cancerous, however, malignant
tumors are cancerous and may metastasize to other parts of the body other than the point
of origin. Malignant cancers that metastasize are more serious in nature because of their
invasive phenotype.
Breast cancer is the form of cancer where cells in the breast tissue, typically
epithelial cells of the breast, divide and grow abnormally [28]. The initiation of breast
cancer is thought to result from uncontrolled cell proliferation and/or an error in the
apoptotic events of breast cells, often the result of genetic damage or alteration. Breast
cancer risk factors include gender, age, weight, family history, child-bearing history,
environmental factors such as smoking or radiation, and genetic predisposition [20, 29].
Genetic predisposition for breast cancer, where a genetic mutation is inherited
from a parent, is correlated to 10-20% of breast cancer cases [10, 30].

The most

commonly inherited mutation predisposing women to breast cancer is of the breast cancer
1 and breast cancer 2, BRCA1 and BRCA2 genes, respectively. Both BRCA1 and
BRCA2 are tumor suppressor genes that normally aid in controlling cell growth and cell
death by preventing cells from growing abnormally [10, 31]. Each person has two
BRCA1 (one on each chromosome #17) and two BRCA2 genes (one on each
chromosome #13); however, when an altered or mutated copy of either the BRCA1 or
BRCA2 gene is present the risk for cancer increases; specifically, an individual with a
BRCA1 or BRCA2 mutation carries a 36-85% lifetime risk for developing breast cancer
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[32]. Genetic testing of women with a family history of breast cancer may reveal one of
the several hundreds of mutations observed in this gene.

A positive test for these

mutations may allow women to actively monitor their breast health in an effort to quickly
find a breast cancer should it arise.
The majority of breast cancers originate in the ducts of the breast (85%), while
others typically originate in the lobules [33]. The progression of breast cell growth from
a normal to cancerous state is a multistep process that does not occur in a defined length
of time. A normal duct of the breast epithelium is composed of epithelial cells (bilayer of
inner luminal epithelial cells for milk production and an outer layer of myoepithelial cells
for milk ejection) along the fully intact basement membrane of the duct [28]. The
progression of breast cancer begins with a hyperproliferation of cells known as
hyperplasia. The epithelial cells still appear normal in structure; however, they begin to
divide uncontrollably resulting in more cells within the duct. The next stage of cancer
progression is known as atypia. At this stage, the epithelial cells begin to look “atypical”
or slightly abnormal upon microscopic examination. This condition is often diagnosed as
benign, however, the patient may still be diagnosed as precancerous, indicating that they
may have a high likelihood of developing cancer later [31, 34]. The next stage of cancer
progression is described as in situ carcinoma. The epithelial cells have grown to an
obviously abnormal appearance. Additionally, they are fast-growing, so much so that
they have begun to form clusters within the lining of the duct. The name for this stage of
growth, in situ, refers to the fact that the cells are still “in place” within the inside of the
ducts in this case. More specifically, this type of cancer is commonly known as ductal
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carcinoma in situ (DCIS) because it is localized to the ducts of the breast. The other
common type of in situ carcinoma is known as lobular carcinoma in situ (LCIS) because
it is localized in the lobules of the breast [31, 33, 34]. The final stage of breast cancer
progression is known as invasive cancer. In this stage, the abnormal cells of the duct,
which were once localized within the duct, have begun to infiltrate or metastasize into the
surrounding normal breast tissue. Degradation of the ductal basement membrane, often
attributed to increased levels of enzymes that degrade the extracellular matrix, allows
cancerous
ancerous cells to travel to other parts of the body via the blood vessels or the lymphatic
vessels [31]. This type of invasive cancer is regarded as very serious because of its
likelihood of spreading to other organs like the liver, lungs, brain and bones
bones.

Figure 1.3: A schematic of breast cancer tumor progression demonstrates cellular
behavior and transformation from a normal breast to the most aggressive disease state.
(Adapted from [31, 34]).
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1.5 Surgical Treatment of Breast Cancer and Breast Reconstruction
The course of treatment recommended for patients with breast cancer will vary
from patient to patient, and depends on several factors, including the stage of the cancer,
whether or not it is benign or malignant, the tumor size, and whether it is in situ or
invasive. For breast cancer patients, there are several courses of treatment available,
including therapeutic options such as chemotherapy, radiation, and hormone therapy,
and/or surgical options, such as lumpectomy and mastectomy. Oftentimes, however, for
many patients the course of treatment will include a combination of one or more surgical
or therapeutic options.
Surgical options for breast cancer treatment include lumpectomies, where only the
affected breast tissue and an immediate surgical margin of tissue are removed (breastconserving), and mastectomies, where the entire area of breast tissue is removed. The
basic lumpectomy procedure is referred to as a partial or segmental lumpectomy.
Additionally, this procedure may include an axillary lymph node dissection, where the
lymph nodes are removed and subsequently evaluated to identify if the specific cancer
has metastasized. A simple or total mastectomy procedure involves removal of the entire
breast, and may sometimes be performed as a preventative measure for women with a
high risk of developing breast cancer. A modified radical mastectomy is a procedure that
involves removal of the entire breast along with the lymph nodes; it is often performed in
the case of large invasive cancers [10, 13, 33-35].
For many patients undergoing surgical treatment for breast cancer, some form of
reconstructive procedure is often sought. Restoration of the natural function of the breast

10

tissue is typically not the primary goal in reconstruction; rather, restoring the aesthetic
function of the breast is largely desired to minimize the anxiety and negative
psychological feelings associated with the disfigurement caused by the large amount of
tissue lost [35-39]. Reconstructive procedures are thus used to restore the symmetry of
the breast by recreating a breast mound that is similar in size, shape, contour, and position
to the opposing breast [40].
In 2008, more than 4.9 million reconstructive procedures were performed in the
United States. Approximately 79,458 of those procedures were breast reconstruction
procedures performed for women [41]. As is the case with the numerous types of breast
cancers and the courses of treatments that vary from patient to patient, there are
numerous reconstruction options that may be used, with no one method ideal for all
patients. For each specific patient, there are several factors that must be taken into
consideration before the ideal reconstruction method is selected. These factors include
the timing of the reconstructive procedure (immediate or delayed post-mastectomy), the
patient’s overall health condition, the patient’s course of cancer treatment, and the
presence of necrotic tissue or scarring resulting from mastectomy procedures [10, 40, 42,
43]. Reconstruction options for breast cancer patients include both acellular and cellular
options, summarized in Table 1.1, all of which have associated disadvantages and
complications.
Acellular options include breast prostheses that may be worn outside the body to
provide the appearance of natural breast tissue when worn beneath clothing. Other
acellular reconstruction options include breast implants and tissue expanders. Oftentimes
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a tissue expander is implanted into the breast area behind the pectoralis muscle of the
chest and later filled or expanded to a sufficient volume that will restore the body’s
symmetry. The expansion process typically occurs over the course of several weeks
using a valve system that was implanted subcutaneously along with the expansion
implant [43]. Breast implants are typically made of a silicone shell, and are often filled
with saline or silicone gel, providing a structure that fills the void area. Patients that wear
some form of prosthetic device outside the body are often limited in their physical
activity due to its movability, and their appearance may seem distorted at times. The
complications associated with the use of breast implants, particularly silicone breast
implants, are largely known.

Breast implants require a subsequent surgery for

implantation, subjecting the patient to further trauma. They have also been shown to
mask the recurrence of breast tumors, and have led to a condition known as capsular
contracture, where the scar tissue capsule that forms around the implant contracts and
results in a hardened breast [37, 38, 40, 44].
Cellular reconstruction methods often consist of the use of autologous tissue flaps
which are taken from the abdomen, back, thigh, or other area of the patient and
transplanted to the effected breast area [37, 38, 40, 42, 44-47]. Removal of a large
portion of tissue, including skin, fat, and musculature, from a site on the body may lead
donor site morbidity and a weakening of its surrounding musculature [3, 38, 48]. The
vascular network of the transplanted tissue is also disturbed, resulting in tissue necrosis
due to lack of sufficient nutrient transport. These procedures are also highly invasive and
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costly for patients. Other cellular options for reconstruction include fat pad or fat tissue
transfers, and collagen injections [3, 49, 50].

Table 1.1: Summary of Breast Reconstruction Methods [45, 47, 48, 51]
Method
Breast Prostheses
Tissue Expanders

Non-Cellular Methods for Breast Reconstruction
Description
External reconstruction method where artificial breast form is worn outside
the body to return the aesthetic function of the breast.
Balloon-like device placed beneath skin immediately following
mastectomy. Commonly followed by saline injections to fill expander.

Implants:
More permanent device, commonly inserted into expanded area after
Silicone Gel removal of tissue expander. Provides a more natural feel compared with
saline.
More permanent device, commonly inserted into expanded area after
Saline
removal of tissue expander. (Salt water).
Cellular Methods for Breast Reconstruction
Method
Description
Collagen Injections
Fat Pads/Fat Tissue
Transfers
Tissue Flaps:

Collagen is injected with a small needle into the desired area (bovine or
autologous collagen).
Harvesting of fat tissue from one area of the body and transferring to the
breast area for use during reconstruction.

Transverse Rectus Abdominis Myocutaneous flap-Oval or elliptical shaped
TRAM patch of skin, fat, and muscle from the abdomen is used to create a new
breast.
Latissimus Dorsi Myocutaneous flap-Flap of skin and muscle removed
LD Flap from the back and transferred to the front of the chest where it is used to
create a new breast or a covering for an implant.
Deep Inferior Epigastric Perforator flap-Skin, fat, and blood vessels
DIEP Flap dissected through the abdominal muscle so that muscle is left intact to
alleviate post-op pain after reconstruction.
Superficial Inferior Epigastric Artery flap-Uses lower abdominal skin and
SIEA fat, without disturbing the muscles or abdominal wall, during
reconstruction.
Superior Gluteal Artery Perforator flap-Skin, fat, and blood vessel flap
S-Gap taken from the gluteus maximus muscle of the buttock, transferred to the
internal mammary vessels, and then shaped into a breast.
Flap taken from the lower buttock that requires the sacrifice of only a
Gluteal Free
small amount of the gluteus maximus muscle.
Flap taken from the thigh of patient and used in primary and secondary
Anterolateral Thigh
breast reconstruction.
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Because the volume of the breast is composed primarily of adipose tissue, adipose
tissue is logically recommended to be used for reconstructing the breasts and to repair
other forms of soft tissue defects [5]. Adipose tissue is found all over the human body,
often in excess amounts that may be obtained through processes such as liposuction, and
transplanted to where the volume is needed. This idea of autologous fat graft
transplantation seems logical in its approach of replacing fat with fat, but the actual use of
this transplantation technique has not been consistently successful in patients [4, 52].
When autologous fat tissue is transplanted from one location to a defect site, or the site
where reconstruction must occur, the primary result is significant resorption of the
transplanted tissue over time, so that 40-60% of the graft volume is lost. One proposed
reason for this resorption is that there is not sufficient revascularization of the tissue once
it is transplanted to its new location [1, 4, 38]. The fat grafts never reach sufficient
vascularity, so blood flow at their center is not adequate for long-term survival of the
tissue, and often leads to tissue resorption [5]. Tissue engineering strategies are thus
being investigated to develop new, alternative methods for breast tissue reconstruction
[53, 54].

1.6 Tissue Engineering for Breast Reconstruction
Tissue engineering methods are being used to develop a wide range of tissues,
including bone, skin, cartilage, vascular, and adipose tissues [55]. Because adipose tissue
provides the most significant portion of the breast’s volume, it is suggested for use as the
cellular basis for tissue engineering strategies used for breast reconstruction and other
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soft tissue defects. The development of tissue engineered adipose tissue would provide
replacement tissue that is similar in texture and shape as autologous breast tissue. With
the numerous complications associated with the currently employed breast reconstruction
methods, the development of tissue engineered adipose tissue would significantly impact
not only the field of breast reconstruction, but the field of plastic surgery in general.
Tissue engineered adipose tissue has the potential to provide reconstruction options that
are natural and autologous, i.e., using the patient’s own healthy cells. Additionally, the
advent of minimally-invasive technologies, enhanced by tissue engineering strategies,
could provide reconstruction options better-suited for breast cancer patients. Minimally
invasive, tissue engineered strategies could effectively reduce post-surgical trauma that
patients would endure from the typically used open procedures required for breast
implant insertion or tissue flap replacements [56].

1.7 Factors Influencing Success of Breast Tissue Engineering
Tissue engineering methods typically involve the use of a cellular source, a
support structure or scaffold to facilitate cellular growth, and specific factors that
promote the growth of the cells of interest. For successful incorporation of a tissue
engineered device into a patient’s body, the implant must respond favorably to the
microenvironment into which it is placed without eliciting a negative cellular response
that could be detrimental to that patient’s health. For this reason, when approaching the
task of developing tissue engineered options for any tissue or organ type, it is essential to
understand the behavior of that specific tissue type and the factors that the implant would
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be subjected to upon implantation. More specifically, when developing strategies for
breast tissue engineering, an understanding of the physical properties of the human breast
and of the normal mammary microenvironment is necessary.

1.8 Influence of the Mechanical Properties of Mammary Tissue
As a soft tissue, the normal mammary gland’s mechanical properties may be
characterized as non-linear, anisotropic, and viscoelastic by nature. By definition, a
material is non-linear when its viscosity exhibits a non-constant response to strain (nonconstant coefficient of viscosity).

Anisotropy refers to a material whose stiffness

depends on the direction of load application; while, viscoelasticity refers to a material
whose stiffness depends on the rate of strain application [9, 57]. Additionally, normal
mammary tissue has been characterized as rubber-like due to its almost incompressible
nature [9, 57, 58]. These characteristics of mammary tissue are dependent on age, water
content, lipid content, temperature, and disease-state of the tissue specimen used for
analysis [9]. The precise makeup of the tissue components, i.e. distribution of ductal
structures within the stromal network, will also influence the specific mechanical
properties of mammary tissue [57, 59].
Further characterization of mammary tissue has included identifying and
quantifying specific mechanical properties of the key tissue components that make up
breast composition. Numerous studies to determine the elastic modulus and the strength
of selected tissues of the breast have been performed, as knowledge of the elastic
properties of breast tissue may be used for modeling of tissue dynamics and for imaging
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of the tissue to detect malignancies [58-61]. Three of the most predominant types of
tissue that make up the mammary gland are skin, glandular tissue, and adipose tissue.
Reports indicate that the elastic modulus of skin is between 200-3000 kPa and its ultimate
tensile strength is approximately 20 MPa [9]. The elastic modulus for normal glandular
tissue has been reported as between 2-66 kPa [60, 62]; while the elastic modulus for
mammary adipose tissue, characterized as white adipose tissue, has been reported as 0.525 kPa [59, 62-66]. Some reports have indicated that normal glandular tissue is 5-50
times stiffer than adipose tissue, which is attributed to the higher lipid and water weight
of the adipose tissue that influences the modulus according to the applied strain rate [9,
67].
When considering the mechanical properties of the mammary gland, it is also
important to account for the diseased state of tissue. In addition to characterization of
normal mammary tissue, researchers have also investigated the mechanical properties of
malignant mammary tissue samples. The mechanical properties of cancerous tissues
have been shown to have an increased stiffness when compared to normal tissue samples;
this has been thought to be an indicator of not only the presence of tumorogenic tissue,
but also an indicator of the cancer stage and level of tumor progression. Evaluation of
fibroadenomas (non-cancerous breast lumps) showed the fibroadenomas to be four times
stiffer than normal tissue, while cancerous tissue was up to seven times stiffer than
normal mammary tissue [58, 61]. Others, however, have reported that the stiffness of
breast cancers may differ in stiffness from surrounding tissues by as much as 90-fold [61,
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68], in which case a significant increase in tissue stiffness would readily signal presence
of non-healthy tissue that should be evaluated.
For breast tissue engineering strategies, it is therefore essential to understand and
consider these physical properties of normal and cancerous mammary tissue, specifically
when selecting materials as cellular support scaffolds.

Scaffolds for adipose tissue

engineering have typically been designed for restoration of tissue volume, as opposed to
the restoration of tissue function. Accordingly, the scaffolds should ideally restore the
aesthetic function of the tissue by imparting a soft, smooth feel closely resembling that of
natural tissue. The rigidity and stiffness of scaffolds used for adipose tissue engineering
is therefore one property that must be considered. Consideration should be given not
only to the aesthetic requirements of a breast reconstruction option, but also to the
specific requirements for culturing cells for use in an autologous option [69-72]. An
ideal scaffold should meet the aesthetic requirements while also providing a surface that
will permit and promote cellular attachment. Preadipocytes, the cells most commonly
used for breast tissue engineering strategies, are anchorage-dependent cells; that is, they
require a relatively stiff surface on which to adhere in order for proliferation and
differentiation to occur [1, 4, 44, 73].

Coupling of these two ideas has proven a

significant undertaking for researchers, as numerous materials with varying physical
properties have been considered for adipose tissue engineering methods useful for breast
reconstruction [2]. Of the implantable materials that are available for use in tissue
engineering, those most widely used are porous biodegradable polymers, which include
poly-L-lactide, polyglycolide, and copolymers of the two [36, 55]. Injectable hydrogels,
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such as alginate, chitosan, etc. appear to have the ideal characteristics for use specifically
in breast tissue regeneration. Studies have been conducted using calcium alginate gels, as
well as hyaluronic acid gels, where the interactions of preadipocytes with the gel material
have been investigated [3, 4, 37].

1.9 Influence of the Mammary Microenvironment
Not only must the mechanical and physical properties of the breast be accounted
for when developing tissue engineering strategies, but the breasts’ normal
microenvironment should be considered. As previously described, the mammary gland
largely consists of glandular tissue embedded within a network of stromal tissue
comprised of adipose tissue and fibrous connective tissue [8, 9, 15, 18, 74]. Epithelial
cells, adipocytes, and fibroblasts are therefore the most prevalent cell types present within
the mammary gland. Accordingly, the interaction between the epithelial cells and the
stromal cells within the normal mammary microenvironment is of significant interest
because the hormonal regulation of cellular processes that occur during mammary gland
development, such as cell differentiation, ductal elongation, and ductal branching
morphogenesis, are dependent on the cooperative interaction of epithelial and stromal
cells of the breast [18, 75-78]. This premise, that the relationship between mammary
epithelial cells and stromal cells significantly impacts mammary development, is widely
accepted and supported by the literature [18, 76, 77, 79].
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Mammary Gland Extracellular Matrix (ECM) and Epithelium
Structurally, the cross-section of the human mammary gland, as shown in Figure
1.4, reveals a bi-layered epithelium consisting of the inner-most luminal epithelial cells
and outer-most myoepithelial cells [76, 77, 80, 81]. The luminal epithelial cells are sotermed because they form the lumen of the mammary gland. Adjacent to the luminal
epithelial cells is a thin layer of myoepithelial cells that comprises the glandular
epithelium. The glandular epithelium lies directly above the basement membrane of the
mammary gland, which is structurally a thin layer of extracellular matrix sheets that
consists primarily of collagen type IV, entactin, perlecan (heparan sulfate proteoglycan),
and laminin [82-84].

The primary functions of the basement membrane are as a

mechanical barrier separating the epithelium from its surrounding stroma and as a support
structure, anchoring the epithelium to its underlying connective tissue. The main
structural component of the fibroblastic connective tissue forming the stroma around the
basement membrane is collagen type I [83, 84].
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Figure 1.34: Structural components of the cross-section of the human mammary gland.
Adapted from references [76, 77, 81, 85]

The stromal cell-epithelial cell relationship within the mammary gland has been
proven to be most important for regulating epithelial cell differentiation and for
modulating ductal morphogenesis in vivo [18, 86, 87]. This point is evidenced by the
need for stromal fibroblasts and/or ECM components, such as collagen, to be present
when culturing epithelial cells for modeling purposes in vitro [25, 79, 81, 83]. Threedimensional (3-D) models of mammary organogenesis and carcinogenesis are widely
used for evaluating normal and cancerous mammary cell behavior in vitro. However, in
order to develop 3-D models that possess organized ductal and acinar structures similar in
morphology to native mammary tissue, it has been shown that epithelial cells must be cocultured with either stromal fibroblasts, or within collagen gels, or within laminin-rich
Matrigel [81-83, 88, 89]. This relationship between the ECM stromal factors and the
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epithelium must be taken into account when developing breast tissue engineering
methods. Many breast tissue engineering strategies are based on the idea of culturing
adipose cells on scaffolds made of some absorbable material that is subsequently
implanted or injected into a previously cancer-stricken patient. It is therefore essential
that the selected materials not emit any by-products that may cause disruption to the
behavior of the native epithelial cells upon implantation. Scaffolds made of collagen, for
example, have been widely used for tissue engineering applications because collagen
degrades enzymatically, and may be processed into a variety of shapes and forms (sheets,
sponges, injectable microspheres, etc.) [6, 44, 71, 90-94]. Because collagen has been
shown to play an important role in the behavior of the mammary epithelium, implanted
collagen-based scaffolds would have to be closely observed for any disruptive signals
that could be delivered to native epithelial cells and cause cancer recurrence or other
immunogenic complications. Researchers using scaffolds made of any other ECM-based
components would similarly need to consider any effect that the ECM scaffolding would
have on surrounding epithelium tissue within the breast [95].

Adipose Tissue Composition
Comparisons of the human mammary gland to the mouse mammary gland are
largely found within the literature, as the mouse mammary gland has been widely used to
understand mammary development and to model developmental processes of the breast
[15, 74, 76, 77, 79]. While many similarities exist between the mouse and the human
mammary gland, these two systems are considered histologically different [15, 74, 95].
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The mouse mammary epithelium is surrounded predominantly by adipose tissue, while
the human mammary epithelium has been shown to be more closely associated with the
fibrous connective tissue of the stroma [15, 74, 96-99]. This has led some researchers to
theorize that the relationship between mammary epithelia and adipose tissue within
humans is not as significant as the epithelial-fibrous stromal relationship, however, the
mere presence of large adipose tissue deposits within the human breast suggest otherwise.
Identified as an endocrine organ capable of secreting hormones and factors proven to
influence epithelial cell behavior, the adipose tissue influence on the mammary
environment cannot be ignored [23, 100-102].
Adipose tissue is a highly specialized connective tissue found in two forms:
brown and white, which function as a heat source for the body and as an energy storage
source within the body, respectively [100]. White adipose tissue is the specific type
found within the mammary gland. The primary cellular component of white adipose
tissue is a collection of lipid-filled cells, adipocytes, held together by collagen fibers.
Other cellular components contained in adipose tissue are stromal-vascular cells
including smooth muscle cells, endothelial cells, fibroblasts, blood cells, and
preadipocytes, which account for one-to two-thirds of adipose tissue composition [37,
103-107]. Autologous fat tissue obtained through liposuction and aspiration procedures
has been considered for breast tissue reconstruction; however this method has been
unsuccessful in restoring tissue volume due to insufficient angiogenesis of the tissue and
the inability of easily-damaged adipocytes to maintain the desired volume in vivo [5, 38,
44, 69]. Preadipocytes, precursor cells committed to the adipocyte lineage are contained
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within the stromal-vascular fraction of enzymatically digested tissue. Preadipocytes are,
however, deemed more advantageous as a cell source than mature adipocytes because
they are easily cultured, easily expanded, and easily obtained. They are capable of both
proliferating to yield larger cell numbers, and of differentiating to form the tissue of
interest [5, 38, 44, 104, 108].
Long thought to be solely an energy storage locale for the body, adipose tissue
has now become recognized as an endocrine or secretory organ within the body.
Adipocytes are capable of secreting many proteins and cytokines (termed adipokines)
that may influence the behavior of other cells within the body [109-111].

Factors

secreted from adipocytes have been categorized by function as influencing ECM
development, cell metabolism, immunological function or other processes within the
body [109]. More specifically, evaluation of the mammary extracellular and intracellular
components of mammary adipose tissue has yielded an extensive listing of proteins found
within in mammary adipose tissue [112]. From this comprehensive list of growth factors
and cytokines, investigators hope to further understand the relationship that exists
between mammary epithelial and adipose cells. With such a large deposit of adipose
tissue within the human breast it seems highly probable that a close paracrine relationship
between mammary epithelial and adipose cells exists [113]. Many sources have listed
factors generally secreted by adipose cells [109].

When considering breast tissue

engineering applications, however, it is necessary to identify factors secreted from
adipocytes that may have some direct influence on epithelial cell behavior. Table 1.2
lists adipocyte-secreted factors that have been proven to influence epithelial cell
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behavior.

Knowledge of these factors and their role in influencing epithelial cell

behavior should be taken into account when developing adipose tissue engineering
strategies, as the inclusion or omission of one or more of these factors could yield
improved breast tissue engineering options. Additionally, knowledge of adipocytesecreted factors that also have exhibited roles in tumor progression, such as matrix
metalloproteinases (MMPs), could yield information regarding mammary tumor
formation [114, 115].
Preadipocytes and adipocytes have commonly been used as the cellular basis for
adipose tissue engineering strategies in breast reconstruction [90, 116].

Additional

attempts toward developing breast tissue engineering strategies have included the use of
mammary epithelial cells co-cultured with adipose cells, since these are two of the most
prevalent cell types present within the breast and it is documented in the literature that
there exists an adipose cell-epithelial cell relationship within the breast [85, 117].

Table 1.2: Adipocyte-Secreted Factors that Influence Epithelial Cell Behavior
Factor

Reference(s)

Estrogen
Glucocorticoids
Insulin-like Growth Factor-1 (IGF-1)
Transforming Growth Factor (TGFβ)
Fibroblast Growth Factor (FGF)
Epidermal Growth Factor (EGF)

[85, 100]
[85, 100, 112]
[96]
[85, 100, 118]
[96, 112]
[85, 112]
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Investigation of the relationship between adipose cells and epithelial cells has led
to the conclusion that adipose cells promote functional differentiation of epithelial cells,
characterized by casein production and milk protein synthesis [119]. Attempts to coculture mammary epithelial cells and adipocytes within a collagen gel yielded cellular
clusters containing structures resembling the ductal structures of the breast [120].
Similarly, co-cultures of preadipocytes with mammary epithelial cells on 3-D silk
scaffolds also resulted in cellular structures appearing to undergo ductal morphogenesis
[102]. Analysis for functionality in these cases was not conducted, so it is not known
whether functional breast tissue was produced or not [102, 120].

For further

development of breast tissue engineering strategies, the use of co-cultures of mammary
epithelial cells and adipose cells seems promising; however, studies further evaluating
that specific relationship are limited. The paucity of research could possibly be attributed
to the difficulties in maintaining mature adipocytes in culture. Due to their buoyant
nature, the lipid-filled cells float in culture so proliferation is limited and cells may not be
readily available. Additionally, breast tissue engineering methods based on co-cultures
of mammary epithelial and adipose cells may not be of greater interest because of the use
of epithelial cells. The majority of breast cancers originate within the ducts of the breast
(85%), often the result of some abnormality of the ductal epithelial cells [33, 85]. The
use of epithelial cells for breast tissue reconstruction options should be carefully
considered as one would not want to introduce altered epithelial cells with the potential to
become cancerous into a former cancer patient. As such, many strategies are therefore
directed toward the use of adipose cells in breast tissue reconstruction.
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Of additional interest to the discussion of adipose tissue influence on the
mammary microenvironment is the role of fatty acids within the breast. Dietary fatty
acids have been identified within deposits of mammary tissue in the body, the
measurement of which has been determined to be useful as a biomarker of dietary fatty
acid intake by individuals [121-126]. Within the literature, it is well-documented that
there is conflicting opinion regarding the influence of dietary fatty acids on the behavior
of breast cancer cells, whereby specific fatty acids have been shown to act as anti-cancer
agents (eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA), while others have
been considered cancer promoting agents (linoleic acid and arachidonic acid) in certain
instances [122, 123, 127-136]. Numerous epidemiological, experimental, and ecological
studies have been conducted to evaluate the relationship between dietary fatty acids and
breast cancer risks [126, 129, 135-142]. Analysis of normal breast tissue samples, i.e.
those that are identified as free of tumorigenic cells, has shown that the fatty acids found
most commonly in the highest concentrations within samples are oleic, palmitic, linoleic,
and stearic acids [133, 143]. In the case of cancerous mammary tissue samples,
investigation of fatty acids contributing to cancer growth or inhibition has led to the
concept that increased levels of linoleic acid and arachidonic acid are associated with
increased risk of breast cancer [127, 128, 133, 144], while increased levels of α-linolenic
acid, EPA, DHA, and conjugated linoleic acid are associated with decreased risk of breast
cancer occurrence [127, 128, 131, 133, 145].

Table 1.3 summarizes, to date, the

influence of investigated fatty acids on breast cancer cell behavior.
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It was shown that preadipocytes supplemented with oleic acid accumulated large
amounts of cytoplasmic lipid fairly rapidly in vitro [146]. Furthermore, the addition of
linoleic acid to the culture medium of preadipocyte cells resulted in significant lipid
accumulation within the cells [147]. The influence that specific fatty acids will have on
epithelial cells of the breast should therefore be considered when developing breast
reconstruction strategies. The release of fatty acids from adipose cells may influence cell
proliferation and other cellular processes within the mammary gland [96, 97]. More
specifically, it has been suggested that extracellular supplementation of adipose cells with
fatty acids [127, 148] could promote and facilitate the lipid filling of those fat cells used
in breast tissue engineering applications [149-151]. One limiting factor to providing
patients with an autologous engineered breast tissue option has been the inability to
maintain a stable volume of adipose tissue long-term. With the inclusion of fatty acids
that will aid in facilitating lipid filling of the cells, it is feasible that this addition will in
turn aid in maintenance of overall implant volume in vivo while promoting increased
adipose cell size through increased lipid accumulation.

It is therefore essential to

understand the role that specific fatty acids possibly play as either breast cancer
promoters or as breast cancer inhibitors—the inclusion of a poorly selected fatty acid
could prove harmful to the overall health of a patient given such an option for breast
reconstruction.
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Table 1.3: Fatty Acid Influence on Breast Cancer Cell Behavior
Fatty Acid
Common Name

Shorthand

Cell/Tissue Type

Influence on Cell
Behavior*

Reference(s)

Inhibit
Inhibit
No Inhibition

[152]

Inhibit

[153]

Inhibit
Inhibit

[154]

Inhibit

[131, 133]

Inhibit
Inhibit

[155-159]

Inhibit
Inhibit

[155]
[127, 157-159]

No Effect
Inhibit
Promote
Promote
Promote

[132]
[132]
[127, 128, 148,
160]
[161]

Promote

[127, 148, 156]

Inhibit
Inhibit

[162]

Inhibit
Inhibit

[132]

Saturated Fatty Acids
Palmitic

16:0

Stearic

18:0

BT474 cells
MDA-MB-361
cells
MCF-7 cells
MDA-MB-435
cells

Monounsaturated Fatty Acids (ω-9)
Oleic

18:1 ,n-9

SK-Br3 cells
BT-474 cells

Polyunsaturated Fatty Acids (ω-3)
α-Linolenic (ALA)

18:3, n-3

Eicosapentaenoic
(EPA)

20:5, n-3

Docosahexaenoic
(DHA)

22:5, n-3

Human mammary
tissue
MDA-MB-231
cells
Human mammary
tissue
MDA-MB-231
cells
Human mammary
tissue

Docosapentaenoic
22:5, n-3
(DPA)
Polyunsaturated Fatty acids (ω-6)

Linoleic

18:2, n-6

Arachidonic

20:4, n-6

γ-Linolenic

18:3, n-6

Conjugated Linoleic
(CLA)

MCF-7 cells
MDA-MB-231
cells
MDA-MB-435
Human mammary
tissue
T47D
Human mammary
tissue
MCF-7 cells
MDA-MB-231
MCF-7 cells
MDA-MB-231
cells

*The influence of each specific fatty acid on cellular behavior was determined to either
“inhibit” tumor cell proliferation and/or metastasis, “promote” tumor cell proliferation;
or have “no effect” on cellular behavior as noted in the cited references.
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1.10 Research Aims
Previous research in our laboratory has been focused toward the development and
optimization of an injectable composite system for breast tissue reconstruction, shown in
Figure 1.5, [163, 164]. The system is comprised of cells seeded on biodegradable beads
of an injectable size; these cellular constructs are then mixed with a degradable hydrogel
delivery medium, resulting in a composite that may be injected into a patient through a
syringe at the defect site. In vitro studies using 3T3-L1 preadipocyte cells cultured on
various surfaces showed that the selection of injectable bead chemistry and topography,
with and without therapeutic components, may be used to influence cellular
differentiation. Preadipocyte cells were cultured in vitro on highly porous gelatin beads
and relatively smooth polylactide beads. Assays to measure lipid production and to
evaluate the genes expressed by the cells revealed that the scaffold material and/or
surface topography did influence cell attachment, lipid production, and gene expression
[165]. Additionally, in vivo studies in a large animal model demonstrated the efficacy of
the composite system.

Implantation of cellular and acellular injectable composite

constructs within a bovine animal model revealed that the selected bead materials were
biocompatible and capable of supporting adipose cell growth [166].
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Figure 1.5: The injectable composite system for breast tissue reconstruction has been
evaluated; however, further improvements on the system are necessary.

While these previous results are promising, there are still aspects of the injectable
composite system that require further investigation to yield a more successful implant
system. More specifically, this work is designed to answer the following questions
regarding the injectable composite system:
1. Is it possible to manipulate isolated adipose cells in vitro to more optimally direct
their differentiation to mature cells?
2. Will the inclusion of fatty acids within our cell cultures promote or maintain the
lipid-filling capabilities of isolated adipose cells in vitro?
3. What influence will fatty acids have on adipose cell-breast cancer cell interactions
in vitro?
To answer these questions, five specific aims, listed in Table 1.4, were outlined.
The following chapters will describe the studies that were performed to address each
specific aim.
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Table 1.4 Research Specific Aims
Specific Aims
Aim 1: Investigate the relationship between mammary epithelial cells and
primary adipose cells in two-dimensional culture
Aim 2: Evaluate adipose cell behavior in three-dimensional cultures with
mammary epithelial cells
Aim 3: Evaluate the influence of exogenous fatty acid on adipose cell
differentiation in two-dimensional in vitro cultures
Aim 4: Evaluate the influence of three-dimensional fatty acid-loaded
substrates on adipose cell differentiation
Aim 5: Evaluate fatty acid influence on adipose cell-breast cancer cell
interactions in vitro
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CHAPTER 2
THE EFFECT OF MAMMARY EPITHELIAL CELL CONDITIONED MEDIA
ON ADIPOSE CELL DIFFERENTIATION IN TWO-DIMENSIONAL (2-D)
CULTURE

2.1 Background
The development of a clinically translatable method of engineering adipose tissue
for breast reconstruction requires investigation of several components. Adipose tissue
engineering strategies have involved the use of preadipocytes and adipocytes to restore
the volume of tissue lost at defect sites. Mature adipocytes in culture are limited in their
proliferative capabilities, and are not readily expanded to high numbers or volume [1-3].
Preadipocytes, which are precursor cells committed to the adipocyte lineage, have also
been suggested for use in adipose tissue engineering. Preadipocytes are deemed more
advantageous as a cell source than mature adipocytes because they are easily cultured,
easily expanded, and easily obtained. They are capable of both proliferating to obtain
larger cell numbers, and of differentiating to form the tissue of interest [4-7].
The process of adipogenesis or the formation of fat is a multi-step process
involving the proliferation and differentiation of preadipocytes. For differentiation of
preadipocyte cell lines to occur, differentiation inducers consisting of insulin,
dexamethasone, and 3-isobutyl-1-myethylxanthine (IBMX) are added to the cultures to
initiate and accelerate the differentiation process [8-14].

The ability to isolate and

culture primary preadipocytes from several species has been demonstrated.
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When

studying differentiation of these cells, the use of primary cells offers several advantages.
Primary preadipocytes can be obtained from adipose deposits in different locations from
a wide variety of animals in order to glean information about the local behavior and
environmental conditions of adipose cells and tissues.
We hypothesize that if the differentiation of these adipose cells could be
controlled in vitro, while maintaining the capacity of the cells to proliferate, researchers
would be able to better dictate how the cells will behave once implanted into the body,
and would be able to produce large volumes of adipose tissue from a small number of
retrieved cells. The interaction of mammary stromal and epithelial cells has been widely
investigated in studies of normal mammary development; the two cell types work
together during processes of ductal expansion and alveolar development. It is therefore
logical that, because these two cell types are found in close proximity in normal tissue, a
co-culture is necessary in order to engineer new tissue for breast reconstruction. That is,
there is likely some signaling or cross-talk that exists between these cell types, such that a
co-culture of the two would prove advantageous. Because most occurrences of breast
cancer originate in the epithelial cells of the breast ducts, it may not be advantageous to
implant epithelial cells simultaneously with adipose cells for breast tissue regeneration.
Rather, exposure of the adipose cells, pre-implantation, to mammary epithelial cells could
provide a stimulus in vitro, which would influence adipose differentiation once
implanted.
Previous studies were conducted to evaluate the effect of mammary epithelial
cells on the differentiation of cells of the adipose lineage. D1 cells, mouse bone marrow
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stromal cells, are mesenchymal cells that are capable of differentiating to bone, cartilage,
and fat cells when cultured in medium with an appropriate stimulus. When cultured with
medium conditioned from MACT (bovine mammary epithelial) cells, the differentiation
of the D1 cells was inhibited, even in the presence of adipogenesis differentiation
inducers.

Additionally, once the cells were cultured in normal medium with

differentiation inducers, the inhibition of differentiation was reversed, and the cells
differentiated as normal [15].
As cells are grown in culture they produce cytokines and other factors that are
expressed in the conditioned media. In the previously described studies, the behavior of
adipose cells, when cultured with conditioned medium from mammary epithelial cell
cultures, was shown to vary depending on the specific type of conditioned medium used
to treat the adipose cells. To better understand the outcome of the conditioned medium
studies, it was necessary to identify any specific factors present in the conditioned
medium that could potentially inhibit or facilitate adipogenesis.
Numerous cytokines, growth factors, and other chemical compounds have been
shown to influence adipogenesis.

One of the most widely produced cytokines is

transforming growth factor-β (TGF-β). TGF-β exists in three isoforms, TGF-β1, TGFβ2, and TGF-β3, which are produced and secreted by many cell types, and thus plays
multiple roles in physiological functions of the body, including immunological and
inflammatory processes, and regulation of cellular differentiation. For example, TGF-β
has been shown to be produced by chondrocytes and osteoblasts, and is a promoter of
chondrogenic differentiation [16]. The role of TGF-β in epithelial cell-mesenchymal cell
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interactions has also been noted; both epithelial and mesenchymal cells produce TGF-β.
Additionally, TGF-β has been shown to play a role in the functional development of
epithelial tissues, such as the lungs, kidneys, and breasts, where TGF-β functions as a key
regulator in ductal growth and formation [17]. Further evaluation of the literature reveals
that TGF-β has been identified as an inhibitor of adipogenesis. Early studies conducted
by Torti and coworkers showed that the addition of either TGF-β1 or TGF-β2 to
differentiated adipose cells resulted in a decrease in adipogenic gene expression and, as a
result, inhibited adipogenesis [18]. The function of TGF-β to inhibit adipogenesis has
also been correlated to decreased levels of PPARγ and C/EBPα, transcription factors that
are known to be critical for adipogenesis [10, 19, 20].
In addition to TGF-β, plasminogen activator inhibitor-1 (PAI-1) has been
identified as a protein produced by adipose tissue that acts in an autocrine manner to
modulate adipogenesis [21].

PAI-1 is a serine protease inhibitor that inhibits

plasminogen activation and fibrinolysis in vivo. PAI-1 is secreted by endothelial cells,
vascular smooth muscle cells, and adipocytes. As a key regulator of fibrinolysis and
thrombus formation, increased levels of PAI-1 have also been associated with increased
risk for cardiovascular diseases and diabetes [22]. Further correlation has also been
drawn to link high levels of PAI-1 in obese mice and humans to insulin resistance; since
insulin is a known modulator of adipogenesis, it is suggested that PAI-1 may also
influence adipocyte differentiation [22-28].

Liang and coworkers showed that

overexpression of PAI-1 inhibited adipogenesis of 3T3-L1 preadipocytes and reduced
PPARγ and C/EBPα transcription factors, while inhibition of PAI-1 promoted
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adipogenesis [21]. PAI-1 has also been associated with TGF-β, as TGF-β has been used
to stimulate PAI-1 production in 3T3-L1 mouse preadipocytes and human adipose tissue
explants [23, 29].
Studies were conducted in order to: 1) determine what effect mammary epithelial
cell conditioned medium would have on primary adipose cells in vitro, 2) determine if the
influence of the conditioned medium on adipogenesis was species-dependent or
independent, and 3) characterize the components of each type of conditioned medium.

2.2 Materials & Methods
Methodologies were first determined to successfully isolate populations of
primary adipose cells from bovine, murine, and human tissue samples. Isolated cells
were then cultured in vitro with specified conditioned media (Table 2.1) to determine the
effects on cell differentiation. Additionally, analyses of specific factors present within
each type of conditioned medium were performed to determine if any similarities could
be identified among the media types and the medium effect on cell behavior. Enzymelinked immunosorbent assays (ELISAs) specific for TGF-β and PAI-1 were conducted to
determine if any measurable quantities of the factors were present within each medium
sample.

Additionally, a protein array was used to identify cytokines specific for

adipocytes and adipokines present in the conditioned media samples. This information
was then used to draw comparisons between the components of each conditioned medium
and the resulting effect of the medium on adipogenic differentiation.
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Table 2.1: Tissue Samples and Cell Lines for Cellular Studies
Species of Fat Tissue Primary
Culture

Complementary Mammary
Epithelial Cell Line

Mouse

NMuMG

Bovine

MACT

Human

MCF10A

Primary Adipose Cell Isolation & Characterization
Cell Isolation
Procurement of human tissue samples for this work was approved by the
Greenville Hospital Systems Institutional Review Board (IRCOR #Pro00002270) and the
Clemson University Institutional Biosafety Committee (#IBC2009-15). Bovine tissue
samples were obtained from cattle at a local slaughterhouse, while murine tissue samples
were obtained from mice at the Clemson University Godley Snell animal research
facility. An enzymatic digestion procedure, detailed in Appendices A, B, and C, was
used to isolate the primary adipose cells from samples of fresh bovine, murine, and
human adipose tissue.

Briefly, following collection of the samples, the tissue was

processed under sterile conditions in a SterilGARD III Advance laminar flow Class II
Biological Safety Cabinet (The Baker Company, Sanford, ME). The tissue samples were
rinsed with sterile transport medium, consisting of Hank’s Balanced Salt Solution (Gibco,
Invitrogen, Carlsbad, CA) supplemented with 1% antibiotic-antimycotic (AA) (Gibco,
Invitrogen, Carlsbad, CA) and 0.2% fungizone (Gibco, Invitrogen, Carlsbad, CA).
Samples were rinsed by pipetting transport medium over the tissue samples twice. Tissue
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samples were then minced by cutting the tissue into small pieces with sterile disposable
scalpels (BD, Franklin Lakes, NJ); the pieces were incubated in a collagenase digestion
solution for 1 hour at 37°C in a rotating water bath (Thermo Scientific Lab-Line,
Waltham, MA) at 100rpm. Following digestion of the tissue, the lysate was filtered using
a 1000-µm nylon mesh (Small Parts Inc., Lexington, KY) placed over a sterilized glass
funnel (Pyrex®, Corning, Corning, NY). The filtrate was centrifuged for 10 minutes at
1000rpm using an Allegra 6R centrifuge (Beckman Coulter, Brea, CA) to separate the
sedimented stromal-vascular cells, consisting primarily of preadipocytes, from the fatty
and aqueous layers of the solution. The resulting preadipocyte cells were seeded in T-25
culture flasks (Corning, Corning, NY) with Dulbecco’s Modified Eagle’s Medium
(DMEM) (Gibco, Invitrogen, Carlsbad, CA) supplemented with 1%

AA, 0.2%

fungizone, 0.4% Insulin-Transferrin-Sodium Selenite (ITS) medium supplement (Sigma,
St. Louis, MO), and 10% fetal bovine serum (FBS) (Mediatech, Herndon, VA). Culture
flasks were incubated at 37°C with 5% CO2. This procedure was used for all tissue
types; however, digestion of the human tissue samples also included a step to lyse red
blood cells contained within the tissue lysate.

Cell Culture
Isolated primary cells were seeded in 12-well culture plates (Corning, Corning,
NY) and grown to confluence. At confluence, an adipogenic differentiation cocktail was
added to the cells to assess differentiation to mature fat cells. The adipogenic cocktail
was prepared by adding 1mL 5mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma, St.
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Louis, MO), 100µL 10mg/mL insulin (Sigma, St. Louis, MO), and 2µL 1mg/mL
dexamethasone (Sigma, St. Louis, MO) to every 10mL of DMEM culture medium. A
volume of 2mL of adipogenic cocktail was added to each well. Cells were cultured with
the adipogenic cocktail for 7 days, after which time cellular differentiation was assessed.

Qualitative Microscopy
Representative cellular morphology for cells isolated from each tissue type was
evaluated. Light microscopic images of cells during culture were captured using an
Axiovert 135 inverted microscope (Zeiss, Thornwood, NY) fitted with a ProgRes™ C10
Plus color digital camera (Jenoptik Optical Systems, Jupiter, FL) and ProgRes Capture
Pro 2.6 imaging software (Jenoptik Optical Systems, Jupiter, FL).

S-100 Staining
The presence of S-100 protein was detected by staining using a Mouse ABC
Staining System kit (Santa Cruz Biotechnology, Santa Cruz, CA). Briefly, the culture
medium was aspirated from the well plates and the cells were rinsed twice with
phosphate buffered saline (PBS; Sigma, St. Louis, MO). The cells were then fixed in
10% Neutral Buffered Formalin (NBF) (Fisher Chemicals, Fair Lawn, NJ) for 1 hour at
room temperature. The NBF was removed from the wells and the cells were rinsed again
with PBS. A volume of 1mL of 1% hydrogen peroxide diluted in PBS was added to each
well for 10 minutes at room temperature. The hydrogen peroxide was aspirated from the
wells and the cells incubated with 1.5% blocking serum for 1 hour at room temperature
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on an orbital shaker. The blocking serum was aspirated from the wells and 200µL of anti
S-100 protein primary antibody (Millipore, Billerica, MA) was added to the wells and
incubated for 30 minutes at room temperature on an orbital shaker. The primary antibody
was removed and samples washed three times with PBS. The secondary antibody,
provided in the kit, was added to the wells and incubated for 30 minutes at room
temperature on an orbital shaker (IKA Works, Wilmington, NC).

The secondary

antibody was removed and samples washed three times with PBS. The AB enzyme
reagent was added to the wells and incubated for 30 minutes at room temperature. The
AB enzyme reagent was removed and the samples washed three times with PBS. Three
drops of peroxidase substrate were added to the wells for 10 minutes at room
temperature.

The excess peroxidase substrate was blotted from the wells and the

presence of S-100 protein, indicated by brown staining within the cells, was imaged using
an inverted microscope and imaging software.

Oil Red O (ORO) Staining
Cell culture medium was aspirated from well plates and the cells were rinsed
twice with sterile PBS. The cells were fixed with 2mL of 10% NBF overnight. An ORO
stock solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in
100mL isopropanol (Fisher Scientific, Fair Lawn, NJ). An ORO working solution was
prepared by mixing 60mL of ORO stock solution with 40mL deionized water and stirring
for 30 minutes. A volume of 500µL of the working solution was added to each well and
incubated for 15 minutes at room temperature. Following incubation, the wells were
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rinsed three times with fresh deionized water. After decanting the excess water, the redstained lipid was imaged using an inverted microscope and imaging software.

Total Triglyceride Measurement
Cell culture medium was aspirated from well plates and the cells rinsed twice
with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL of 1%
Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were
incubated for 30 minutes at room temperature.

Standard glycerol solutions of

concentrations ranging from 0 to 200µM glycerol were prepared by dissolving glycerol
(#G7793, Sigma, St. Louis, MO) in deionized water. Following incubation, the cells
from each well were collected with the Triton X-100 solution into microcentrifuge tubes
(Fisher Scientific, Fair Lawn, NJ) and centrifuged for 10 minutes at 3000rpm. A volume
of 100µL of each sample and standard was pipetted into the wells of a 96-well plate
(Corning, Corning, NY) in triplicate. A volume of 100µL of Infinity™ Triglyceride
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated
for 15 minutes at room temperature. The absorbance was read at 490nm on a microplate
reader (BioTek Instruments, Inc., Winooski, VT).

Statistical Analysis
Statistical analyses of triglyceride data for preliminary characterization were
performed using a paired t-test with significance level of p<0.05 (n=3). Graphical error
bars represent the standard error of the mean.
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Conditioned Media Influence on Adipose Cell Behavior
Conditioned Media Collection
MACT cells (CRL-10274, ATCC, Manassas, VA) were cultured in T-150 flasks
(Corning, Corning, NY) with 15mL of DMEM (ATCC, Manassas, VA) until confluence.
The MACT culture medium consisted of 500mL DMEM supplemented with 10% FBS, 1%
AA, and 0.2% fungizone. MACT conditioned medium (MACT-CM) was collected every 2–
3 days from confluent MACT cells; the medium was stored at 4˚C if designated for use
within the week or -20°C if intended for later use. Immediately before medium changes, the
MACT-CM was warmed to 37˚C and centrifuged at 1000 rpm for 5 minutes to collect
residual cellular debris.
NMuMG cells (CRL-1636, ATCC, Manassas, VA) were cultured in T-150 flasks
with 15mL of DMEM (ATCC, Manassas, VA) until confluence. The NMuMG culture
medium consisted of 500mL of DMEM supplemented with 10% FBS, 2% AA, 0.2%
fungizone, and 0.l% insulin. NMuMG conditioned medium (NMuMG-CM) was collected
every 2–3 days from confluent NMuMG cells; the medium was stored at 4˚C if designated
for use within the week or -20°C if intended for later use. Immediately before medium
changes, the NMuMG-CM was warmed to 37˚C and centrifuged at 1000 rpm for 5 minutes
to collect residual cellular debris.
MCF10A cells (CRL-10317, ATCC, Manassas, VA) were cultured in T-150
flasks with 15mL of Mammary Epithelial Cell Growth Medium (MEGM) (Lonza,
Walkersville, MD) until confluence. The MCF10A culture medium consisted of 500mL
MEGM supplemented with the contents of one MEGM bullet kit consisting of 2mL
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bovine pituitary extract, 0.5mL human epidermal growth factor, 0.5ml hydrocortisone,
0.5mL insulin, and 0.5mL gentamicin. MCF10A conditioned medium (MCF10A-CM)
was collected every 2-3 days from confluent MCF10A cells; the medium was stored at
4˚C if designated for use within the week or -20°C if intended for later use. Immediately
before medium changes, the MCF10A-CM was warmed to 37°C and centrifuged at 1000
rpm for 5 minutes to collect residual cellular debris.

Cell Seeding
Primary bovine, murine, and human adipose cells were isolated from tissue
samples using the enzymatic digestion procedures as described in Appendices A, B, and
C. Each individual cell type was seeded in T-25 culture flasks with 5mL of DMEM
supplemented with AA, fungizone, ITS, and FBS. The cells were grown to confluence,
and the culture medium was changed every 2-3 days. At confluence the cells were
subcultured and grown to confluence in T-150 culture flasks until a sufficient cell number
was obtained.
Bovine, murine, and human adipose cells were seeded individually in 12-well culture
plates at 20% seeding density (7.6x104 cells per well) to evaluate the effect of each type of
conditioned medium on the adipose cell behavior. Only cells of passage four or lower were
used for these studies. Cells were initially cultured with 2mL DMEM per well until 2 days
post-seeding. At that time, the DMEM was removed from the cells and the cells were then
cultured with 2mL of media according to the conditions shown in Figure 2.1.

The

adipogenic differentiation cocktail consisted of the following: per 10mls DMEM, 1ml
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IBMX + 100µl insulin +2µl dexamethasone. The cells were cultured under these conditions
for 14 days, with medium changes every 22-3 days.

Figure 2.1: The control samples for each cell type were cultured with DMEM only or
with an adipogenic differentiation cocktail (AC). The experimental samples for each cell
type were cultured with a specified conditioned media, or with the conditioned media in
combination with the adipogenic cocktail.

Metabolic Activity
Cellular metabolic activity was quantitatively assessed using alamarBlue® Cell
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).

The

alamarBlue® reagent was adde
added
d to each well at 10% of the amount of culture medium in
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each well (200µl added to the 2mL in each well). Well plates were incubated for 3 hours
at 37°C on a shaker plate. Following incubation, 150µl of the reaction solution was
removed from each well of the cell culture plates to corresponding wells of a blackwalled, clear-bottom 96-well microplate (Corning, Corning, NY) to assay the
fluorescence of samples resulting from the reduction of the dye by metabolically active
cells, as visualized by a color change from blue to pink. Samples were assessed using a
Fluoroskan Ascent FL microplate reader (Labsystems, Finland) with fluorescence
excitation wavelength of 544nm and emission wavelength of 590nm.

RNA Isolation
Samples of ribonucleic acid (RNA) were isolated from cells cultured at each
condition. The culture medium was aspirated from the wells of the culture plates and the
cells were rinsed with 1mL of sterile PBS. The RNA was isolated from the samples
using the reagents and instructions supplied in an RNeasy Mini Kit (QIAGEN, Valencia,
CA) (Appendix D). The cell membranes of the cell samples were directly lysed by
adding 600µL of Buffer RLT to the wells of the culture plates. The samples were
incubated at room temperature in the Buffer RLT for 15 minutes. Each sample was then
homogenized by pipetting the lysate onto a QIAshredder spin column inserted into a 2ml
collection tube. The tubes were centrifuged for 2 minutes at 13,000 rpm. Following
centrifugation, 600µL of 70% ethanol was added to the homogenized lysate of each
sample and mixed well. Following transfer of the samples to RNeasy mini columns, the
samples were subjected to a series of wash and centrifugation steps. To elute the RNA
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sample, 50µL of RNase-free water was added to the RNeasy columns and the samples
were centrifuged for 1 minute at 13,000 rpm. The elution step was repeated and the
sample RNA was collected in a 1.5ml collection tube. The final volume of each RNA
sample was 100µL. All samples were stored at -80°C.

Analysis of RNA Concentration and Purity
The concentration and purity of the isolated RNA samples were measured using
the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., San Jose, CA), RNA 6000
Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000 Ladder (Ambion, Inc., Austin,
TX), RNA 6000 Nano LabChip® (Caliper Technologies Corp., Mountain View, CA),
and 2100 Expert Software (Agilent Technologies, Inc.) (Appendix E). Prepared samples
were loaded on the LabChip®, placed in the Bioanalyzer, and analyzed using the
Eukaryote Total RNA Nano program from the 2100 Expert software to determine the
concentration of the RNA sample (reported as ng per mL), the RNA integrity number,
and the 28s:18s ribosomal ratio.

Real Time Quantitative RT-PCR
Three genes were selected to assess the differentiation of the isolated cells.
Primers specific for the following genes were used in the RT-PCR analysis: peroxisome
proliferator activator receptor-gamma (PPAR-γ), adipocyte-specific fatty-acid-binding
protein-2 (aP2), and beta-actin (β-actin). PPAR-γ and aP2 were selected to identify cells
in the early and late stages of adipocyte differentiation; and β-actin was used as the
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housekeeping gene. Primers specific for each species of cells and accession numbers for
the mRNA sequences for each specified gene are listed in Table 2.2. The primer pairs for
each gene were ordered from Integrated DNA Technologies (IDT) (Coralville, Iowa).
Real-time, one step RT-PCR was performed using the Quantifast™ SYBR®
Green RT-PCR kit (Qiagen). RNA samples, primers, and components of the RT-PCR kit
were maintained on ice during the reaction setup. Template RNA samples were diluted
to a working concentration of 10ng/uL and primers were diluted to 25µM. Sample
reactions were prepared according to the table shown in Appendix F. No Template and
Minus-RT control samples were prepared for each set of reactions by adding RN-ase free
water to the reaction tubes instead of template RNA or the RT mix, respectively. All RTPCR reactions were performed using a Rotor-Gene RG-3000 light cycler (Corbett
Research, Sydney, Australia) equipped with Rotor-Gene 6.1 software (Corbett Research).
The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine the
relative expression level for each gene of interest using β-actin as the reference gene.
Calculations were performed using Equations 2.1 through 2.4 shown below.
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Table 2.2 RT-PCR Primers
Bovine
β-actin

Sequence
Fwd: 5’-CTCTTCCAGCCTTCCTTCCT-3’
Rev: 5’-GGGCAGTGATCTCTTTCTGC-3’

Accession No.
NM173979

PPAR-γ

Fwd: 5’-CGCACTGGAATTAGATGACAGC-3’
Rev: 5’-CACAATCTGTCTGAGGTCTGTC-3’

Y12420

aP2

Fwd: 5’-AGGTACCTGGAAACTTGTCT-3’
Rev: 5’-GACAACGTATCCAGCAGAA-3’

X89244

Murine

Sequence
Fwd: 5′-TGGAATCCTGTGGCATCCATGAAAC-3′
Rev: 5′-TAAAACGCAGCTCAGTAACAGTCCG-3’

β-actin

Accession No.
NM007393

PPAR-γ

Fwd: 5′-ACTGCCTATGAGCACTTCAC-3′
Rev: 5′-CAATCGGATGGTTCTTCGGA-3′

NM011146

aP2

Fwd: 5′-GAATTCGATGAAATCACCGCA-3′
Rev: 5′-CTCTTTATTGTGGTCGACTTTCCA-3′

NM024406

Human

Sequence
Fwd: 5′-TGACGGGGTCACCCACACTGTGCCCATCTA-3′
Rev: 5′-CTAGAAGCATTTGCGGTGGACGATGGAGGG-3′

Accession No.

β-actin

PPAR-γ
aP2

NM001101

Fwd: 5′-AGACAACAGACAAATCACCAT-3′
Rev: 5′-CTTCACAGCAAACTCAAACTT-3′

NM015869

Fwd: 5′-TGCAGCTTCCTTCTCACCTTGA-3′
Rev: 5′-TCCTGGCCCAGTATGAAGGAAATC-3′

NM001442

∆Ct(Control) = Ct(Target) – Ct(Reference)

Equation 2.1

∆Ct(Sample) = Ct(Target) – Ct(Reference)

Equation 2.2

∆∆Ct = ∆Ct(Sample) = ∆Ct(Control)

Equation 2.3

Relative Expression = 2-∆∆Ct

Equation 2.4

Where: Control = Control sample condition
Sample = Experimental sample condition
Target = Gene of interest (i.e., aP2 or PPAR-γ)
Reference = Housekeeping gene (i.e., β-actin)
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Statistical Analysis
SAS 9.2 (Cary, NC) statistical software was used to compare the effect of each
conditioned medium on cellular metabolic activity and triglyceride production.
Statistical analyses were performed using a general complete block design with three
replicates per treatment, randomly assigned to each cell type. Follow-up analyses were
conducted using Fisher’s Protected Least Significant Difference (LSD). Observations
with standardized residuals more than two standard deviations from the mean were
excluded from the analysis. A significance level of p<0.05 (n=3) was used for all
comparisons. Graphical error bars represent the standard error of the mean.

Conditioned Media Characterization
Conditioned Media Collection
MACT cells were cultured in T-150 flasks with 15mL of DMEM until confluence.
The MACT culture medium consisted of 500mL DMEM supplemented with 10% FBS, 1%
AA, and 0.2% fungizone. MACT conditioned medium (MACT-CM) was collected from
confluent MACT cells; aliquots of the medium were assayed immediately.
NMuMG cells were cultured in T-150 flasks with 15mL of DMEM until
confluence. The NMuMG culture medium consisted of 500mL DMEM supplemented
with 10% FBS, 2% AA, 0.2% fungizone, and 0.l% insulin.

NMuMG conditioned

medium (NMuMG-CM) was collected from confluent NMuMG cells; aliquots of the
medium were assayed immediately.
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MCF10A cells were cultured in T-150 flasks with 15mL of MEGM until
confluence. The MCF10A culture medium consisted of 500mL MEGM supplemented
with the contents of one MEGM bullet kit consisting of 2mL bovine pituitary extract,
0.5mL human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL
gentamicin.

MCF10A conditioned medium (MCF10A-CM) was collected from

confluent MCF10A cells; aliquots of the medium were assayed immediately.

TGF- β 1 ELISA
The amount of TGF-β1 present within samples of each type of conditioned
medium was determined using a Multispecies TGF-β1 quantitative sandwich ELISA kit
(Invitrogen, Camarillo, CA).

Conditioned medium samples were collected from

confluent cultures of cells and centrifuged for 10 minutes at 1000 x g. A volume of
0.05mL of extraction solution was added to 0.25mL of each sample in microtubes and
incubated for 30 minutes at 4°C.

Reagents and standard solutions were prepared

according to the standard protocol.

A volume of 200µl of standards and extracted

samples were added to wells of the microplate. Biotinylated anti-TGF-β1 solution in the
amount of 50µl was added to each well; the plate was covered and incubated for 3 hours
at room temperature. The solutions were aspirated from the wells and the plate was
rinsed four times with wash buffer. A volume of 100µl of streptavidin-HRP working
solution was added to the wells and then incubated for 30 minutes at room temperature.
Following aspiration of the solution and washing of the plate, 100µl of stabilized
chromogen was added to each well and the plate was incubated for 30 minutes at room
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temperature in the dark. Stop Solution in the amount of 100µl was added to each well
and the absorbance of the samples and standards was read at 450nm on a microplate
reader.

PAI-1 ELISA
The amount of PAI-1 present within samples of each type of conditioned media
was determined using a PAI-1 quantitative sandwich ELISA kit (AssayPro, St. Charles,
MO). Conditioned medium samples were collected from confluent cultures of cells and
centrifuged for 10 minutes at 2000 x g. A volume of 1.5mL of the supernatant was
collected in microtubes for the assay. Reagents and standard solutions were prepared
according to the standard protocol. Standards and samples in the amount of 50µl of were
added to wells of the microplate, pre-coated with a polyclonal antibody specific for PAI1, and incubated for 2 hours at room temperature. The microplate was washed five times
with wash buffer, after which 50µl of Biotinylated PAI-1 Antibody was added to each
well and incubated for 1 hour at room temperature. After washing the microplate with
wash buffer, 50µl of streptavidin-peroxidase conjugate was added to each well and
incubated for 30 minutes at room temperature. The plate was washed with wash buffer
and then 50µl of chromogen substrate was added to each well and incubated for 10
minutes. A volume of 50µl of Stop Solution was added to each well and the absorbance
of samples and standards was read at 450nm on a microplate reader (BioTek Instruments,
Winooski, VT).
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Adipokine Protein Array
Further characterization of the components within each conditioned medium
sample was performed using an Adipokine Antibody Array (Raybiotech, Norcross, GA).
This commercially available kit was used for simultaneous detection of the presence of
multiple adipose-related cytokines, including TGF-β and PAI-1 among others (Figure
2.2). Conditioned medium samples were collected from confluent cultures of cells and
stored at -20°C. To conduct the assay, the samples were thawed at room temperature and
centrifuged for 10 minutes at 2000 x g. A volume of 1.5mL of the supernatant was
collected in microtubes for the assay. Reagents were prepared according to the standard
protocol. Assay membranes provided in the kit were placed into individual wells of an
eight-well tray. A volume of 2mL of 1X Blocking Buffer was added to each well and the
membranes were incubated for 30 minutes at room temperature. Following incubation,
the buffer was removed and 1mL of sample medium was added to the individual wells.
The membranes were then incubated at 4°C overnight. The next day, the sample was
removed from each well and the membranes were washed according to the
manufacturer’s protocol. A volume of 1mL of biotin-conjugated antibodies provided in
the kit were added to each membrane and incubated for 2 hours at room temperature.
After washing each membrane, 2mL of diluted HRP-conjugated streptavidin was added
to each membrane and incubated for 2 hours at room temperature. After washing the
membranes, 500uL of detection buffer was pipetted onto each membrane and incubated
for 2 minutes at room temperature. The excess detection buffer was drained from the
membrane and the signals on the membrane were detected using the chemiluminesence
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filters of a MultiImage™ Light Cabinet (Alpha Innotech Corp., San Leandro, CA). The
relative intensity of the resulting signals was determined and quantified using
AlphaEase® FC FluoroChem™ SP software, version 4 (Alpha Innotech Corp.).

Figure 2.2: Function of the Adipokine Antibody Array (Raybiotech)

Statistical Analysis
Statistical analyses of quantitative data from the ELISA assays were performed
using a paired t-test with significance level of p<0.05 (n=3).
represent the standard error of the mean.
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Graphical error bars

2.3 Results
Primary Adipose Cell Isolation & Characterization
Cell Morphology and S-100 Staining
The representative cell morphology for the isolated bovine, murine, and human
cells was imaged as shown in Figure 2.3 A-C. The bovine, murine, and human cells were
stained for S-100 protein following the initial isolation. As shown in Figure 2.3 D-F, the
bovine, murine, and human cultures all contained cells that stained positively for the S100 protein, suggesting that there are preadipocytes present within the cultures of isolated
cells.

Figure 2.3: Representative cellular morphology (A-C) and staining of S-100 protein (DF) for bovine, murine, and human primary adipose cells.
indicated.
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Total magnification is

Oil Red O Staining
Addition of the adipogenic cocktail confirmed that the isolated adipose cells were
capable of differentiating to mature adipocytes. Samples of bovine, murine, and human
cells were stained with ORO following culture with the adipogenic cocktail for up to 14
days. Control samples of each cell type, grown in DMEM only, without an adipogenic
cocktail, were stained with ORO for comparison. Staining of the control cell samples
reveal a minimal presence of lipid, indicated by limited amounts of red staining within
the bovine, murine, and human cells shown in Figure 2.4 A-C. Staining of cells cultured
with the adipogenic cocktail reveal a larger number of red-stained cells, exhibiting large,
intracellular lipid droplets within the bovine, murine and human cells, as shown in Figure
2.4 D-F. The lipid within the murine and human cells (Figure 2.4 E-F), however,
appeared to be larger in size and more uniformly defined than that detected within the
bovine cells.

Total Triglyceride Content
Measurable quantities of triglyceride were detected within samples of the isolated
bovine, murine, and human cells grown in DMEM culture medium. As shown in Figure 2.5,
measurement of the total triglyceride concentration within the bovine, murine, and human
cells (n=3 per condition), following culture with the adipogenic cocktail, showed that the
triglyceride content within the cells significantly increased (p<0.05) with the addition of the
cocktail, indicating that the cells were actively differentiating in the presence of the
adipogenic cocktail.
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Figure 2.4: Staining of control samples, cultured in DMEM without an adipogenic cocktail
revealed minimal presence of lipid (A-C). ORO staining of intracellular lipid within bovine,
murine, and human adipose cells following culturing with adipogenic cocktail revealed the
presence of large, defined lipid droplets indicating that the cells will differentiate to mature
fat cells with the appropriate stimuli (D-F). Total magnification for all images is 320x.
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Figure 2.5: Measurement of total triglyceride content within cultured cells. The amount
of triglyceride within the bovine, murine, and human cells cultured with the adipogenic
cocktail was significantly higher (p<0.05) than that measured in the respective cells
cultured in the normal DMEM culture medium. Each data point represents the mean
value of n=3 samples per condition. Error bars represent the standard error of the mean.

Conditioned Media Influence on Adipose Cell B
Behavior
Metabolic Activity
As shown in Figure 2.6, for the bovine cells in these studies, treatment of the cells
with MACT-CM,
CM, NMuMG
NMuMG-CM, or MCF10A-CM
CM did not result in any statistical
differences in metabolic activity when compared to the respective condi
conditioned
tioned medium
samples combined with the adipogenic cocktail (i.e., MACT
MACT-CM
CM was not statistically
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different from MACT-CM + AC) (p<0.05). Addition of the MACT-CM medium alone,
without the adipogenic cocktail, resulted in a significant increase in metabolic activity
when compared to the DMEM control sample; however no difference was observed when
the NMuMG-CM or MCF10A-CM samples were compared to the DMEM control.
Comparison of the MACT-CM+AC, NMuMG-CM+AC, and MCF10A-CM+AC samples
to the AC control sample revealed significant differences in metabolic activity for each
conditioned medium.
Also shown in Figure 2.6, treatment of the murine cells with MACT-CM,
NMuMG-CM, or MCF10A-CM did not result in any statistical differences in metabolic
activity when compared to the respective conditioned media samples combined with the
adipogenic cocktail (p<0.05). Addition of the MCF10A-CM medium alone, without the
adipogenic cocktail, resulted in a significant increase in metabolic activity of the murine
cells when compared to the DMEM control; there was no difference when MACT-CM or
NMuMG-CM samples were compared to the DMEM control.

Comparison of the

MACT-CM+AC and MCF10A-CM+AC to the AC control sampled revealed significant
differences in metabolic activity of the murine cells.
Treatment of the human cells with the AC media and the MCF10A-CM revealed
statistically significant decreases in metabolic activity when compared to the respective
medium sample treated with DMEM (i.e., metabolic activity of AC was significantly less
than the DMEM sample, see Figure 2.6) (p<0.05). There was no significant difference in
metabolic activity of human cells treated with MACT-CM, NMuMG-CM, or MCF10ACM when each was compared to the DMEM control sample. There was, however, a
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significant difference between the MACT-CM+AC, NMuMG-CM+AC, and MCF10ACM+AC samples when compared to the AC control.
Final comparison of the metabolic activity, by cell type, was performed using the
samples treated with AC to determine the specific effect of the different types of medium
on each cell type. Treatment of bovine cells with each conditioned medium resulted in
significantly higher metabolic activity when compared to the AC control. There was no
difference in metabolic activity of the bovine cells among the conditioned media treated
samples.

Treatment of murine cells with MACT and MCF10A conditioned media

resulted in significantly higher metabolic activity than the AC control and the NMuMG
samples.

Treatment of human cells with MACT and NMuMG conditioned media

resulted in more metabolically active cells than the control AC samples and the MCF10A
treated samples.
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Bovine Cells

Murine Cells

Human Cells

Comparison by Cell Type

Figure 2.6: Results from alamarBlue® metabolic activity assay showed that the
conditioned media used to culture cells influences the metabolic activity in a speciesspecific manner. Asterisks (*) indicate statistical differences between the specified
conditions. Ampersands (&) indicate statistical differences from all other media used to
treat the bovine cells; “at” (@) and percent (%) symbols denote results that are
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statistically lower than those obtained from the other media used to treat the murine
cells; dollar ($) and pound (#) symbols indicate results that are statistically lower than
those obtained from the other media used to treat the human cells (p<0.05). Each data
point represents the mean value of n=3 samples per condition. Error bars represent the
standard error of the mean.

ORO Staining
Oil Red O staining for intracellular lipid within the bovine adipose cells showed
very little lipid present within cells treated with DMEM only (Figure 2.7A). When the
adipogenic cocktail was added to the bovine cells, differentiation seemed to be induced,
as evidenced by red-stained lipid droplets within the cells (2.7B). Treatment of the
bovine cells with MACT-CM and MACT-CM+AC (2.7C & D) resulted in a large
presence of lipid droplets within the cells samples. Treatment of bovine cells with
NMuMG-CM alone (2.7E) resulted in a smaller amount of lipid than other conditions,
while the NMuMG-CM+AC samples had more red stained lipid, present in small droplets
around the cell nuclei (2.7F). Morphological differences in cell shape were observed in
cells treated with MCF10A-CM and MCF10A-CM+AC (2.7 G & H); however, treatment
of bovine cells with MCF10A-CM and MCF10A-CM+AC yielded red-stained lipid
droplets, indicating that differentiation was occurring.
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Figure 2.7: Oil Red O staining of bovine adipose cells. Total magnification for all
images is 320x.
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Measurement of the absorbance of the extracted Oil Red O solution was used to
quantify the lipid content for the bovine cell samples.

As shown in Figure 2.8, a

significantly larger amount of lipid was measured in the AC sample treated with the
adipogenic control than that measured in the DMEM-only sample; however, the amount
of lipid measured in the AC sample was significantly lower than all other samples treated
with conditioned media in the presence of the adipogenic cocktail (p<0.05).
Additionally, the samples treated with NMuMG-CM+AC had a significantly higher
amount of lipid than the samples cultured with NMuMG-CM only (p<0.05). Treatment
of the bovine cells with MACT-CM+AC resulted in a significantly greater amount of
lipid than all other samples treated with conditioned media in combination with the
adipogenic cocktail (p<0.05).
Oil Red O staining for intracellular lipid within the murine cells showed small
lipid droplets stained within the DMEM control sample (Figure 2.9A). Clearly rounded
and larger diameter lipid droplets were observed when murine cells were treated with the
AC medium (2.9B). Treatment of murine cells with MACT-CM showed dark red-stained
lipid; however, the shape of the lipid was not as uniform as that stained in the control AC
samples, suggesting some alteration in cell behavior (2.9C). When cultured in MACTCM+AC, the resulting lipid within the murine cells was rounded and more distributed
throughout the culture, however, the droplets were smaller in size (2.9D). Staining of
cells treated with NMuMG-CM and NMuMG-CM+AC both showed a similar pattern of
staining, where the brightly stained lipid droplets were smaller in diameter and nonuniform throughout the cultures (2.9 E & F). Murine cell culture with MCF10A-CM
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Figure 2.8: Oil Red O measurements showed that the addition of the adipogenic cocktail
and conditioned media influences the amount of lipid formed within bovine cells.
Asterisks (*) indicate statistical differences between the specified conditions. Pound (#)
and percent (%) symbols denote results that are statistically lower than all other
conditions treated with DMEM and conditioned media or AC and conditioned media,
respectively (p<0.05). “At” (@) symbol denotes results significantly larger than all other
samples treated with AC and conditioned media (p<0.05).

Each data point represents

the mean value of n=3 samples per condition. Error bars represent the standard error of
the mean.
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resulted in small lipid droplets dispersed throughout the sample (2.9G).

MCF10A-

CM+AC culture resulted in small intracellular lipid droplets in size; however, the lipid
appeared more organized around cell nuclei and clearly rounded in shape (2.9H). The
extracted Oil Red O solutions for the murine samples of all treatment conditions were not
available for analysis.
Oil Red O staining of human cells cultured in DMEM showed small red-stained
lipid droplets within the cells (Figure 2.10A). The addition of the adipogenic cocktail to
human cells resulted in differentiation of the cells, as evidenced by the clearly rounded,
brightly stained, uniform intracellular lipid seen within the AC samples (2.10B).
Addition of MACT-CM and MACT-CM+AC to the human cells resulted in a similar
staining pattern. The lipid droplets were smaller in size than those observed in the AC
samples; however, there was a large amount of staining observed (2.10 C & D). Staining
of the human cells treated with NMuMG-CM showed small intracellular lipid droplets
within the cells (2.10E), while NMuMG-CM+AC yielded a larger amount of stained lipid
that appeared more disorganized in appearance (2.10F).

When cultured with the

MCF10A-CM, red stained lipid was observed throughout the culture (2.10G); however,
there was very little staining within the human cells cultured with MCF10A-CM+AC
(2.10H). The extracted Oil Red O solutions for the human samples of all treatment
conditions were not available for analysis.
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Figure 2.9: Oil Red O staining of murine adi
adipose
pose cells. Total magnification for all
images is 320x.
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Figure 2.10: Oil Red O staining of human adipose cells. Total magnification for all
images is 320x.

Total Triglyceride Measurement
As shown in Figure 2.11, treatment of the bovine cells with MACT-CM and
NMuMG-CM in the presence of the adipogenic cocktail resulted in significantly higher
amounts of triglyceride than the respective samples cultured without the adipogenic
cocktail (i.e., cells treated with MACT-CM+AC had significantly higher total triglyceride
than those treated with MACT-CM) (p<0.05). Addition of the MACT-CM media alone,
without the adipogenic cocktail, resulted in a significant increase in triglyceride when
compared to the DMEM control samples; however, no difference was observed when the
results from the NMuMG-CM or MCF10A-CM samples were compared to those from
the DMEM controls. Comparison of the results from MACT-CM+AC and NMuMGCM+AC samples to those from the AC control revealed significant increases in the
amount of triglyceride produced in those bovine cells.
Also shown in Figure 2.11, treatment of murine cells with each type of
conditioned medium in the presence of the adipogenic cocktail resulted in significant
differences in measured triglyceride concentration when compared to their respective
sample cultured without the adipogenic cocktail. Addition of the MACT-CM, NMuMGCM, and MCF10A-CM media alone, without the adipogenic cocktail, resulted in
significant differences when compared to the DMEM control sample; total triglyceride
from the MACT-CM+AC sample was significantly higher than that cultured in DMEM,
while results from the NMuMG-CM+AC and MCF10A-CM+AC groups were both lower
than those of the DMEM group. Comparison of results from the MACT-CM+AC sample
to that from the AC control sample revealed a significant increase in triglyceride
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concentration, while the NMuMG-CM+AC and MCF10A-CM+AC samples were
significantly lower in concentration than the AC control.
For the human cells, as shown in Figure 2.11, treatment of the human cells with
NMuMG-CM+AC resulted in a significantly higher amount of triglyceride when
compared to the NMuMG-CM sample without the adipogenic cocktail. Addition of
MCF10A-CM+AC, however, resulted in a significantly lower amount of triglyceride than
that found in the MCF10A-CM sample. When cultured with MACT-CM and NMuMGCM, there was a significant increase in triglyceride when compared to the DMEM control
sample. Comparison of the NMuMG-CM+AC sample to the AC control revealed a
significant increase in triglyceride, while the MCF10A-CM+AC sample was significantly
lower in concentration than the AC control.
Final comparison of the triglyceride concentrations, by cell type, was performed
using the samples treated with AC to determine the specific effect of the different types
of medium on each cell type. Treatment of the bovine cells with MACT and NMuMG
conditioned media resulted in significantly higher amounts of triglyceride when
compared to the AC control. Type of conditioned medium used to treat the bovine cells
resulted in significant differences in triglyceride concentrations. . Murine cells cultured
in MACT conditioned media had significantly higher amounts of triglyceride than any
other conditioned media samples and the AC control. The murine cells cultured with
NMuMG and MCF10A conditioned media had significantly lower
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Bovine Cells

Murine Cells

Human Cells

Comparison by Cell Type

Figure 2.11: Measurement of total triglyceride content showed that the conditioned
medium used to culture cells influences the triglyceride produced by a specific species of
cells. Asterisks (*) indicate a statistical difference between specified conditions. “At”
(@), pound (#), and percent (%) symbols denote results that are statistically different
than the bovine samples treated with AC. Letters a, b, c, and d denote results that are all
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statistically different from each other. Samples denoted with numbers 1, 2, and 3 are all
statistically different than the human samples treated with AC (p<0.05). Each data point
represents the mean value of n=3 samples per condition. Error bars represent the
standard error of the mean.

amounts of triglyceride than the murine cells treated with MACT conditioned medium
and the adipogenic cocktail. Human cells treated with NMuMG conditioned medium had
significantly higher amounts of triglyceride than those cultured with MACT or MCF10A
conditioned media, or the adipogenic control. Additionally, cells treated with MCF10A
conditioned medium had significantly lower amounts of triglyceride than all other
samples.

Quantitative RT-PCR
As shown in Figure 2.12A, treatment of the bovine adipose cells with MCF10ACM+AC resulted in significantly higher expression of PPAR-γ than treatment of the cells
with MACT-CM alone (p<0.05). Treatment of the bovine cells with MACT-CM only
resulted in significantly higher PPAR-γ expression than that measured in the DMEMonly control sample (p<0.05). There were no other significant differences in PPAR-γ
expression for the bovine cells.
Treatment of the bovine cells with the adipogenic cocktail, i.e. the AC samples,
resulted in significantly higher aP2 expression than the cells treated with MACTCM+AC, as shown in Figure 2.12B (p<0.05). Additionally, the bovine cell samples
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treated with conditioned media without the adipogenic cocktail (MACT-CM, NMuMGCM, and MCF10A-CM samples) expressed significantly lower amounts of aP2 than the
DMEM-only control sample (p<0.05).
As shown in Figure 2.13A, treatment of the murine cells with the adipogenic
cocktail resulted in significantly higher PPAR-γ expression than the DMEM only control
sample (p<0.05). Additionally, treatment with MACT-CM+AC and MCF10A-CM+AC
resulted in significantly higher PPAR-γ expression than that measured in cells treated
with MACT-CM or MCF10A-CM, respectively (p<0.05). Murine cell samples treated
with MACT-CM+AC and NMuMG-CM+AC expressed significantly lower amounts of
PPAR-γ than cells cultured with the AC media alone, or the cells cultured with MCF10ACM+AC (p<0.05).
Treatment of the murine cells with the adipogenic cocktail resulted in
significantly higher expression of aP2 than that measured in the DMEM control sample,
as shown in Figure 2.13B (p<0.05). Treatment of the murine cells with MACT-CM+AC
and MCF10A-CM+AC resulted in significantly higher expression of aP2 than those cells
cultured with MACT-CM and MCF10A-CM only, respectively (p<0.05). The murine
cells treated with NMuMG-CM+AC expressed a significantly lower amount of aP2 than
each of the other samples treated with conditioned media in
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A

B

Figure 2.12: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by bovine adipose
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method.
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).
Percent symbol (%) denotes value statistically different from all other bovine cell
samples treated with DMEM and the indicated conditioned medium. Each data point
represents the mean value of n=3 samples per condition. Error bars represent the
standard error of the mean.
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A

B

Figure 2.13: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by murine adipose
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method.
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).
Percent symbol (%) denotes values statistically different from all other murine cell
samples treated with AC and the indicated conditioned medium.

Each data point

represents the mean value of n=3 samples per condition. Error bars represent the
standard error of the mean.
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A

B

Figure 2.14: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by human adipose
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method.
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).
Percent symbol (%) denotes values statistically different from all other human cell
samples treated with DMEM and the indicated conditioned medium. Pound (#) and “At”
(@) symbols denote values statistically different from all other samples treated with AC
and the specified conditioned medium. Each data point represents the mean value of n=3
samples per condition. Error bars represent the standard error of the mean.
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combination with the adipogenic cocktail (MACT-CM+AC or MCF10A-CM+AC) or
than cells treated with the adipogenic cocktail (AC) alone (p<0.05).
As shown in Figure 2.14A and B, treatment of the human cells with the AC
samples resulted in significantly higher expression of PPAR-γ and aP2 than cells cultured
with DMEM alone (p<0.05). The cells treated with the adipogenic cocktail expressed a
significantly higher amount of aP2 than all other samples treated with conditioned media
in the presence of the adipogenic cocktail (p<0.05). Of the samples cultured with each
conditioned medium only, without the adipogenic cocktail, cells treated with MCF10ACM expressed significantly higher amounts of PPAR-γ and aP2 than the NMuMG-CM
samples, MACT-CM samples, and the DMEM control samples (p<0.05). Additionally,
human cells treated with MCF10A-CM+AC expressed significantly higher amounts of
PPAR-γ than the adipogenic control sample and also the MACT-CM+AC and NMuMGCM+AC samples (p<0.05).

The cells treated with NMuMG-CM+AC expressed

significantly lower amounts of PPAR-γ than the adipogenic control and also the MACTCM+AC and MCF10A-CM+AC samples; however, the NMuMG-CM+AC samples
expressed significantly higher amounts of aP2 than the MACT-CM+AC and MCF10ACM+AC samples (p<0.05).
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Conditioned Media Characterization
TGF- β 1 ELISA
As shown in Figure 2.15, measurement of the concentration of TGF-β1 present
within each sample of conditioned medium indicated increased amounts of TGF-β1 in
MACT-CM and NMuMG-CM when compared to their corresponding base media.
MCF10A base medium had a significantly higher amount of TGF-β1 than any other
sample of base medium (p<0.05), and a greater amount of TGF-β1 than the conditioned
MCF10A medium. The human mammary epithelial cells, MCF10A cells, produced
larger amounts of TGF-β1 than either the bovine or murine cells, MACT or NMuMG,
respectively.

PAI-1 ELISA
Measurement of PAI-1 indicated that there was no detectable quantity of PAI-1 in
any of the samples of base medium (Figure 2.16). Analysis of the conditioned media
samples showed that the bovine and human, MACT and MCF10A cells, respectively,
expressed comparable levels of PAI-1. The murine cells, the NMuMG cells, however,
expressed a significantly lower amount of PAI-1 than either the MACT or MCF10A cells
(p<0.05).
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Figure 2.15: Results of the TGF
TGF- β 1 ELISA indicate increased concentrations of TGF- β
1 for MACT and NMuMG conditioned media samples, while the amount of TGF- β 1 in
MCF10A conditioned medium was lower than that detected in the base medium. Percent
symbol (%) indicates statistical difference when comparing MCF10A TGFTGF β
concentration with that of MACT and NMuMG base medium and of MCF10A-CM
MCF10A
(p<0.05). Each data point represents the mean value of n=3 samples per condition. The
standard error of the mean was sso
o small that error bars are not visible on the graph.
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Figure 2.16: Results of the PAI
PAI-1
1 ELISA indicates a significantly higher amount of PAI-1
PAI
in MACT and MCF10A conditioned media than that present in the NMuMG conditioned
medium (p<0.05). Percent (%) symbol represents a statistically lower amount of PAI-1
PAI
in the NMuMG conditioned media. No measurable quantities of PAI
PAI-1
1 were detected in
any of the base medium samples. Each data point represents the mean value of n=3
samples per condition. The standard error of the mean was so small that error bars are
not visible on the graph.
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Adipokine Protein Array
Evaluation of the adipokine protein array revealed the presence of only one
adipokine within the media samples. For each of the fresh media samples and each of the
conditioned media samples, the same products consistently appeared on each membrane.
Comparison of the membrane image with the array map, as shown in Figure 2.17,
showed that vascular endothelial growth factor (VEGF) was the only factor in these
samples detected by the array. ELISAs for transforming growth factor-beta (TGF-β) and
plasminogen activator inhibitor-1 (PAI-1) indicated the presence of those specific factors
within conditioned media, however, TGF-β and PAI-1 were not detected in samples
assayed with this array. Measurement of the density of the resulting products, using the
imaging software, showed that comparable levels of VEGF were present in each of the
base medium samples. There was no difference in the VEGF density of the MACT base
medium and the MACT conditioned medium. Likewise, there was no difference in the
VEGF density of the NMuMG base medium and the NMuMG conditioned medium.
There was a significantly higher VEGF density measured in the MCF10A conditioned
medium than in the MCF10A base medium (p<0.05).

Additionally, there was no

difference detected in the VEGF density measured among any of the conditioned media
samples.
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Figure 2.17: The resulting image of the adipokine protein arrays showed similar results
indicating that VEGF was the only adipokine detected within the fresh and conditioned
media samples for each species.
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Figure 2.18: Results of the adipokine protein array showed comparable levels of VEGF
in the MACT and NMuMG base media and their respective conditioned media samples.
Asterisk (*) indicates a significantly higher amount of VEGF in the MCF10A-CM sample
than that measured in the MCF10A base medium (p<0.05). Error bars represent the
standard error of the mean.

2.4 Discussion
Primary Adipose Cell Isolation & Characterization
The enzymatic digestion procedure used for isolating primary adipose cells from
fresh bovine, murine, and human tissue samples yielded a population of cells that could
be expanded in vitro and used for cellular studies. Since these cell populations are
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primary, the composition of the cultures will likely include a heterogeneous population
consisting of the cells normally found in the adipose tissue samples; our methods,
however, were successful in isolating populations of the stromal cells, including
preadipocytes, of which we are most interested.

Resulting increases in triglyceride

concentrations within the cells and presence of intracellular lipid within the primary cells
treated with the adipogenic cocktail indicate that isolated cells will differentiate to mature
adipocytes that may be useful for our studies.

Conditioned Media Influence on Adipose Cell Behavior
The relationship between epithelial cells and stromal cells within the breast has
been investigated in order to determine how these cells interact in normal mammary
development. Adipose cells are one of the most populous types of stromal cells present
within the breast, and as such, the relationship between adipose cells and mammary
epithelial cells is of interest. This research is focused on assessing adipose cell behavior
in response to the presence of mammary epithelial cells. More specifically, it is of
interest to identify how adipose cells used for breast tissue engineering applications
behave in the presence of mammary epithelial cells—do the adipose cells differentiate to
mature cells, is adipose cell differentiation be delayed or inhibited, or is there no effect on
the adipose cells?
Cell-specific cytokines and proteins are secreted from cells into their surrounding
culture environment to “condition” the medium. Since conditioned media contain these
cell-specific factors, they are often used in biological experiments to determine cellular
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relationships. It is also widely accepted that adipose tissue is a secretory organ, producing
factors that will influence the behavior of surrounding cells.

This relationship is

particularly observed in the breast; however, it is not known how adipose cell behavior is
affected by factors produced from closely surrounding epithelial cells.

Hirano and

coworkers demonstrated that conditioned medium from mammary tumor cells enhanced
adipogenesis of preadipocyte cells in vitro, indicating that a relationship exists between
cancerous mammary cells and adipose cells [30]. The relationship between normal
mammary epithelial cells and adipose cells, however, has not been widely investigated.
To investigate the relationship between adipose cells and normal mammary
epithelial cells, conditioned media from three types of mammary epithelial cells were
used to treat primary adipose cells isolated from bovine, murine, and human tissue
samples. Three different species of cells were used for this analysis to determine if
similar outcomes were observed from one species to the other, particularly because
murine animal models are often used for mammary studies, and a bovine animal model
has been suggested as a potential large-animal model for mammary studies [31, 32].
Previous studies showed that bovine mammary epithelial cell-conditioned media
inhibited the differentiation of mouse mesenchymal stem cells to adipocytes [15]. In our
studies, it was determined that conditioned media do influence the behavior of primary
adipose cells. Additionally, it was determined that the effect of conditioned media on
adipogenesis depends on the type of conditioned media with which the cells are cultured.
In addition to serving as an indicator of metabolic activity, alamarBlue® is also
deemed an indicator of cell proliferation. Here, the less metabolically active AC control
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samples for each adipose cell type were likely proliferating at a lower level than those
treated with conditioned media, because the AC-treated cells were differentiating at a
higher rate, where proliferation was likely no longer occurring.

Alternatively, the

addition of conditioned media to cell cultures could, in turn, possibly introduce factors
that appear to stimulate metabolic activity. To verify this possibility, analysis of cell
number for each condition would aid in determining whether the increase in metabolic
activity for conditioned media treated samples is attributed to actual cell growth and
proliferation or not.
Adipose differentiation is characterized by biochemical and morphological
changes, whereby preadipocyte cells begin to accumulate intracellular lipid droplets, and
cell shape changes from a fibroblast-like spindle shape to a rounded shape characteristic
of mature adipocytes [4, 10, 33, 34]. The enzymatic digestion procedure to isolate cells
from fresh tissue samples is designed to yield a population of cells consisting primarily of
preadipocytes. As a result, it is not surprising to see red-stained lipid droplets within
cells cultured with DMEM medium, or to detect quantities of triglyceride within those
cells.

With the addition of the adipogenic cocktail, however, it is expected that

differentiation of the cells will be induced, resulting in preadipocyte cell maturation.
Since no significant change in triglyceride content was observed when bovine
cells were cultured with AC as opposed to DMEM, this adipogenic cocktail may not be
the most optimal for this cell type. The role of insulin, dexamethasone, and IBMX in
stimulating adipogenesis was previously noted [11, 14, 35]. It is, however, key to point
out that this adipogenic cocktail was optimized for murine preadipocyte cell lines. For
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bovine cells, adipogenesis can be stimulated using additional media additives, such as
thiazolidinediones (i.e., rosiglitazone and troglitazone that are used to treat diabetes)
which act by binding to PPAR receptors that play key roles in adipogenesis [36, 37]. In
order to minimize the variables associated with this study, the differentiation cocktail was
kept constant for all cell types; however, the adipogenesis of the bovine cells may have
been influenced for this reason.
As preadipocytes progress through the differentiation process to become mature
adipocytes, they not only undergo morphological changes, but also undergo changes at
the genetic level, where genes are expressed at different stages of development. One
gene characteristic of cells of the adipose lineage is peroxisome proliferator activator
receptor (PPAR)-γ, which is expressed early in the differentiation process at low levels
[10, 38-40]. As adipogenesis progresses, the level of PPAR-γ expression increases [10,
39, 41]. PPAR-γ belongs to the family of nuclear hormone receptors and is key in the
induction and maintenance of differentiated adipocytes.

The expression of PPAR-γ

induces growth arrest and initiates adipogenesis in fibroblast cell lines [10, 42]. The
expression of adipocyte-specific fatty-acid-binding protein-2 (aP2) can be detected in
mature adipocytes [43]; this lipid binding protein is expressed when cells accumulate
lipid [12, 38, 41, 44, 45].
RT-PCR was performed to evaluate expression of PPAR-γ and aP2 for the cells
treated with each type of conditioned medium. Expression of PPAR-γ by bovine cells
treated with each medium indicated that the bovine cells are undergoing early
adipogenesis. The relatively low level of aP2 expression by the bovine cells indicates
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that the bovine cells are not in a mature state. This is also apparent when considering the
Oil Red O results, where the bovine cells have visible red-stained lipid, but the lipid
droplets are relatively small (not filling the cell cytoplasm) and not well-defined in shape.
Evaluation of the RT-PCR results for the murine cells indicated that the cells
treated with each type of conditioned media are undergoing adipogenesis, as evidenced
by the increased expression of PPAR-γ and aP2 when compared to the control sample.
The low expression of PPAR-γ and aP2 observed by the cells treated with NMuMG-CM
and NMuMG-CM+AC correlate with the lower level of triglyceride measured within
cells of these conditions when compared to the control samples. Cells treated with
NMuMG-CM may express adipogenic markers, but the differentiation of these murine
cells to mature fat cells appears to be limited in some manner.

Additionally, the

increased expression of PPAR-γ and aP2 observed in cells treated with MCF10ACM+AC suggests that these cells are undergoing adipogenesis and actively maturing. The
lower level of triglyceride and the minimal staining observed within the cells treated with
MCF10A-CM+AC may be a result of the buoyant nature of lipid. Because of its buoyant
nature, the intracellular lipid of these cells may have been lost to the surrounding culture
media by the end of the study and therefore not measured in the triglyceride assay or
stained by Oil Red O.
Human cells treated with the adipogenic cocktail expressed high levels of PPAR-γ
and aP2, indicating that the cells are actively maturing. When the human cells were
treated with MACT-CM+AC, there was no difference in the expression of PPAR-γ,
however, the significantly lower level of aP2 in MACT-CM+AC cells when compared to
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the adipogenic control suggests that the MACT conditioned media may be limiting
differentiation to mature cells. Human cells treated with NMuMG-CM+AC expressed
higher levels of aP2 which coincided with the increased levels of triglyceride measured in
NMuMG-CM+AC treated cells and indicated a positive influence on adipogenesis.
Human cells treated with MCF10A-CM+AC expressed higher levels of PPAR-γ,
suggesting that these cells are actively undergoing adipogenesis, however, the lower
levels of aP2 accompanied with the low level of triglyceride and minimal Oil Red O
staining for the MCF10A-CM+AC treated cells suggests otherwise. These cells may be
of the adipogenic lineage, but they are not actively maturing, suggesting the combination
of MCF10A-CM with the adipogenic cocktail may have a negative effect on
adipogenesis.
Table 2.3 shows a summary of the results from these conditioned media studies.
Based on the triglyceride measurements, the Oil Red O staining, and the gene expression
data, the overall effect of the conditioned media was designated to have “No effect” on
adipogenesis, a “+” (positive) effect on adipogenesis, or a “-“(negative) effect on
adipogenesis.
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Table 2.3: Summary of Conditioned Media Influence on Adipose Cell Behavior
Conditioned Media Source
Fat Cell Type

Bovine Epithelial
Murine Epithelial
Human Epithelial
(MACT)
(NMuMG)
(MCF10A)
No Effect
Bovine
+
+
Murine
+
+
Human
+
When compared to the AC control, conditioned media was shown to:
+ = positively influence adipogenesis
(Increased triglyceride/lipid  Differentiation promoted)
- = negatively influence adipogenesis
(Decreased triglyceride/lipid  Differentiation delayed or inhibited)
No Effect = have no effect on adipogenesis
(Unchanged triglyceride/lipid  Differentiation not affected)

The presence of intracellular lipid was observed within each cell type for each
condition, as shown by Oil Red O staining and triglyceride measurement. There were,
however, differences observed in the quantity of lipid and the lipid shape, distribution,
and uniformity when the cell samples that were treated with different types of
conditioned media were compared. For example, as shown in Table 2.3, treatment of the
human cells with NMuMG-CM seemed to have a positive effect on adipogenesis based
on increased aP2 expression and increased triglyceride levels, while the MACT-CM and
MCF10A-CM seemed to have a negative effect on adipogenesis as reflected by lower
levels of gene expression and triglyceride.
In most instances, similarities in staining patterns and quantity of triglyceride
could be observed, where samples with more stained lipid also had higher quantities of
triglyceride.

This was very apparent for the bovine cells when the triglyceride

measurements were compared to the Oil Red O values.
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The greatest amount of

triglyceride was measured in the bovine cells treated with MACT-CM and MACTCM+AC; likewise, the greatest amount of lipid was measured in the bovine cells treated
with the MACT-CM and MACT-CM+AC, indicating a positive influence on
adipogenesis by the MACT conditioned medium. When the results of the triglyceride
assay and Oil Red O were compared for bovine cells treated with MCF10A conditioned
medium, however, it was noticed that there was no difference in the amount of
triglyceride produced in cells treated with the MCF10A media when compared to the
adipogenic control, but that there was a significant increase in lipid when cells were
treated with MCF10A media as opposed to the adipogenic control.
The variability in the outcome from these studies, however, is obviously a result
of culturing cells from different species with different types of conditioned media. It was
initially expected that, because of the close relationship between adipose and epithelial
cells within the body, the conditioned medium of a species would not negatively affect,
delay or inhibit, the differentiation of adipose cells of the same species (i.e., MACT-CM
from bovine mammary epithelial cells would positively influence bovine adipose cell
differentiation). Adipose cells and epithelial cells work together to affect physiological
development in vivo, however, it was not shown in our studies that the addition of
conditioned media from one species will always positively influence adipogenesis (e.g.
increase triglyceride and lipid).

In fact, culture of murine and human cells with

conditioned mediums from NMuMG and MCF10A cells, respectively, inhibited
adipogenesis. Studies by Calvo and coworkers previously showed that mouse mammary
epithelial cells (NMuMG) produced factors that inhibited adipogenesis of mouse 3T3-L1
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preadipocytes when co-cultured together, an outcome further confirmed by our studies
[16, 46]. Additionally, Calvo and Julianelli showed that other epithelial cell types, not
just mammary epithelial cells, produced factors that inhibited adipogenesis [16]. It is
therefore likely that enhanced adipogenesis is not observed in these conditioned media
studies because not all in vivo factors are present. In addition to adipose and epithelial
cells, fibroblasts and other cells within the breast work simultaneously for normal
physiological processes to occur. Not having each factor present in an in vitro culture
will likely influence the resulting observations, however, there is still useful information
obtained from these studies regarding the adipose-mammary epithelial cell relationship.
In the case of the bovine cells cultured with MACT-CM, there was increased
triglyceride and lipid production within bovine adipose cells. In this instance, it is
conceivable that the addition of MACT-CM from bovine mammary epithelial cells did
enhance or facilitate differentiation of the bovine adipose cells. There was a significantly
larger amount of lipid measured by the ORO solution for the bovine cells cultured with
AC as compared with that for DMEM; however, since there was not a significant
difference in the triglyceride measurement observed between the bovine DMEM and AC
samples, it was concluded that differentiation, with the specific adipogenic cocktail that
was used, did not fully occur. Therefore, the significant increase in lipid and triglyceride
that was observed from the addition of MACT-CM and MACT-CM+AC to the bovine
cells is likely due to positive signaling that the MACT conditioned medium is providing
to the bovine adipose cells, such that adipogenesis occurs even without an appropriate
adipogenic cocktail.
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Conditioned Media Characterization
Results of the TGF-β ELISA indicated that measurable quantities of TGF-β were
present in each type of base medium and the respective conditioned media samples. The
MCF10A base medium had a higher TGF-β concentration than any other base media or
conditioned media samples. As shown in Table 2.4, MACT and NMuMG media are
similar; however, the MCF10A medium is noticeably different. This difference in media
components is likely responsible for the difference seen in TGF-β concentration for each
base medium type. Additionally, the presence of TGF-β in each base medium is likely
attributed to the concentration of serum added to the MACT and NMuMG medium, and
the bovine pituitary extract added to the MCF10A medium.

Table 2.4: Components of each Mammary Epithelial Cell Base Medium
MACT Medium
 Dulbecco’s
Modified Eagle
Medium (DMEM)
(ATCC)
 Fetal bovine serum
 Fungizone
 Antibioticantimycotic

NMuMG Medium







Dulbecco’s
Modified Eagle
Medium (DMEM)
(ATCC)
Fetal bovine serum
Fungizone
Antibioticantimycotic
Insulin

MCF10A Medium







Mammary Epithelial
Growth Medium
(MEGM) (Lonza)
Bovine pituitary
extract
Gentamicin
Human epidermal
growth factor
Hydrocortisone
Insulin

When considering the results of the conditioned media studies, some correlation
with TGF-β concentration may be observed. The MCF10A conditioned medium had a
higher concentration of TGF-β than the MACT and NMuMG conditioned media, and the
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MCF10A medium was shown to have a negative influence on the adipogenic
differentiation of human cells, and no effect on the bovine cells. This outcome supports
previous knowledge of TGF-β as an inhibitor of adipogenesis, as found in the literature
[18-20].

The lower concentrations of TGF-β were found in MACT and NMuMG

conditioned media samples, and no effect or a positive effect on adipose cell
differentiation was observed. These observations suggest a correlation between TGF-β
concentration in the conditioned media samples and adipogenesis, indicating further that
the influence on adipogenesis by conditioned media may not be species dependent, but
dependent on specific factors that are found in a conditioned medium sample.
While it is known that PAI-1 is actively produced by adipose tissue and other
vascular cells, there is also evidence to suggest that PAI-1 may be produced by other cell
types, as quantities of PAI-1 were detected in conditioned medium from bovine
mammary epithelial cells by Heegard and coworkers [47]. Results of the PAI-1 ELISA
showed that there was no measurable quantity of PAI-1 present within any of the base
medium samples. There were, however, quantities of PAI-1 detected within conditioned
media from MACT, NMuMG, and MCF10A cells. This suggests that PAI-1 is only
produced in this instance by the cultured mammary epithelial cells, and is not present
within the serum or any other media additives. There was no difference in the amount of
PAI-1 produced by the MACT and MCF10A cells, however, the influence of MACT and
MCF10A conditioned medium on adipogenesis was not the same.

The MACT

conditioned media has a more positive effect on adipogenesis, resulting in increased
triglyceride and lipid within bovine and murine cells, while the MCF10A conditioned
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media overall had a more negative effect on adipogenesis, resulting in decreased
triglyceride and lipid within murine and human cells. The NMuMG conditioned media
sample had a significantly lower concentration of PAI-1 than the MACT or MCF10A
samples, and overall the NMuMG conditioned medium increased adipogenesis.

As

stated in the literature, increased levels of PAI-1 have been associated with inhibiting
differentiation of adipose cells, while lower levels of PAI-1 have been associated with
enhancing adipogenesis [23, 29]. Contrary to this idea, though, Scroyen and coworkers
have suggested that PAI-1 does not play a functional role in murine adipogenesis [48].
Our results indicate that the exact role of PAI-1 may yet still be unknown, as lower levels
of PAI-1, such as in the NMuMG medium, did enhance adipogenesis, but higher levels of
PAI-1 did not conclusively inhibit adipogenesis.
VEGF, identified by the adipokine antibody array, was likely expressed within
each of the base medium samples and the conditioned medium samples since it is a
common factor found in serum, which was added to the base medium, and also produced
by a number of cell types, including epithelial cells [49, 50]. VEGF is associated with
angiogenesis, or the formation of new blood vessels and also the migration, and
proliferation of endothelial cells, smooth muscle cells, and other cell types. Additionally,
since adipogenesis is closely associated with angiogenesis and VEGF facilitates
angiogenesis, the presence of VEGF within the mammary epithelial cell-conditioned
media could provide an additional stimulus for enhancing adipogenesis in vitro [51, 52].
It is possible that the levels of PAI-1 and TGF-β were not significant at the time
the media samples were assayed, and therefore, not detected by the adipokine array.
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When the conditioned media samples were previously assayed with the ELISAs, the
media samples were collected and immediately assayed. The samples for the protein
array, however, were collected and frozen at -20○C for approximately 4 weeks before
assessing with the protein array. Some degradation of the sample proteins may have
occurred during this time, resulting in this outcome. Additionally, it is very likely that
during the imaging of each array membrane, the images were underexposed, such that
any additional products were not visible in the resulting images. Repeated analysis may
be necessary with increased exposure time to capture higher resolution images to better
view resulting products.

2.5 Conclusions
The results of the S-100 staining, Oil Red O staining, and Total Triglyceride assay
indicate that we are able to successfully isolate a population of primary bovine, murine,
and human adipose cells that are capable of differentiating to mature adipose cells when
cultured with the appropriate stimuli. These methods for cell isolation were used to
obtain cultures of cells used in subsequent cell culture studies for this work.
Our studies of the relationship between mammary epithelial cells and adipose
cells have shown that adipose cell differentiation is influenced by mammary epithelial
cells. The effect of conditioned media from mammary epithelial cells on adipose cells
depends on the source of conditioned medium. In order to definitively determine the
relationship between mammary epithelial cells and adipose cells, it will be necessary to
conduct further analysis. There may be factors expressed by mammary epithelial cells,
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which may not have been produced in significant amounts in the conditioned media
samples, thereby altering the outcome of these results. Direct co-culture studies, placing
both adipose and mammary epithelial cells in the same environment, may need to be
conducted to further prove our conclusions.
The effect that each type of conditioned medium has on adipose cell
differentiation will depend on the specific medium used to culture cells. Adipokines
VEGF, TGF-β, and PAI-1 were expressed in the conditioned media in these studies and
were noted as key to adipogenesis. More definitive studies and further correlation with
the results from conditioned media studies may be used to conclusively identify the effect
of mammary epithelial cell-conditioned media on adipogenesis.
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CHAPTER 3
EVALUATION OF EPITHELIAL CELL CO-CULTURE ON ADIPOSE CELL
DIFFERENTIATION IN THREE-DIMENSIONAL (3-D) CULTURE

3.1 Background
The studies detailed in Chapter 2 described the influence of mammary epithelial
cell conditioned media on primary adipose cell differentiation in two-dimensional (2-D)
culture. It has been widely shown that growing cells in 3-D culture has an influence on
cellular behavior. For successful implementation of our injectable composite system, the
three-dimensional beads must support adipose cell attachment in vitro in order for
proliferation and differentiation to occur. Previous work showed that culturing adipose
cells on injectable sized beads led to increased triglyceride production when compared to
production by cells cultured in 2-D [1, 2]. Additionally, differences in adipogenic genes
expressed by adipose cells were observed when cells were grown in 2-D versus 3-D
culture [3].
Various materials have been used in previous studies to determine how adipose
cells will respond to beads made of those materials. Evaluation of adipose cells cultured
on gelatin, alginate, and polylactide beads showed that adipose cells do not readily attach
to alginate and polylactide beads, resulting in fewer cells covering the beads and
ultimately fewer cells that differentiated to mature cells [1].

Adipose cells readily

attached to the gelatin beads and proliferated to completely cover the surfaces of the
gelatin beads. Finding a bead that would support cellular attachment was important;
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however, in the case of these gelatin beads, the cells became so abundant that they
detached from the surface of the beads with even the slightest disturbance [1]. It is
therefore crucial to evaluate beads made of alternate materials for use in the injectable
composite system.
Chitosan is a natural biomaterial derived from the de-acetylation of chitin (a
copolymer of N-acetyl-glucosamine and N-glucosamine units linked by β(14)
glycosidic bonds [4-6].

Other than cellulose, chitin is the second most abundant

polysaccharide on earth and is typically found in the exoskeleton of crustaceans such as
crabs and shrimp [7-9]. As a natural material, the source of chitin and derivation process
used to obtain chitosan will result in products of varied molecular weight and degree of
deacetylation (DD). Chitosan may range in molecular weight from 300 to more than
1000kDa and have DD values from 30 to 95% [4, 6]. The degradation of chitosan,
therefore, is characterized based on the molecular weight and degree of deacetylation,
where chitosan degradation of chitosan will decrease as the DD increases [7]. Chitosan is
typically insoluble in water or basic pH environments, but is soluble in acidic
environments. Degradation of chitosan in vivo occurs via lysozyme enzymatic activity
and hydrolysis.
Chitosan has been widely investigated for biomedical applications such as wound
healing, anti-microbial treatment of bacteria, and drug delivery [6, 10, 11]. The use of
chitosan for biomedical applications is so extensive because it is readily available, costeffective, biocompatible, biodegradable, and easily processed to form structures of varied
shape and porosity [5, 11, 12]. As a result of these desirable attributes, chitosan has been
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investigated for engineering skin, bone, cartilage, liver, nerve, and vascular tissues [1316].
The use of chitosan for adipose tissue engineering has not been widely
investigated by many researchers; however, great potential for chitosan in adipose tissue
engineering applications exists. Chitosan is easily processed into scaffolds of various
shapes and sizes. Fabrication of injectable chitosan microspheres that would be wellsuited for minimally-invasive applications, such as those where adipose tissue
engineering would be useful, has been reported [16, 17]. Additionally, the ease of
combining growth factors and therapeutics within chitosan, due to its cationic nature,
may potentially produce scaffolds that will facilitate adipose cell attachment and
differentiation to mature fat cells to form new tissue in vivo. To produce a bead that will
more optimally support adipose cell growth, while allowing successful delivery by
injection, we opted to use beads made of a chitosan-gelatin blend.
Adipose cells grown on microcarrier beads for inclusion in an injectable
composite system will encounter mammary epithelial cells upon implantation in vivo. It
is therefore necessary to understand how the adipose cell behavior will be influenced by
growth on 3-D microcarriers in the presence of mammary epithelial cells. This study was
performed to evaluate primary adipose cell behavior when cultured with mammary
epithelial cells in 3-D.
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3.2 Materials & Methods
Solution Preparation
A 1% v/v glacial acetic acid was prepared by mixing 1mL glacial acetic acid
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water. The glacial acetic acid was
filter sterilized using a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning,
Corning, NY). Chitosan (Deacetylation Degree: ≥90%, Acros Organics, Morris Plains,
NJ) and gelatin (Type A from porcine skin; Bloom Number: ~300, Sigma, St. Louis,
MO) powders were autoclaved at 124°C for 25 minutes to sterilize. All other steps in the
bead fabrication process were carried out in a SterilGARD III Advance laminar flow
Class II Biological Safety Cabinet (The Baker Company, Sanford, ME) to maintain
sterility. A 3% w/v chitosan-gelatin solution was prepared by dissolving 3g of chitosan
and 3g of gelatin in 100mL of 1% v/v glacial acetic acid and stirring at low heat until
completely dissolved. A 0.5N solution of sodium hydroxide (NaOH) was prepared by
dissolving 20g NaOH salt (Fisher Chemicals, Fair Lawn, NJ) in 1L of distilled water and
stirring at room temperature. The solution was filter sterilized using the 0.22µm PES
filters.

Bead Preparation & Characterization
The chitosan-gelatin beads were formed using an electrostatic bead generator
(Nisco, Zürich, Switzerland) shown in Figure 3.1. The chitosan-gelatin solution was
drawn into a 20cc syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge
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needle (Becton Dickinson). The syringe was secured in place on top of a syringe pump
(kdScientific, New Hope, PA) that was set to eject the solution at a rate of 15 mL/hour.

Figure 3.1: Electrostatic Bead Generator

The chitosan-gelatin
gelatin solution ejected from the syringe was guided through plastic
tubing attached at the end of the syringe, into a metal needle of th
thee electrostatic bead
generator. The syringe was secured in place on top of a syringe pump (kdScientific, New
Hope, PA) that was set to eject the solution at a rate of 15 mL/hour. The chitosan-gelatin
chitosan
solution was ejected from the syringe and guided through
gh plastic tubing attached to the
end of the syringe, into a metal needle of the electrostatic bead generator. The needle
was placed so that the point of ejection was approximately 4cm above the surface of the
NaOH solution below. The NaOH was pipette in
into
to a glass 80 x 40mm dish (Pyrex®,
Corning, Corning, NY) until just overflowing(>180mL)
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into a 100 x 20mm glass

collection dish (Pyrex) beneath. The NaOH was continuously stirred at an agitation rate
of 25%. The applied voltage potential was set at 6.5kV to obtain beads. The fabricated
beads were collected in the 80 x40 cm dish and stirred for an additional 30 minutes post
formation in the NaOH solution at the same agitation rate. The NaOH was drained from
the beads and the resulting beads were washed three times with sterile phosphate buffered
saline (PBS). The beads were placed in sterile Dulbecco’s Modified Eagle Medium
(DMEM) (Gibco, Invitrogen, Carlsbad, CA) until cell seeding in well plates.
To evaluate the morphology of the prepared scaffolds, images of each type were
captured using an EMZ-TR stereomicroscope (Meiji Techno, Tokyo, Japan) with a
Lumina light source (Chiu Technical Corporation, Kings Park, NY) and a SPOT
INSIGHT Color digital camera (Diagnostic Instruments, Sterling Heights, MI).

Gel Permeation Chromatography (GPC)
Samples of chitosan and gelatin were characterized using GPC to determine an
approximate range of the weight average molecular weight (Mw) for the materials. In
order to determine the effects of autoclave sterilization of the powders, samples of the asreceived powders and post-sterilization powders were evaluated.

The GPC system

consisted of a Waters 1525 Binary HPLC Pump, a Waters Ultrahydrogel™ 250 HPLC
column, a Waters 2707 Autosampler, a Waters 2414 refractive index detector, and the
Waters Breeze 2 software package (Waters, Milford, MA).
Deionized water (Millipore, Billerica, MA) was degassed by stirring under house
vacuum overnight. The degassed water was used to prepare the mobile phase solution
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consisting of 0.20M sodium acetate (Sigma) in 0.33M glacial acetic acid (Fisher). The
mobile phase was then filtered before use with the 0.22µm PES filters (Corning). Fluka
ReadyCal poly(ethylene glycol) and poly(ethylene oxide) standards of Mw 232-932,000
Sigma) were used to calibrate the system and to form a standard curve for subsequent
calculations. Standards were prepared by dissolving the powder in mobile phase for a
concentration of 1.5g/L. The chitosan and gelatin samples were dissolved in mobile
phase for a concentration of 2mg/mL. The dissolved samples were filtered through
Acrodisc® 0.2µm nylon filters (Pall Life Sciences, Port Washington, NY) directly into
sample vials. A volume of 50µL was injected for each sample and standard. The flow
rate was maintained at 0.7mL/minute and the run temperature was 25°C. Samples and
standards were both injected twice.

Atomic Force Microscopy (AFM)
Since the beads for the injectable composite system will be enclosed within a
surrounding hydrogel matrix, the properties of the matrix-bead system were characterized
using atomic force microscopy (AFM). Samples were constructed for evaluation, as
shown in Figure 3.2A, and the stiffness of plain collagen-agarose gels was determined.
Additionally, the gel stiffness was evaluated to determine how the inclusion of beads
influenced the gel properties.
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A

B
Figure 3.2: Collagen-Agarose Samples (A) and Silicone Molds for Casting CollagenAgarose Gels (B)

A volume of 1mL of collagen-agarose solution was prepared by mixing 450µL of
3mg/mL PureCol® Purified Bovine Collagen (Advanced Biomatrix, San Diego, CA) with
450µL of 1% agarose solution (Type VII-A, Sigma, St. Louis, MO) and 100µL of
collagen reconstitution buffer. The collagen reconstitution buffer consisted of 0.22g
sodium bicarbonate (Fisher, Fair Lawn, NJ) and 0.48g HEPES (Fisher) in 10mL
deionized water (Millipore, Billerica, MA). The collagen-agarose gels were formed by
placing two high-density silicone sheets (thickness per sheet = 1mm) with circular molds,
as shown in Figure 3.2B, on top of each other. The silicone sheets were placed on top of
a polystyrene slide and the collagen-agarose gel solution was distributed evenly to each
circular mold. The gel-bead sample had an individual chitosan-gelatin bead placed into
the center of the circular mold such that the gel completely surrounded the bead. The
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slide was then incubated for 10 minutes at 4○C to gel the solution to. The elastic modulus
was tested immediately using AFM.
An MFD-3D-BIO™ atomic force microscope (Asylum Research, Santa Barbara,
CA) and borosilicate AFM tips of radius 2.5µm and spring constant 0.093N/m were used.
During testing, the AFM tip approached the gel surface at a speed of 5µm/second and the
contact force was measured until an indentation depth of 10µm. Each gel was tested at
three random points in the central area of the gel, and measured three times. The gel
sample containing the chitosan-gelatin bead was tested at the interface of the gel and
bead. The gel elastic modulus was estimated by fitting a Hertz model to indentation
depths from 800 to 1000nm as shown in Equation 3.1 [18, 19].


Where:





/ /



Equation 3.1

F = Measured Force
υ = Poisson’s Ratio (0.5 for hydrogel)
δ = Indentation Depth
R = AFM Tip Radius

Cell Isolation and Culture
Human tissue samples were obtained from Greenville Hospital System and
digested according to the protocol detailed in Appendix A. The isolated primary cells
were seeded in T-25 culture flasks (Corning, Corning, NY) with DMEM supplemented
with 1% antibiotic/antimycotic (AA) (Gibco) 0.2% fungizone (Gibco), 0.4% InsulinTransferrin-Sodium Selenite (ITS) media supplement (Sigma), and 10% fetal bovine
serum (FBS) (Mediatech, Herndon, VA). Culture flasks were incubated at 37°C with 5%
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CO2. Cells were grown to confluence and then passaged to larger flasks until a sufficient
number was obtained to seed on beads.
MCF10A cells (ATCC, Manassas, VA) were cultured in T-150 flasks with 15mL
of Mammary Epithelial Cell Growth Medium (MEGM) (Lonza, Walkersville, MD) until
confluence. The MCF10A culture medium consisted of 500mL MEGM supplemented
with the contents of one MEGM bullet kit including 2mL bovine pituitary extract, 0.5mL
human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL
gentamicin. MCF10A conditioned medium (MCF10A-CM) was collected every 2-3 days
from confluent MCF10A cells; the medium was stored at 4˚C if used within the week or
at -20°C if intended for later use. Immediately before medium changes, the MCF10ACM was warmed to 37°C and centrifuged at 1000 rpm for 5 minutes to collect residual
cellular debris.
Cell Seeding
Cells for this co-culture study were seeded according to the conditions shown in
Table 3.1.

To determine the effect of culturing the adipose cells on beads in 3-D,

control samples were also cultured in well plates with either MCF10A cells seeded on
transwell inserts, as shown in Figure 3.3 or with MCF10A conditioned media. Cell
seeding for this study was completed in two stages for the initiation of the co-culturing
system. The timeline for cell seeding is shown below in Figure 3.4.
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Table 3.1: Co-Culturing
ulturing Conditions for Cell Seeding
Condition

Description

AC

Cells cultured either in 2-D or 3-D
D with the
adipogenic cocktail only
Cells cultured either in 2-D or 3-D
D with MCF10A
cells seeded on transwell inserts
Cells cultured either in 2-D or 3-D
D with MCF10A
conditioned medium

AC + MCF10A-Cell
AC + MCF10A-CM

Co-Culturing Study
Figure 3.3:: Transwell Inserts for Co

Figure 3.4 Study Timeline
A volume of 0.6mL of chitosan
chitosan-gelatin
gelatin beads were placed into individual wells of
24-well Ultra-low
low Binding plates (Corning, Corning, NY)). Primary human adipose cells
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of passage 3 were seeded into each well containing beads, with 2.5x105 cells added to
each well. Additionally, the same number of cells was seeded in 24-well tissue culture
plates (Corning) to prepare the 2-D samples.

Cells were maintained in DMEM at

standard culturing conditions of 37°C and 5% CO2 on an orbital shaker at 50rpm (IKA®
Works, Wilimington, NC). After two days of culture, upon medium change, cells were
cultured with an adipogenic differentiation cocktail. The adipogenic cocktail consisted of
100µl insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St. Louis, MO), and
1mL IBMX (Sigma, St. Louis, MO) per 10mL of DMEM medium. Also at Day 2,
2.0x104 MCF10A cells, of passage 7, were seeded onto the surfaces of the transwell
insert membranes (0.4µm) (Corning) that were maintained in a separate set of well plates.
MCF10A cells were maintained in MEGM at standard culturing conditions. At Day 5,
the inserts containing MCF10A cells were transferred to the well plates containing the
adipose cells on beads and the adipose cells in 2-D. Additionally, at Day 5, MCF10ACM was added to the specified wells. Cells were then evaluated at Day 12 to determine
the influence of culturing the adipose cells with mammary epithelial cells in vitro.

Live/Dead Cell Viability Staining
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was
used to qualitatively assess cellular attachment to the beads and to assess cellular viability
after culturing on the beads in vitro. The LIVE/DEAD® working solution, consisting of
10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM, was prepared
in a sterile 15mL centrifuge tube according to the manufacturer’s instructions. Culture
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medium was aspirated and beads were rinsed with 1mL of sterile PBS. The PBS was
aspirated from the scaffolds and 1mL of the working LIVE/DEAD® solution was added
to each well of the plate containing beads. The plate was allowed to incubate for 45
minutes at room temperature and protected from light. Following the incubation period,
images of the contents of each well were captured using the Axiovert 135 fluorescence
inverted microscope (Zeiss, Thornwood, NY), with color digital camera and imaging
software. The wells were evaluated for green and red fluorescence caused by the activity
of the calcein AM and EthD-1, respectively, present in the working solutions. Esterase
present in live cells cleaves the calcein AM, resulting in a green fluorescence, while the
red fluorescence occurs when EthD-1 enters a dead cell.

Metabolic Activity
Cellular metabolic activity was quantitatively assessed using alamarBlue® Cell
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).

The

alamarBlue® reagent was added to each well at 10% of the amount of culture medium in
each well. Well plates were incubated for three hours at 37°C on a shaker plate (IKA®
Works, Wilmington, NC). Following incubation, 150µl of the reaction solution was
transferred from the cell culture plates to wells of a black-walled, clear-bottom 96-well
microplate to assay the fluorescence of samples resulting from the reduction of the dye by
metabolically active cells to produce a color change from blue to pink. The absorbance
was read using a Biotek Synergy MX Multi-Mode Microplate Reader (Biotek
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Instruments, Winooski, VT) at wavelengths of 570nm and 600nm. The percent reduction
of alamarBlue® was calculated using Equation 3.2 shown below.

%  

Where:



!"

 !

!"

 100%

Equation 3.2

A1 = absorbance of experimental well at 570nm
A2 = absorbance of experimental well at 600nm
N1 = absorbance of negative control (medium plus alamarBlue® reagent
without cells) at 570nm
N2 = absorbance of negative control (medium plus alamarBlue® reagent
without cells) at 600nm

PicoGreen® DNA Assay
The deoxyribonucleic acid (DNA) concentration of cells cultured on the beads
and in 2-D was determined using the Quant-iT™ PicoGreen® dsDNA assay kit (P7589,
Invitrogen, Molecular Probes, Carlsbad, CA). At Day 12, culture medium was aspirated
from the well plates and cells were rinsed with sterile PBS. A 1X TE Buffer (10mM
Tris-HCl, 1mM EDTA, pH 7.5) was prepared from the 20X stock solution provided in
the kit. A volume of 1mL of the 1X TE buffer was added to each well of the plate. The
plates were frozen and thawed three times to lyse the cells. A pipet tip was used to
scrape the cells in each well.

An aqueous working solution of the Quant-iT™

PicoGreen® reagent was prepared by making a 1:200 dilution of the concentrated
solution with 1X TE buffer. A 2µg/mL stock solution of dsDNA in 1X TE buffer was
prepared and further diluted to prepare DNA standards, ranging from 0 to 1000ng/mL,
that were used to generate a standard curve. A volume of 100µL of each sample and
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standard was pipetted to wells of a black-walled 96-well plate. Working solution in the
amount of 100µL was pipetted to each well and the plate was incubated for 5 minutes in
the dark at room temperature. The fluorescence was read using a Flouroskan Ascent®
FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm excitation and 520nm
emission wavelengths.

Oil Red O Staining (ORO)
Cell culture medium was aspirated from well plates and the cells and beads were
rinsed twice with sterile PBS The cells were fixed with 2mL 10% Neutral Buffered
Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight. An ORO stock solution was
prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) to 100mL isopropanol
(Fisher Chemicals, Fair Lawn, NJ)). An ORO working solution was prepared by mixing
60mL of ORO stock solution with 40mL deionized water and stirring for 30 minutes. A
volume of 500µL of the working solution was added to each well and incubated for 15
minutes at room temperature. Following incubation, the wells were rinsed three times
with fresh deionized water. After decanting excess water, the red-stained lipid was
imaged using an inverted microscope and imaging software. After imaging, 500µL of
isopropanol was added to each sample well and incubated for 20 minutes to extract the
stain. The extraction solution was collected into microcentrifuge tubes (Fisher Scientific,
Fair Lawn, NJ) and 100µL of each sample was pipetted to the wells of a 96-well plate
(Corning, Corning, NY). The absorbance of the samples was read at 530nm.
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Total Triglyceride Measurement
Cell culture medium was aspirated from well plates and the cells and beads were
rinsed twice with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL
of 1% Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were
incubated for 30 minutes at room temperature.

Standard glycerol solutions of

concentrations ranging from 0 to 200µM glycerol were prepared by dissolving glycerol
(Sigma, St. Louis, MO) in deionized water. Following incubation, the cells from each
well were collected with the Triton X-100 solution into microcentrifuge tubes and
centrifuged for 10 minutes at 3000rpm. A volume of 100µL of each sample and standard
were pipette into the wells of a 96-well plate in triplicate. A volume of 100µL of
Infinity™ Triglyceride Reagent (Thermo Fisher Scientific, Waltham, MA) was added to
each well and incubated for 15 minutes at room temperature. The absorbance was read at
490nm on a Biotek Synergy MX Multi-Mode Microplate Reader (Biotek Instruments,
Winooski, VT).

Real-Time RT-PCR
Samples of ribonucleic acid (RNA) were isolated from the adipose cells cultured
at each condition. The culture medium was aspirated from the wells of the culture plates
and the cells and beads were rinsed with 1mL of sterile PBS. The RNA was isolated
from the samples using the reagents and instructions supplied in an RNeasy Mini Kit
(QIAGEN, Valencia, CA) (Appendix D). The concentration and purity of the isolated
RNA samples was measured using the Agilent 2100 Bioanalyzer (Agilent Technologies,
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Inc., San Jose, CA), RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000
Ladder (Ambion, Inc., Austin, TX), RNA 6000 Nano LabChip® (Caliper Technologies
Corp., Mountain View, CA), and 2100 Expert Software (Agilent Technologies, Inc.)
(Appendix E). PPAR-γ and aP2 were selected to identify cells in the early and late stages
of adipocyte differentiation; β-actin was selected as the housekeeping gene. Primers
specific for the human genes and accession numbers for the mRNA sequences for each
specified gene were listed in Table 2.2. Real-time, one step RT-PCR was performed
using the Quantifast™ SYBR® Green RT-PCR kit (Qiagen) with conditions as shown in
Appendix F. The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine
the relative expression level for each gene of interest using β-actin as the reference gene.

Statistical Analysis
Statistical analyses were performed using SAS 9.2 software (Cary, NC) to
compare the effect of each culture medium on cell behavior. The Least Squares Means
(LSMEANS) was used with a significance level of p < 0.05 (n=3). Graphical error bars
represent the standard error of the mean.

3.3 Results
Gel Permeation Chromatography
An estimated molecular weight range was determined for the as-received chitosan
and gelatin powders, using the standard curve generated from the retention times for each
molecular weight standard.

The estimated range for the as-received chitosan was
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253,000 to 341,393Da, while the sterilized chitosan was 256,946 to 310,672Da. The asreceived gelatin was estimated to be 262,269 to 343,859Da and the sterilized gelatin was
262,571 to 343,499Da. There was no significant difference measured between molecular
weights of the as-received and sterilized samples.

Table 3.2: Estimated Mw Range of Chitosan and Gelatin Samples
Sample

Estimated Mw Range (Da)

As-Received Chitosan

253,060 - 341,393

Sterilized Chitosan

256,946 - 310,672

As-Received Gelatin

262,269 – 343,859

Sterilized Gelatin

262,571 – 343,499

Atomic Force Microscopy
After applying the Hertz model equation to the resulting AFM data, the estimated
elastic modulus, as shown in Table 3.3, for the plain collagen-agarose gel was determined
to be 22.71±1.76 kPa. The addition of the chitosan-gelatin bead to the gel resulted in a
significant increase in the gel stiffness to 33.93±3.7 kPa (p<0.05).

Table 3.3: Estimated Elastic Modulus
Sample

Estimated Elastic Modulus
(kPA)

Gel

22.71 ± 1.76

Gel Containing ChitosanGelatin Bead

33.93 ± 3.7 *

* Indicates statistically different value (p<0.05)
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Live/Dead Cell Viability Staining
Qualitative assessment of cell viability showed a similarly minimal number of
live cells attached to beads for each cell condition, as shown in Figure 3.5. Dead cells
were not apparent.

Figure 3.5: Live/Dead staining at Day 12 showed minimal number of live cells attached
to the surface of beads for each cell condition. Total magnification for each image is
25x.
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Metabolic Activity
The results of the alamarBlue® assay for metabolic activity are shown in Figure
3.6. Results of the alamarBlue® assay indicate that the most metabolically active cells
were the samples cultured with the adipogenic cocktail in 2-D. The cells cultured with
the adipogenic cocktail and with MCF10A-CM were significantly more metabolically
active than the adipose cells cultured on beads with the adipogenic cocktail and
MCF10A-CM (p<0.05). The addition of conditioned medium to the cells in 2-D and the
adipose cells on beads resulted in significantly lower metabolic activity than cells
cultured with the adipogenic control and the cells co-cultured with the MCF10A cells in
transwell inserts (p<0.05).

PicoGreen® DNA Assay
The DNA concentration within each sample of adipose cells was quantified using
PicoGreen® DNA assay, as shown in Figure 3.7. The amount of DNA measured in each
2-D sample was significantly higher than the respective condition cultured on beads
(p<0.05). Additionally, the MCF10A-CM sample in 2-D had a significantly higher DNA
concentration than the adipogenic control and the cells cultured with MCF10A-Cell in 2D (p<0.05).
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Figure 3.6: Results of alamarBlue® assay indicate that cells cultured in 2-D were more
metabolically active than the adipose cells cultured on beads (p<0.05). Asterisks (*)
denote significantly different values. Pound (#) and percent symbol indicate samples
with metabolic activity statistically different from the other conditions in 2-D and on
beads, respectively. Graphical error bars represent the standard error of the mean.
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Figure 3.7: Results of the PicoGreen® assay showed that the cells cultured in 2-D had a
significantly higher DNA concentration than samples cultured on beads for any condition
(p<0.05).

Asterisks (*) indicate statistically different values.

Percent symbol (%)

indicates value statistically higher than the AC and MCF10A-Cell samples in 2-D.
Graphical error bars represent the standard error of the mean.

Oil Red O Staining
Oil Red O staining of human adipose cells cultured for each condition in 2-D
revealed intracellular lipid within the cells. As shown in Figure 3.8A, clearly rounded
lipid droplets of increased size were present within the cells treated with the adipogenic
control in 2-D.

Lipid droplets in the 2-D cells co-cultured with MCF10A cells were
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smaller in size and more undefined than those in the 2-D AC samples (Figure 3.8C).
Additionally, the cells in 2-D cultured with MCF10A conditioned medium

Figure 3.8: Oil Red O staining of human adipose cells cultured in 2-D and on chitosangelatin beads. Total magnification for 2-D images is 320x, and for bead images is 200x.
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Figure 3.9: Measurement of the absorbance of the Oil Red O extraction solution showed
significantly higher amounts of lipid in the human adipose cells cultured in 2-D than the
cells cultured on beads for each condition, indicated by asterisks (*) (p<0.05). Percent
(%) symbol indicates a significantly lower value than the other conditions at 2-D.
Graphical error bars represent the standard error of the mean.

had lipid droplets dispersed throughout the sample; however, the droplets were small and
immature (Figure 3.8E). Human adipose cells seeded on chitosan-gelatin beads at each
condition were stained with Oil Red O; however, there were little to no visible lipid
droplets present on the beads at any condition (Figure 3.8B, 3.8D, and 3.8F).
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Absorbance measurements of the Oil Red O extraction solution, as shown in
Figure 3.9, indicated significantly higher amounts of lipid for all samples in 2-D culture
than for their respective samples cultured on beads (p<0.05). The extraction solution
values for the 2-D adipogenic cocktail sample were, however, significantly lower than
those for the cells cultured with MCF10A-Cells and MCF10A-CM in 2-D (p<0.05).

Total Triglyceride Measurement
As shown in Figure 3.10, the total triglyceride within the human adipose cells for
each condition in 2-D culture was significantly higher than their respective samples
cultured on chitosan-gelatin beads (p<0.05). There was no difference measured between
the samples of any condition in 2-D.
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Figure 3.10: Measurement of total triglyceride content showed that the cells cultured in
2-D produced significantly higher amounts of triglyceride than their respective samples
cultured on beads (p<0.05).

Asterisks (*) indicate statistically different values.

Graphical error bars represent the standard error of the mean.

Quantitative Real Time RT-PCR
As shown in Figure 3.11A, culturing of the human adipose cells in 2-D with
MCF10A-Cells, resulted in significantly lower PPAR-γ expression than the 2-D
adipogenic control sample (p<0.05). The cells cultured with MCF10A-CM, however,
expressed significantly more PPAR-γ than the 2-D AC sample (p<0.05). The cells
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A

B

Figure 3.11: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by human adipose
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method.
Asterisk (*) indicates a statistical difference between specified conditions (p<0.05).
Pound symbol (#), dollar sign ($), and percent symbol (%) denote values statistically
different from each other for PPAR-γ expression. At symbol (@) for PPAR-γ and percent
(%) for aP2 indicate values statistically higher than other respective samples on in 2-D.
Graphical error bars represent the standard error of the mean.
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cultured on beads with MCF10A-Cells expressed significantly higher amounts of PPARγ than all other samples (p<0.05).
When evaluating human adipose cell samples of each condition for aP2
expression, it was shown that the cells cultured in 2-D with the adipogenic cocktail
expressed a significantly higher amount of aP2 than all other samples in 2-D (p<0.05).
There was no difference observed between any of the samples cultured on beads.

3.4 Discussion
Researchers have investigated the relationship between epithelial cells and
stromal cells within the breast to determine how these cells interact during normal
mammary development. We hypothesized that mammary epithelial cells would influence
the differentiation of adipose cells since the two cell types are closely related in the
mammary gland.

To further develop our injectable composite system for breast

reconstruction, it was essential to understand the relationship between mammary
epithelial cells of the microenvironment and adipose cells.
When selecting a material for use as scaffolding in adipose tissue engineering,
several aspects must be considered. Scaffold selection depends on the physical,
mechanical, and chemical properties of the material [20]. Because the tissue that is being
reconstructed is a “soft” tissue, a scaffold material that imparts a natural feel is ideal,
particularly for restoration of breast tissue in women [21-23]. Additionally, the cell type
of interest will affect the material selected for use as a scaffold. Preadipocytes are
anchorage-dependent cells, meaning that they require a surface, i.e. substrate, of defined
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stiffness in order for attachment, proliferation, and differentiation to occur [24-26]. The
porosity of a scaffold surface can be selectively modified to both encourage cellular
attachment and to allow the diffusion of nutrients and vascular ingrowth within a scaffold
[21, 27]. More specifically, it has been shown that dispersed, cultured fat is difficult to
maintain on two-dimensional (2-D) surfaces in static flow [28], perhaps attributable to
the fact that mature adipocytes are capable of a phenomenon known as dedifferentiation,
where the cells lose accumulated lipid and revert to a previous fusiform state observed in
preadipocytes [29, 30]. Moreover, culturing anchorage dependent cells on appropriate
substrata can result in increased proliferation and ultimately the presence of a greater
number of cells with the potential to differentiate in culture [31].
The chitosan used for manufacturing the chitosan-gelatin beads for this work is
characterized between 100,000-300,000 Da with degree of deacetylation ≥90% according
to the manufacturer’s technical specifications. The gelatin blended with chitosan for our
beads is characterized by its bloom of approximately 300. The bloom is an indicator of
the strength of a gel, where a higher bloom means a stronger gel. The bloom is also
proportional to the average molecular weight of the gelatin. A high bloom, ranging from
225 to 325, corresponds to a molecular weight range of 50,000 to 100,000 [32-34].
It has been noted that certain sterilization methods, including gas, autoclave, and
gamma irradiation may result in alterations of the chitosan molecular structure that can
affect its properties [7]. To sterilize our chitosan and gelatin powders in preparation for
cell culturing, we autoclaved the chitosan and gelatin powders. From GPC we were able
to estimate the molecular weight of the as-received and sterilized chitosan and gelatin
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powders. Since no statistical significance was determined between the as-received and
sterilized molecular weights for either the chitosan or gelatin, it was determined that our
sterilization methods did not significantly alter the molecular properties of these
materials.
Characterization of mammary tissue has included identifying and quantifying
specific mechanical properties of the key tissue components that make up the breast
composition. Numerous studies to determine the elastic modulus and the strength of
selected tissues of the breast have been performed, as knowledge of the elastic properties
of breast tissue may be used for modeling of tissue dynamics and for imaging of the
tissue to detect malignancies [35-38]. Three of the most predominant types of tissue that
make up the mammary gland are skin, glandular tissue, and adipose tissue. Reports
indicate that the elastic modulus of skin is between 200-3000 kPa and its ultimate tensile
strength is approximately 20 MPa [39]. The elastic modulus for normal glandular tissue
has been reported as between 2-66 kPa [35, 40]; while the elastic modulus for mammary
adipose tissue, characterized as white adipose tissue, has been reported as 0.5-25 kPa [36,
40-44]. Some reports have indicated that normal glandular tissue is 5-50 times stiffer
than adipose tissue, which is attributed to the higher lipid and water weight of the adipose
tissue that influences the modulus according to the applied strain rate [39, 45].
For breast reconstruction, scaffolds have typically been designed for restoration of
tissue volume, as opposed to the restoration of tissue function. As a result, the scaffolds
should ideally restore the aesthetic function of the tissue by imparting a soft, smooth feel
closely resembling that of natural tissue. The rigidity and stiffness of scaffolds used for
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adipose tissue engineering is therefore one property that must be considered. When
compared to the elastic modulus of the tissue components of the breast, the modulus of
our proposed injectable composite system would not be as stiff as skin, but would have a
modulus within the estimated range for normal glandular tissue and adipose tissue,
indicating that the properties of the injectable composite system could closely resemble
that of natural breast tissue.
At the conclusion of the study, it was found that the most metabolically active
samples were the cells cultured in 2-D, likely because there were significantly more cells
measured in the 2-D samples than were measured in the bead samples, according to the
PicoGreen® assay of DNA concentration. One possible explanation for the significant
difference in cell number among the 2-D and bead samples is that the addition of beads to
the culture system resulted in an increase in surface area that the cells had to cover over
the culture period. Placing beads in the well plates introduced grooves and spaces such
that the cells may not have been as readily in contact with each other as they were in the
well plates. Cell-cell interactions that encourage cellular growth and proliferation may
have been limited by the beads, indicating that a larger number of cells may need to be
seeded in the 3-D system, or that the time for culturing the cells on beads should be
lengthened.
Because the number of cells found on the beads was significantly lower than the
number of cells in the 2-D samples, it was anticipated that this result would influence the
outcome of the other assays to assess adipogenesis.

Indeed the measured ORO

absorbance from the cellular bead samples is likely attributed to Oil Red O stain solution
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absorbed by the beads that was released with extraction in isopropanol and is not an
indicator of lipid from stained cells. The results of the triglyceride assay also suggest that
the significant difference in triglyceride concentration observed between the 2-D samples
and the samples on beads was attributed to the significantly lower number of cells on the
beads at the end of the study.
Previous studies, in Chapter 1, evaluating the influence of conditioned media on
primary human adipose cells in 2-D showed that MCF10A conditioned media negatively
influenced adipogenesis.

Here, however, evaluation of the 2-D samples showed

comparable absorbance of the Oil Red O extraction solution and comparable triglyceride
concentration for the 2-D AC samples and also the 2-D samples cultured with MCF10A
cells and MCF10A conditioned medium. The different outcome here is possibly a result
of different culturing and seeding conditions used in this study.

For the previous

conditioned media studies, human adipose cells were cultured for two days and then
MCF10A conditioned medium and the adipogenic cocktail were added simultaneously to
the cells. Here, the cells were cultured with the adipogenic cocktail for two days and then
supplemented with MCF10A conditioned media two days later. As a result, the cells in
the conditioned media studies of Chapter 1 were exposed to the conditioned media for a
longer period of time and the conditioned media was better able to influence adipogenesis
of the cells. The cells here likely had an opportunity to have differentiation initiated by
the adipogenic cocktail and the conditioned media did not have a similar negative effect
on adipogenesis because the cells were already undergoing differentiation. This indicates
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that attention must be paid to the specific time points for introducing conditioned media
to cells, depending on the desired outcome.
The gene expression data for the samples in 2-D and on the beads showed the
presence of PPAR-γ within each of the samples, indicating that adipose cells were present
for each condition. The significantly higher amount of PPAR-γ expression measured in
the MCF10A-Cell sample on the beads has no clear explanation. Since a comparable
number of cells were measured on all the samples cultured on beads, one would expect
comparable gene expression. This indicates that there likely may have been some dnase
contamination in the MCF10A-Cell samples grown on beads. Analysis of aP2 gene
expression showed that the highest expression of aP2 was observed in the 2-D adipogenic
control samples and indicated that there were mature cells present within those samples.
Little to no expression of aP2 in the other samples indicates that those cells are not
mature.

In regard to the other samples in 2-D, MCF10A-Cell and MCF10A-CM,

comparable levels of triglyceride and lipid were observed in the 2-D AC sample and the
2-D MCF10A-Cell and MCF10A-CM samples which suggested that the conditioned
media and mammary epithelial cells did not have an effect on the adipose cell
differentiation. The significantly lower aP2 expression observed in the 2-D MCF10ACell and MCF10A-CM samples when compared to the 2-D AC samples suggests that the
cells cultured with MCF10A cells and conditioned media were in fact not as mature as
the 2-D AC cells and that the MCF10A cells may have had a negative influence on
adipogenesis.
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3.5 Conclusions
The autoclave conditions that were used for preparing sterile powders to
manufacture sterile chitosan-gelatin beads for cell culturing did not significantly alter the
material properties of the chitosan and gelatin. Measure of the elastic modulus of the
components of the injectable composite system showed that the inclusion of chitosangelatin beads within a collagen-agarose gel matrix significantly increases the stiffness of
the gel matrix.

The estimated stiffness of the collagen-agarose gel matrix and the

collagen-agarose gel containing the chitosan-gelatin bead was comparable to the modulus
of the normal tissue components of the mammary gland, suggesting that the injectable
composite system of these materials could be successful for restoring the aesthetic
function of the breast because of the similar material properties.
From this study, the significant difference in cell number observed between the 2D and samples and samples grown on beads indicates that for the injectable composite
system, either a higher number of cells should be seeded initially on the beads, or the
cells should be allowed to culture on the beads for a longer period of time before
differentiation is induced. Additionally, the time point during cell culture at which
conditioned media should be added to cells, should be determined taking into account the
desired potential outcome of the conditioned media treatment. Finally, while it is known
that culturing of adipose cells on beads will influence their differentiation, to determine
the true effects of co-culturing the adipose cells on beads with mammary epithelial cells,
this study may need to be repeated with increased adipose cell numbers seeded on the
beads and/or the length of culturing increased.

153

3.6 References
1.

Gomillion, C.T., Evaluation of tissue engineered injectable devices for breast
tissue engineering, in Bioengineering. 2005, Clemson University: Clemson, SC.

2.

Gomillion, C., A.N. Cavin, S.E. Ellis, and K.J.L. Burg. Evaluation of tissue
engineered injectable devices for breast tissue engineering. in Transactions of the
30th Annual Meeting of the Society for Biomaterials. 2005. Memphis, TN.

3.

Cavin, A.N., Adipocyte response to injectable breast tissue engineering scaffolds,
in Department of Bioengineering. 2005, Clemson University: Clemson, SC.

4.

Kim, I.Y., S.J. Seo, H.S. Moon, M.K. Yoo, I.Y. Park, B.C. Kim, and C.S. Cho,
Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv,
2008. 26(1): p. 1-21.

5.

Mano, J.F., G.A. Silva, H.S. Azevedo, P.B. Malafaya, R.A. Sousa, S.S. Silva, L.F.
Boesel, J.M. Oliveira, T.C. Santos, A.P. Marques, N.M. Neves, and R.L. Reis,
Natural origin biodegradable systems in tissue engineering and regenerative
medicine: present status and some moving trends. J R Soc Interface, 2007. 4(17):
p. 999-1030.

6.

Shi, C., Y. Zhu, X. Ran, M. Wang, Y. Su, and T. Cheng, Therapeutic potential of
chitosan and its derivatives in regenerative medicine. J Surg Res, 2006. 133(2): p.
185-92.

7.

Bumgardner, J.D., R. Wiser, P.D. Gerard, P. Bergin, B. Chestnutt, M. Marin, V.
Ramsey, S.H. Elder, and J.A. Gilbert, Chitosan: potential use as a bioactive
coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym
Ed, 2003. 14(5): p. 423-38.

8.

Drury, J.L. and D.J. Mooney, Hydrogels for tissue engineering: scaffold design
variables and applications. Biomaterials, 2003. 24(24): p. 4337-51.

9.

Lee, K.Y. and D.J. Mooney, Hydrogels for tissue engineering. Chem Rev, 2001.
101(7): p. 1869-79.

154

10.

Boucard, N., C. Viton, D. Agay, E. Mari, T. Roger, Y. Chancerelle, and A.
Domard, The use of physical hydrogels of chitosan for skin regeneration
following third-degree burns. Biomaterials, 2007. 28(24): p. 3478-88.

11.

Huang, Y., S. Onyeri, M. Siewe, A. Moshfeghian, and S.V. Madihally, In vitro
characterization of chitosan-gelatin scaffolds for tissue engineering.
Biomaterials, 2005. 26(36): p. 7616-27.

12.

Alves, N.M. and J.F. Mano, Chitosan derivatives obtained by chemical
modifications for biomedical and environmental applications. Int J Biol
Macromol, 2008. 43(5): p. 401-14.

13.

Di Martino, A., M. Sittinger, and M.V. Risbud, Chitosan: a versatile biopolymer
for orthopaedic tissue-engineering. Biomaterials, 2005. 26(30): p. 5983-90.

14.

Malafaya, P.B., A.J. Pedro, A. Peterbauer, C. Gabriel, and H. Redl, Chitosan
particles agglomerated scaffolds for cartilage and osteochondral tissue
engineering approaches with adipose tissue derived stem cells. J Mat Sci: Mat in
Med, 2005. 16: p. 1077-1085.

15.

Malafaya, P.B., G.A. Silva, and R.L. Reis, Natural-origin polymers as carriers
and scaffolds for biomolecules and cell delivery in tissue engineering
applications. Adv Drug Deliv Rev, 2007. 59(4-5): p. 207-33.

16.

Munarin, F., P. Petrini, S. Fare, and M.C. Tanzi, Structural properties of
polysaccharide-based microcapsules for soft tissue regeneration. J Mater Sci
Mater Med, 2009. 21(1): p. 365-75.

17.

Cruz, D.M., J.L. Ivirico, M.M. Gomes, J.L. Ribelles, M.S. Sanchez, R.L. Reis,
and J.F. Mano, Chitosan microparticles as injectable scaffolds for tissue
engineering. J Tissue Eng Regen Med, 2008. 2(6): p. 378-80.

18.

Dimitriadis, E.K., F. Horkay, J. Maresca, B. Kachar, and R.S. Chadwick,
Determination of elastic moduli of thin layers of soft material using the atomic
force microscope. Biophys J, 2002. 82(5): p. 2798-810.

155

19.

Radmacher, M., Measuring the elastic properties of biological samples with the
AFM. IEEE Eng Med Biol Mag, 1997. 16(2): p. 47-57.

20.

Hemmrich, K. and D. von Heimburg, Biomaterials for adipose tissue engineering.
Expert Rev Med Devices, 2006. 3(5): p. 635-45.

21.

Beahm, E.K., R.L. Walton, and C.W. Patrick, Jr., Progress in adipose tissue
construct development. Clin Plast Surg, 2003. 30(4): p. 547-58, viii.

22.

Halberstadt, C., C. Austin, J. Rowley, C. Culberson, A. Loebsack, S. Wyatt, S.
Coleman, L. Blacksten, K. Burg, D. Mooney, and W. Holder, Jr., A hydrogel
material for plastic and reconstructive applications injected into the
subcutaneous space of a sheep. Tissue Eng, 2002. 8(2): p. 309-19.

23.

Rowley, J.A., G. Madlambayan, and D.J. Mooney, Alginate hydrogels as
synthetic extracellular matrix materials. Biomaterials, 1999. 20(1): p. 45-53.

24.

Atala, A. and R.P. Lanza, Methods of tissue engineering. 2002, San Diego, Calif.:
Academic Press. xli, 1285.

25.

Patrick, C.W., Jr., Adipose tissue engineering: the future of breast and soft tissue
reconstruction following tumor resection. Semin Surg Oncol, 2000. 19(3): p. 30211.

26.

Patrick, C.W., Jr., Tissue engineering strategies for adipose tissue repair. Anat
Rec, 2001. 263(4): p. 361-6.

27.

Burg, K.J.L. and S.W. Shalaby, Biodegradable materials. Tissue engineering of
vascular prosthetic grafts, ed. P.P. Zilla and H.P. Greisler. 1999, Austin: R.G.
Landes Co. 621.

28.

Tontonoz, P., E. Hu, and B.M. Spiegelman, Stimulation of adipogenesis in
fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 1994.
79(7): p. 1147-56.

156

29.

Lau, D.C., G. Schillabeer, Z.H. Li, K.L. Wong, F.E. Varzaneh, and S.C. Tough,
Paracrine interactions in adipose tissue development and growth. Int J Obes
Relat Metab Disord, 1996. 20 Suppl 3: p. S16-25.

30.

Tholpady, S.S., C. Aojanepong, R. Llull, J.H. Jeong, A.C. Mason, J.W. Futrell,
R.C. Ogle, and A.J. Katz, The cellular plasticity of human adipocytes. Ann Plast
Surg, 2005. 54(6): p. 651-6.

31.

Katz, A.J., R. Llull, M.H. Hedrick, and J.W. Futrell, Emerging approaches to the
tissue engineering of fat. Clin Plast Surg, 1999. 26(4): p. 587-603, viii.

32.

Gelatin. [cited 2010 November]; Available from:
http://www.gelatin.co.za/gltn1.html.

33.

Bloom. 2006 [cited 2010 November]; Available from:
http://www.sizes.com/units/bloom.htm.

34.

GMIA Standard Methods for the Testing of Edible Gelatin. 2006 [cited 2010
November].

35.

Krouskop, T.A., T.M. Wheeler, F. Kallel, B.S. Garra, and T. Hall, Elastic moduli
of breast and prostate tissues under compression. Ultrason Imaging, 1998. 20(4):
p. 260-74.

36.

Samani, A., J. Zubovits, and D. Plewes, Elastic moduli of normal and
pathological human breast tissues: an inversion-technique-based investigation of
169 samples. Phys Med Biol, 2007. 52(6): p. 1565-76.

37.

Sarvazyan, A.P., O.V. Rudenko, S.D. Swanson, J.B. Fowlkes, and S.Y.
Emelianov, Shear wave elasticity imaging: a new ultrasonic technology of
medical diagnostics. Ultrasound Med Biol, 1998. 24(9): p. 1419-35.

38.

Wellman, P.S., R.D. Howe, E. Dalton, and K.A. Kern, Breast Tissue Stiffness in
Compression is Correlated to Histological Diagnosis, in Harvard Bio-Robotics
Laboratory Technical Report. 1998, Harvard University: Cambridge, MA.

157

39.

Gefen, A. and B. Dilmoney, Mechanics of the normal woman's breast. Technol
Health Care, 2007. 15(4): p. 259-71.

40.

McKnight, A.L., J.L. Kugel, P.J. Rossman, A. Manduca, L.C. Hartmann, and R.L.
Ehman, MR elastography of breast cancer: preliminary results. AJR Am J
Roentgenol, 2002. 178(6): p. 1411-7.

41.

Kruse, S.A., J.A. Smith, A.J. Lawrence, M.A. Dresner, A. Manduca, J.F.
Greenleaf, and R.L. Ehman, Tissue characterization using magnetic resonance
elastography: preliminary results. Phys Med Biol, 2000. 45(6): p. 1579-90.

42.

Samani, A. and D. Plewes, A method to measure the hyperelastic parameters of
ex vivo breast tissue samples. Phys Med Biol, 2004. 49(18): p. 4395-405.

43.

Sinkus, R., J. Lorenzen, D. Schrader, M. Lorenzen, M. Dargatz, and D. Holz,
High-resolution tensor MR elastography for breast tumour detection. Phys Med
Biol, 2000. 45(6): p. 1649-64.

44.

Van Houten, E.E., M.M. Doyley, F.E. Kennedy, J.B. Weaver, and K.D. Paulsen,
Initial in vivo experience with steady-state subzone-based MR elastography of the
human breast. J Magn Reson Imaging, 2003. 17(1): p. 72-85.

45.

Duck, F., Physical Properties of Tissue: A Comprehensive Reference Book. 1990,
San Diego: Academic Press.

158

CHAPTER 4
IN VITRO EVALUATION OF FATTY ACID INFLUENCE ON ADIPOSE CELL
DIFFERENTIATION IN TWO-DIMENSIONAL (2-D) CULTURE

4.1 Background
It has already been noted that adipose tissue is the storage site for fat. The formation
of adipose tissue, or lipogenesis, is influenced by many factors such as insulin, glucose, and
fatty acids [1]. Within fat tissue, adipocyte cells store lipids primarily in the form of
triglyceride, which is made up of three fatty acids attached to a glycerol molecule. Fatty
acids are therefore often considered to be the building blocks of triglyceride, the stored fat
within adipose tissue [2].
Common fatty acids were listed in Table 1.3 of Chapter 1. Fatty acids are composed
of carbon and hydrogen, and may be classified as either saturated or unsaturated, depending
on the lack of presence of double bonds between the carbon and hydrogen units of the
molecule. Saturated fatty acids do not have any double bonds present in their structure; their
structure is a straight, tightly-packed chain. Unsaturated fatty acids have a double bond
present between the hydrogen and carbon units which cause bends or kinks within the fatty
acid chain. The structure of fatty acids influences their physical properties; tightly bound
saturated fatty acids have a higher melting temperature and are solid at room temperature,
while unsaturated fatty acids are liquid at room temperature due to their low melting
temperature. Fatty acids are either synthesized within the body, or consumed by dietary
intake of food. The body, however, is not capable of synthesizing all fatty acids; those not
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synthesized in the body must be consumed, and are known as essential fatty acids. The
essential fatty acids include linoleic acid, arachidonic acid, and linolenic acid, and they are
required for synthesis of other key factors in the body, such as prostaglandins [2, 3].
Research has shown that many mammalian cells grown in vitro often require
exogenous lipid or fatty acids in the culture medium to facilitate healthy cultures. Cultures
of rat preadipocyte cells that were given medium supplemented with oleic acid,
demonstrated large accumulation of cytoplasmic lipid fairly rapidly [4]. Additionally, in the
human diet, it has been suggested that fatty acids may influence adipogenesis at the
transcriptional level. The addition of a specific fatty acid, linoleic acid, to culture medium
of adipose stromal-vascular (preadipocyte) cells, resulted in significant lipid accumulation
observed within the cells [5]. In these cases, there was no other significant indicator of
adipose cell differentiation besides the large accumulation of lipid; however, this outcome
could prove advantageous for optimizing adipose tissue engineering strategies. Adipose
tissue mass may increase either by an increase in the number of adipocytes present within
adipose tissue (hyperplasia), or by an increase in the size of the adipocytes (hypertrophy) [3,
6, 7]. Since mature adipocytes do not actively proliferate, the likelihood of the number of
cells in adipose tissue increasing is minimal. Therefore, the most promising means of
increasing adipose tissue mass for adipose tissue engineering would be to stimulate an
increase in the size of cells available. We hypothesize that the inclusion of fatty acid
supplements to our injectable composite system will enhance the success of the system for
breast tissue reconstruction by stimulating lipid filling of the adipose cells to facilitate an
increase in adipose tissue mass. Initial studies were therefore performed to first determine
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what effect exogenous fatty acid would have on adipose cell differentiation in 2-D culture.
After identifying the optimal concentration of linoleic acid, subsequent studies
were performed to determine whether or not there was a difference in cell behavior when
the fatty acid was added at different stages of cell culturing.

For instance, would

differentiation be influenced by adding fatty acid at the initial seeding of cells, or postinduction of differentiation? Additional studies were therefore performed to determine
the influence of linoleic acid, when added at specified culture periods, on D1 cell
differentiation to adipocytes.

4.2 Materials & Methods
Determination of Optimal Fatty Acid Concentrations for Cell Cultures
Cell Culturing
Murine bone marrow stromal cells, D1 cells (CRL-1242, ATCC, Manassas, VA),
of passage 11 were seeded in 24-well culture plates (Corning, Corning, NY) at 20%
seeding density (2.6x104 cells per well). Cells were maintained in Dulbecco’s Modified
Eagle Medium (DMEM) (ATCC, Manassas, VA) supplemented with 10% FBS
(Mediatech, Herndon, VA), 0.2% fungizone (Gibco, Invitrogen, Carlsbad, CA), and 1%
Antibiotic-Antimycotic (Gibco, Invitrogen, Carlsbad, CA) at standard culturing
conditions of 37°C and 5% CO2. After two days of culture, upon medium change, cells
were then cultured with either an adipogenic differentiation cocktail, or with increasing
concentrations of linoleic acid-albumin (LA) (L9530, Sigma, St. Louis, MO), ranging
from 0.25-12% linoleic acid in the culture medium (Table 4.1). The adipogenic cocktail
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(AC) consisted of 100µl insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St.
Louis, MO), and 1mL IBMX (Sigma, St. Louis, MO) per 10mLs of DMEM medium.
Culture medium was changed every 2 days during the study. Cells were then evaluated at
Day 7 and Day 14 to determine the influence of increasing amounts LA on cell behavior.

Table 4.1: Linoleic Acid Cell Culturing Conditions: Optimization
Medium

Description

No Additives

DMEM only throughout

Normal
Cocktail

Adipogenic cocktail (AC)

Both
Additives

Adipogenic Cocktail + 1% LA (AC + LA)

0.25%

DMEM + with 0.25% LA

0.50%

DMEM + with 0.50% LA

1%

DMEM + with 1% LA

2%

DMEM + with 2% LA

4%

DMEM + with 4% LA

6%

DMEM + with 6% LA

8%

DMEM + with 8% LA

10%

DMEM + with 10% LA

12%

DMEM +with 12% LA

Note: Percentage of linoleic acid added to cells was based on the
volume of linoleic acid added per well, i.e. 4% LA = 80µL LA per
2mL DMEM in each well
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pH Measurements
Preliminary evaluation of fatty acid-supplemented cultures with LA resulted in
bright yellow media, indicative of changes in the pH of the medium over the course of
the study. With increasing concentrations of fatty acid added to the culture medium, the
pH of the medium was evaluated over time to determine if any significant changes
occurred.

Samples of the culture medium were preserved at medium changes and

evaluated using a Model 8805 pH meter (VWR, West Chester, PA) to determine the
average pH value for each sample over time.

PicoGreen® DNA Assay
The deoxyribonucleic acid (DNA) concentration within each sample was
determined using the Quant-iT™ PicoGreen® dsDNA assay kit (P7589, Invitrogen,
Molecular Probes, Carlsbad, CA). At Day 7 and Day 14, culture medium was aspirated
from the well plates and cells were rinsed with sterile PBS. A 1X TE Buffer (10mM
Tris-HCl, 1mM EDTA, pH 7.5) was prepared from the 20X stock solution provided in
the kit. A volume of 1mL of the 1X TE buffer was added to each well of the plate. The
plates were frozen and thawed three times to lyse the cells. A pipet tip was used to
scrape the cells in each well.

An aqueous working solution of the Quant-iT™

PicoGreen® reagent was prepared by making a 1:200 dilution of the concentrated
solution with 1X TE buffer. A 2µg/mL stock solution of dsDNA in 1X TE buffer was
prepared and further diluted to prepare DNA standards, ranging from 0 to 1000ng/mL,
that were used to generate a standard curve. A volume of 100µL of each sample and

163

standard was pipetted to wells of a black-walled 96-well plate. Working solution in the
amount of 100µL was pipetted to each well and the plate was incubated for 5 minutes in
the dark at room temperature. The fluorescence was read using a Flouroskan Ascent®
FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm excitation and 520nm
emission wavelengths.

Oil Red O Staining (ORO)
Cell culture medium was aspirated from well plates and the cells were rinsed
twice with sterile PBS (Sigma, St. Louis, MO). The cells were fixed with 2mL 10%
Neutral Buffered Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight. An ORO stock
solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) to 100mL
isopropanol (Fisher Scientific, Fair Lawn, NJ)). An ORO working solution was prepared
by mixing 60mL of ORO stock solution with 40mL deionized water and stirring for 30
minutes. A volume of 500µL of the working solution was added to each well and
incubated for 15 minutes at room temperature. Following incubation, the wells were
rinsed three times with fresh deionized water. After decanting excess water, the redstained lipid was imaged using an inverted microscope and imaging software.

Total Triglyceride Measurement
Cell culture medium was aspirated from well plates and the cells rinsed twice
with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL of 1%
Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were
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incubated for 30 minutes at room temperature.

Standard glycerol solutions of

concentrations ranging from 0 to 200µM glycerol were prepared by dissolving glycerol
(#G7793, Sigma, St. Louis, MO) in deionized water. Following incubation, the cells
from each well were collected with the Triton X-100 solution into microcentrifuge tubes
and centrifuged for 10 minutes at 3000rpm. A volume of 100µL of each sample and
standard was pipetted into the wells of a 96-well plate in triplicate. A volume of 100µL
of Infinity™ Triglyceride Reagent (Thermo Fisher Scientific, Waltham, MA) was added
to each well and incubated for 15 minutes at room temperature. The absorbance was read
at 490nm on a microplate reader (BioTek Instruments, Inc., Winooski, VT).

Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing
Intervals
Cell Culturing
Murine bone marrow stromal cells, D1 cells, of passage 11 were seeded in 12well culture plates at 20% seeding density (7.6x104 cells per well). Cells were seeded
according to the conditions specified in Table 4.2. Cells were maintained in Dulbecco’s
Modified Eagle Medium supplemented with 10% FBS, 0.2% fungizone, and 1%
Antibiotic-Antimycotic at standard culturing conditions of 37°C and 5% CO2.

The

culture condition, denoted as LA Begin, included 4% v/v linoleic acid-albumin (LA)
(Sigma, St. Louis, MO); the linoleic acid-albumin was added to the DMEM medium at
the initial cell seeding. At confluence, upon medium change, cells were cultured with
either an adipogenic differentiation cocktail or maintained in DMEM with or without 4%

165

LA. The adipogenic cocktail consisted of 100µl insulin, 2µl dexamethasone, and 1mL
IBMX per 10mL of DMEM. Culture medium was changed every two days during the
study. Cells were evaluated at Day 12 to determine the influence of LA on cellular
behavior.

Table 4.2 Linoleic Acid Cell Culturing Conditions: Differentiation
Medium

Description

DMEM

DMEM only throughout

AC

Adipogenic cocktail added at confluence

LA Begin

4% LA added at initial cell seeding

LA Begin
+AC

4% LA added at initial cell seeding + adipogenic cocktail
at confluence

LA Confl

4% LA added at confluence

LA Confl +
AC

4% LA + adipogenic cocktail added at confluence

LA Diff

4% LA added after cells differentiated with adipogenic
cocktail for 6 days

Note: Percentage of linoleic acid added to cells was based on the volume
of linoleic acid added per well, i.e. 4% LA = 80uL LA per 2mL DMEM in
each well

Gas Chromatography
Culture medium was aspirated from cells in well plates and the cells were rinsed
with sterile PBS. A volume of 1mL of PBS was then added to each well and the cells
were scraped with a pipet tip and transferred to microcentrifuge tubes. Tubes were stored
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at -20°C until evaluated for lipid content. Detailed methods used for sample preparation
are found in Appendix D of this document. For gas chromatography (GC) analysis,
samples were first thawed at room temperature and then transferred to glass round bottom
tubes (Pyrex, Corning, Corning, NY). Total lipids were extracted from the cells using
organic solvents according to the procedures of Folch and coworkers [8]. The resulting
lipid extracts were transmethylated according to the procedures of Park and coworkers
[9]. A volume of 100µL of methylene chloride (Fisher, Fair Lawn, NJ) and 1mL of
sodium methoxide in methanol (Sigma, St. Louis, MO) was added to each sample tube.
The tubes were flushed with nitrogen gas and heated at 90°C for 10 minutes, then cooled
to room temperature. A volume of 1mL of 14% boron trifluoride in methanol (Sigma, St.
Louis, MO) was added to each sample tube. The tubes were flushed with nitrogen,
heated again to 90°C for 10 minutes, and cooled to room temperature. A volume of
500µL of GC grade hexane (VWR, West Chester, PA) and 500µL of GC grade hexane
containing the internal standard (1ug/µL C23:0 methyl ester, Sigma, St. Louis, MO) was
added to each sample. Deionized water in the amount of 2mL was added to each sample
and the tubes were vortexed for two minutes, then centrifuged at 1500rpm for five
minutes. The upper layer of the separated phases in each tube was transferred to a
disposable glass test tube (Fisher, Fair Lawn, NJ) containing a small amount of
anhydrous sodium sulfate (Fisher, Fair Lawn, NJ). The liquid in the disposable tubes was
then transferred to a GC vial and fatty acid methyl esters were analyzed using an HP6850
Series II Gas Chromatograph fitted with an autosampler (Agilent Technologies, Santa
Clara, CA).

Chemstation software was used to analyze the resulting data (Agilent
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Technologies). Specific fatty acids were identified by comparing the internal standard
and retention times. The weight percentage of fatty acids was calculated according to the
values from the resulting plots applied to Equation 4.1 and 4.2 shown below.
%& '( )* 
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Equation 4.2

Where: Total Area = area of entire sample plot
AreaISTD = area of the internal standard located on the resulting plot
AreaFatty Acid = area of specific fatty acids located on the resulting plot

Statistical Analysis
Statistical analyses were performed using SAS 9.2 software (Cary, NC) to
compare the effect of each culture medium on cell behavior. The Least Squares Means
(LSMEANS) was used with a significance level of p < 0.05 (n=4 for PicoGreen and
Triglyceride assays performed for LA optimization studies; n=3 for all other assays).
Graphical error bars represent the standard error of the mean.

4.3 Results
Determination of Optimal Fatty Acid Concentrations for Cell Cultures

pH Measurements
Measurement of the pH of samples of the culture medium from each condition
showed that the addition of linoleic acid in concentrations 2% or greater influenced the
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pH values of the culture medium (Figure 4.1). The culture environment became slightly
more acidic, as compared to the DMEM and AC control samples, as the amount of
linoleic acid was increased to concentrations greater than 2%. When compared to the
DMEM and AC control samples, cells treated with 8%, 10%, and 12% fatty acid all had a
significantly lower pH, indicating that the medium was more acidic with the addition of
the linoleic acid. There was no statistical difference between the pH of samples treated
with 4% and 6% fatty acid.

PicoGreen® DNA Assay
The DNA concentration within each sample was quantified using a PicoGreen®
DNA assay, as shown in Figure 4.2. For each condition, the amount of DNA within
samples was significantly higher on Day 14 than on Day 7. Among the Day 7 samples,
DNA concentration of the samples treated with 6% and 8% linoleic acid had significantly
lower DNA concentrations. At Day 14, samples treated with 4% linoleic acid had
significantly higher DNA concentrations, while the samples treated with 0.25% linoleic
acid had significantly lower concentrations than the AC samples.

The DNA

concentration for cells treated with 4% linoleic acid was significantly higher (p < 0.05)
than the concentration measured in cells treated with 6% and 2% linoleic acid at Day 14.
There was no statistically significant difference between the DNA concentrations
measured in the AC or AC+LA samples at either time point.
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Figure 4.1: Measurement of the pH values for each sample condition showed that
increasing the amount of fatty acid added to the culture medium does influence the
acidity of the culture environment. Asterisks (*) indicate statistically different value
compared to the DMEM and AC controls (p<0.05). Graphical error bars represent the
standard error of the mean.
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Figure 4.2: Results of the PicoGreen® assay showed that cells evaluated at Day 14 had a
significantly higher DNA concentration than samples evaluated at Day 7 for all
conditions (p<0.05). Asterisks (*) indicate values statistically lower than the AC value at
Day 7. Percent symbols (%) indicate value statistically lower than AC at Day 14. Pound
#
symbol (#) indicates value statistically higher than the AC, 2%, and 6% values at Day 14.
Graphical error bars represent the standard
error of the mean.
%

*

*

Oil Red O Staining
Oil Red O staining of cells treated with linoleic acid showed little to no lipid in
D1 cells cultured in DMEM at Day 7 or Day 14 (Figure 4.3 A & G). Staining of the
samples treated with the adipogenic cocktail showed clearly rounded, large lipid droplets

171

at both Day 7 and Day 14, indicating that the D1 cells were actively differentiating (4.3 B
& H). When linoleic acid was added to the D1 cells treated with the adipogenic cocktail
(AC+LA sample), a similar pattern of lipid staining was observed as was seen in the AC
control (4.3 C & I). Of the samples treated with linoleic acid, only representative images
of samples receiving low, mid, and high concentrations of linoleic acid are shown. The
addition of 1% linoleic acid resulted in small red lipid droplets within the cells; however,
the lipid droplets were not uniform or well-defined, even over the course of the study
from Day 7 to Day 14 (4.3 D & J). As increased concentrations of linoleic acid were
added to the D1 cells, more lipid was present in the samples, as seen in the 4% and 12%
samples shown in Figure 4.3 E-F & K-L.

Total Triglyceride Measurement
As shown in Figure 4.4, the total triglyceride within the D1 cell samples
significantly increased from Day 7 to Day 14 for all conditions except for the DMEM,
0.25%, 0.5%, and 1% conditions. When compared to the AC controls at Day 7, the 0.5%,
and 1% linoleic acid samples had significantly less triglyceride. The 12% linoleic acid
samples had significantly higher amounts of triglyceride. Additionally, there was no
difference between the 2%, 4%, and 6% linoleic acid samples. At Day 14, the DMEM,
0.25%, 0.5%, 1%, and 2% samples produced significantly lower concentrations of
triglyceride than the AC control. There was no difference between the 4% and 6%
linoleic acid samples; there was, however, a significantly higher amount of triglyceride
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Figure 4.3: Oil Red O staining of samples treated with linoleic acid. Total magnification
for all images is 320x.
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produced in the 4% samples when compared to the 2% samples. There was no difference
between the AC and AC+LA samples at either Day 7 or Day 14.

Figure 4.4: Measurement of total triglyceride content showed that the addition of linoleic
acid to D1 culture medium does influence triglyceride production. Asterisks (*) indicate
statistically significant differences.

Pound symbols (#) indicate significantly lower

concentrations than the AC samples at Day 7. Percent signs (%) indicate significantly
higher concentrations than the AC samples at Day 7. Dollar signs ($) indicate
significantly lower concentrations than the AC samples at Day 14. Ampersand symbols
(&) indicate significantly different triglyceride values (p<0.05). Graphical error bars
$

represent the standard error of the$mean.
#$

#$
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Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing
Intervals
Gas Chromatography
The fatty acid profile for samples of each condition is shown in Figure 4.5. The
percentage of each individual fatty acid within cell samples was calculated and the sum
of identifiable fatty acids was determined. More than 85% of total fatty acids were
identified from the evaluated samples. Of the identified fatty acids within the D1 cells,
four specific fatty acids were most abundant within cells of each sample condition.
Palmitic, stearic, oleic, and linoleic fatty acids were all found in the highest percentages
for each condition.
Comparison of the percentages of the four most prevalent fatty acids is shown in
Figure 4.6.

For samples treated with DMEM, the percentage of linoleic acid was

significantly lower (p<0.05) than the percentages of stearic, palmitic, or oleic acid; the
percentage of oleic acid, however was significantly higher than stearic, palmitic, and
linoleic acid.

For samples treated with AC, the percentage of linoleic acid was

significantly lower than palmitic and oleic acid.

The percentage of oleic acid was

significantly higher than linoleic and stearic acid, but there was no difference between the
percentage of oleic acid and palmitic acid for samples treated with AC. For all samples
that were supplemented with linoleic acid, the percentage of linoleic acid was
significantly higher than stearic, palmitic, or oleic acid percentages. For samples treated
with linoleic acid at the initial seeding, denoted as LA Begin, there was no significant
difference in the percentage of oleic, stearic, or palmitic acids. For samples treated with
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linoleic acid at initial seeding and then cultured with the adipogenic cocktail, denoted LA
Begin + AC, the percentage of palmitic acid was significantly higher than that of stearic
and oleic acid. When linoleic acid was added to cells once they reached confluence (LA
Confl) the percentage of palmitic acid was significantly higher than the percentage of
stearic and oleic acid. Similarly, when linoleic acid and the adipogenic cocktail were
both added at confluence (LA Confl+AC) the percentage of palmitic acid was
significantly higher than stearic and oleic acid. Finally, when linoleic acid was added to
the cells after they were stimulated to differentiate for six days, there was no difference in
the percentage of stearic, oleic, or palmitic acids.
Comparison of the amount of palmitic acid present within cells of each condition
showed no difference in the percentage of palmitic acid present in samples treated with
DMEM or AC. When compared to the DMEM control, there was no difference in the
percentages of palmitic acid and any samples cultured with linoleic acid. Additionally,
when compared to the AC control, there was no difference in the percentage of palmitic
acid and any samples cultured with linoleic acid. Comparison of samples treated with
linoleic acid showed no difference in the percentage of palmitic acid, regardless of when
the linoleic acid was added to the culture medium of the cells.
Comparison of the amount of stearic acid present within cells of each condition
showed no difference in the percentage of stearic acid present in samples treated with
DMEM or AC. The percentage of stearic acid in the DMEM samples was significantly
higher than all conditions, with the exception of the LA Diff samples. When compared to
the AC control, there was no difference in the percentage of stearic acid and any samples
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Carbon #
12
14
14:1 c9
15
16
16:1 c9
17
18
18:1 t9
18:1 t10
18:1 c9
18:1 c11
18:2 Omega-6
18:3 Omega-3
18:2 c9t11
18:2 c11t13
18:2 t10c12
18:2 c9c11
18:2 t11t13/t8t10
18:2 t9t11/t10t12
20:4 Omega-6
20:5 Omega-3
22:5 Omega-3
22:6 Omega-3

Common Name
Lauric
Myristic
Myristoleic
Pentadecanoic
Palmitic
Palmitoleic
Heptadecanoic
Stearic
Trans-9 octadecenoic
Trans-10 octadecenoic
Oleic
Cis-11 octadecenoic
Linoleic
Linolenic
CLA cis9 trans11
CLA cis11 trans13
CLA trans10 cis12
CLA cis9cis11
CLA trans11 trans13/trans8 trans10
CLA trans9 trans11/trans10 trans12
Arachidonic acid
EPA
DPA
DHA
Total Fatty Acid Percentage (SUM)
Unidentified Fatty Acids (100%-SUM)

Media Type
Average Percent (%) of Total Fatty Acid Composition
Note: Values reported as Percent of Fatty Acid ± Standard Deviation (n=3 samples per condition)
DMEM
AC
LA Begin
LA Begin + AC
LA Confl LA Confl + AC
LA Diff
0.69 ± 0.19
4.06 ± 3.58
0.36 ± 0.06
2.03 ± 0.30
16.47 ± 1.02
2.15 ± 0.20
0.47 ± 0.12
15.92 ± 1.49
0
0
26.00 ± 1.09*
0
6.32 ± 0.20
2.67 ± 0.91
1.47 ± 1.22
1.25 ± 0.46
0
0.54 ± 0.15
0.92 ± 0.11
0.45 ± 0.04
3.34 ± 0.50
0.61 ± 0.06
1.26 ± 0.22
1.72 ± 0.38
88.75
11.25

0.83 ± 0.09
2.79 ± 0.43
0.47 ± 0.18
1.58 ± 0.15
20.89 ± 2.52*
3.65 ± 1.57
0.45 ± 0.10
13.08 0.47
0
0
25.47 ± 2.51*
0
7.17 ± 0.14
2.47 ± 0.24
0.72 ± 0.14
1.19 ± 0.14
0
0.44 ± 0.06
0.75 ± 0.03
0.38 ± 0.03
2.40 ± 0.20
0.43 ± 0.08
0.96 ± 0.11
1.34 ± 0.05
87.46
12.54

0.38 ± 0.09
1.78 ± 0.23
0.24 ± 0.05
0.74 ± 0.25
13.02 ± 2.24*
0.70 ± 0.63
0.94 ± 0.70
8.56 ± 1.09
0.65 ± 0.36
0.38 ± 0.65
6.85 ± 6.71
1.75 ± 1.57
44.61 ± 14.13*
0.15 ± 0.27
0.19 ± 0.33
3.45 ± 1.65
0.16 ± 0.27
0.24 ± 0.02
1.06 ± 0.20
0.15 ± 0.13
2.07 ± 0.90
0.54 ± 0.08
0.41 ± 0.05
0.49 ± 0.24
89.51
10.49

0.66 ± 0.12
2.41 ± 0.71
0.41 ± 0.16
0.56 ± 0.10
15.35 ± 2.94*
0.72 ± 0.16
0.32 ± 0.02
8.82 ± 0.61
0.44 ± 0.04
0
4.03 ± 1.94
1.12 ± 0.41
45.02 ± 2.19*
0.15 ± 0.13
0
3.72 ± 0.58
0.05 ± 0.09
0.31 ± 0.10
1.03 ± 0.31
0.11 ± 0.10
2.26 ± 0.64
0.48 ± 0.08
0.44 ± 0.11
0.41 ± 0.17
88.83
11.17

0.43 ± 0.09
0.41 ± 0.07
1.89 ± 0.43
2.23 ± 0.37
0.43 ± 0.25
0.53 ± 0.33
0.57 ± 0.10
0.65 ± 0.05
15.07 ± 3.78* 18.19 ± 1.82*
0.86 ± 0.46
1.12 ± 0.17
0.79 ± 0.36
0.99 ± 1.09
8.45 ± 0.97
7.31 ± 1.05
0.49 ± 0.17
0.29 ± 0.09
0.17 ± 0.29
0.12 ± 0.20
7.80 ± 5.33
6.50 ± 2.55
1.34 ± 0.44
1.43 ± 0.10
44.08 ± 6.18* 44.70± 3.93*
0.12 ± 0.11
0.15 ± 0.17
0.04 ± 0.06
0.00
3.33 ± 0.53
2.79 ± 0.28
0.00
0.17 ± 0.04
0.28 ± 0.14
0.55 ± 0.33
0.90 ± 0.19
0.31 ± 0.53
0.18 ± 0.05
0.15 ± 0.02
1.68 ± 0.09
1.76 ± 0.39
0.57 ± 0.27
0.43 ± 0.07
0.50 ± 0.28
0.53 ± 0.06
0.41 ± 0.12
0.42 ± 0.12
90.40
91.73
9.60
8.27

0.73 ± 0.08
1.97 ± 0.16
0.35 ± 0.05
0.73 ± 0.27
15.27 ± 2.50
1.51 ± 0.34
0.33 ± 0.06
10.37 ± 0.18
0
0
14.75 ± 1.02
3.93 ± 0.28
31.14 ± 0.92*
0.53 ± 0.08
0.06 ± 0.11
1.83 ± 0.16
0.66 ± 0.28
0.51 ± 0.34
0.41 ± 0.17
0.53 ± 0.40
1.28 ± 0.17
0.42 ± 0.09
0.45 ± 0.03
0.45 ± 0.03
88.21
11.79

Figure 4.5: The fatty acid composition of each sample condition was determined by gas chromatography analysis. The most
abundant fatty acids present within each sample were palmitic, stearic, oleic, and linoleic. The percentage of linoleic acid was
consistently higher for samples that were cultured with linoleic acid in vitro. Asterisks (*) indicate values significantly higher
than all other fatty acids for that sample condition (p<0.05)
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cultured with linoleic acid. Comparison of samples treated with linoleic acid showed no
difference in the percentage of stearic acid, regardless of when the linoleic acid was
added to the culture medium of the cells.
Comparison of the amount of oleic acid present within cells of each condition
showed no difference in the percentage of oleic acid present in samples treated with
DMEM or AC. When compared to the DMEM control, the percentage of oleic acid was
significantly higher than that of any samples treated with linoleic acid. Similarly, when
compared to the AC control, the percentage of oleic acid was significantly higher than the
percentage of oleic acid in any samples treated with linoleic acid during culture.
Comparison of samples treated with linoleic acid during culture showed that the
percentage of oleic acid in the LA Diff samples (linoleic acid added 6 days postdifferentiation) was significantly higher than any other samples that were cultured with
linoleic acid.
Comparison of the amount of linoleic acid present within cells of each condition
showed no difference in the percentage of linoleic acid present in samples treated with
DMEM or AC. When compared to the DMEM and AC controls, the percentage of
linoleic acid was significantly higher in all other samples that were cultured with linoleic
acid, regardless of when the linoleic acid was added to the culture medium. Comparison
of all samples treated with linoleic acid during culture showed that the percentage of
linoleic acid in the LA Diff samples was significantly lower than any other samples
cultured with linoleic acid at any point during the study.
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Figure 4.6: The fatty acids found in the highest percentage for each medium were
palmitic, stearic, oleic, and linoleic. Samples noted as a, c and b, d have significantly
higher and lower percentages of palmitic and stearic acids than samples treated with
DMEM and AC, respectively. Samples noted as e, g, i, k, and l have significantly higher
palmitic, stearic, and oleic acid percentages than samples treated with a specific
medium. Samples noted as f, h, and j have significantly higher stearic and oleic acid
percentages than samples treated with a specific medium. Asterisks (*) note samples
with significantly higher percentages of linoleic acid than DMEM and AC samples.
Pound signs (#) note samples that have significantly higher percentages of oleic acid
than DMEM and AC samples. Percent signs (%) note samples with significantly higher
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percentage of stearic acid than all other samples. Graphical error bars represent the
standard error of the mean.

Oil Red O Staining
Representative images of the DMEM and AC control samples at Day 8 are shown
in Figure 4.7A and C, respectively. The image of the DMEM sample shows the normal
morphology of a confluent layer of D1 cells (4.7A). Oil Red O staining for intracellular
lipid resulted in minimal red-stained lipid in samples cultured with DMEM alone at Day
12 (Figure 4.7B). The addition of the adipogenic cocktail to the D1 cells resulted in the
formation of lipid droplets as seen in Figure 4.7C; Oil Red O staining of the cells, shown
in Figure 4.7D, confirmed the presence of large, red-stained lipid droplets characteristic
of differentiating cells.
Representative images of D1 cells treated with linoleic acid at various stages of
cell culture are shown in Figure 4.8 A, C, E, G, I. The addition of linoleic acid to D1
cells at initial seeding, LA Begin (4.8A), at confluence, LA Confl (4.8E), and
differentiation for six days, LA Diff (4.8I), resulted in what appear to be minimal changes
in cell morphology when compared to the AC control (4.7C). When linoleic acid was
added at the initial seeding and then supplemented with the adipogenic cocktail (LA
Begin+AC), obvious changes in cell morphology occurred. As shown in Figure 4.8C,
rounded lipid droplets that appear as bright, opaque circles, are visible throughout the
sample. As shown in Figure 4.8I, when linoleic acid and the adipogenic cocktail were
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both added at confluence (LA Conf AC), the D1 cell morphology appeared to be similar
to that of the AC control sample. Oil Red O staining of cell samples at Day 12

Figure 4.7: At Day 8, representative microscopic images of D1 cells cultured in DMEM
(A) and AC (C) show a confluent layer of stromal cells, and the cells accumulating lipid
droplets upon differentiation, respectively. Oil Red O staining at Day 12 of the D1 cells
cultured in DMEM (B) and AC (D) highlighted minimal lipid within the undifferentiated
cells, but clearly rounded red-stained lipid when the AC was added. Total magnification
for all images is 320x.
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highlighted red-stained lipid droplets within cells of each condition (Figure 4.8 B, D, F,
H, and J). There were apparent differences in the amount of stained lipid and the pattern
of staining within each sample condition.

When linoleic acid was added at initial

seeding, LA Begin, accumulated lipid appeared largely disorganized and non-uniform
throughout the cells (4.8B). When D1 cells were initially seeded with linoleic acid and
then supplemented with the adipogenic cocktail, LA Begin+AC, stained lipid appeared to
become more uniformly rounded within the cells (4.8D), similar to cells treated with AC
alone. Addition of linoleic acid once the D1 cells reached confluence, LA Confl, resulted
in red-stained lipid that appeared to be lighter in color and more randomly distributed
throughout the cell sample (4.8F). When both linoleic acid and the adipogenic cocktail
were added to the D1 cells at confluence, LA Confl+AC, brightly stained rounded lipid
droplets were apparent throughout the culture (4.8H). Finally, addition of linoleic acid
following differentiation of the D1 cells for six days with the adipogenic cocktail, LA
Diff, resulted in large, darker red stained lipid droplets that were clearly rounded and
similar in shape to those seen in the AC samples; the staining of the LA Diff samples,
however, was darker than that seen in the AC samples (4.8J).
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Figure 4.8: Representative images of each sample were captured at Day 8 (A, C, E, G,
and I). Oil Red O staining of each sample at Day 12 showed varied patterns of staining,
depending on when linoleic acid was added to D1 culture medium (B, D, F, H, and J).
Total magnification for all images is 320x.
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Total Triglyceride Measurement
As shown in Figure 4.9, measurement of total triglyceride concentration within
D1 cells showed that when compared to the DMEM control, the amount of triglyceride
was significantly higher in all other sample conditions. When compared to the AC
control sample, the amount of triglyceride was significantly higher in all other sample
conditions containing linoleic acid, with the exception of the LA Diff samples. The

Figure 4.9: Measurement of total triglyceride concentration confirmed there was no
difference between AC and LA Diff, denoted by asterisks (*), and there was no difference
between LA Begin and LA Confl + AC, denoted by percent signs (%) (p<0.05). All other
measured concentrations were significantly different from each other. Graphical error
bars represent the standard error of the mean.
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amount of triglyceride in the LA Begin + AC samples was significantly higher than all
other sample conditions. Additionally, there was no significant difference in the amount
of triglyceride measured in cells treated with linoleic acid at initial seeding (LA Begin)
and cells treated with both the linoleic acid and the adipogenic cocktail once the D1 cells
reached confluence (LA Confl + AC).

4.4 Discussion
Determination of Optimal Fatty Acid Concentrations for Cell Cultures
Measurement of the pH of the culture medium from each sample was performed
to determine if the addition of fatty acids had any influence on the acidity of the culture
environmentand to help determine an optimal concentration of fatty acid to use for future
studies—i.e. to define a concentration that would provide the desired outcome without
compromising the culture environment. The addition of linoleic acid did not begin to
influence the medium pH until concentrations of 2% or greater were added to the cells.
A significant difference in pH was not observed until concentrations greater than 8%
were added to the cells. There was no significant difference between the pH of samples
treated with 4% and 6% linoleic acid, so our concentrations of interest were limited to
either 2% or 4%. Additional analyses were then considered to determine which was
more optimal for future studies, 2% or 4%.
For each condition, there was a significant increase in DNA concentration from
Day 7 to Day 14, indicating that the cells were still proliferating after Day 7 of culture,
such that the cell number increased over time. The samples treated with 6% and 8%
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linoleic acid had a significantly lower amount of DNA, suggesting that the cell number
was lower due to the addition of a higher amount of fatty acid. At Day 14, it was
observed that the samples treated with 4% linoleic acid had a significantly higher amount
of DNA than the AC samples, indicating that there was a higher number of cells present
within the 4% samples. Additionally, when compared to the 6% and 2% samples, the 4%
sample had a higher DNA concentration at Day 14, suggesting that optimal cell number
may be obtained by treating cells with 4% linoleic acid. It is also important to note that
the cells cultured with the AC+LA (adipogenic cocktail + 1%LA) resulted in no
significant difference in DNA concentration when compared to the AC. As it is shown
that addition of linoleic acid to the culture medium does influence DNA concentration, it
is likely that the concentration of linoleic acid combined with the adipogenic cocktail
should be increased from 1%.
Adipogenesis is characterized by biochemical and morphological changes, where
preadipocytes begin to accumulate intracellular lipid droplets, and cell shape changes
from a fibroblast-like spindle shape to a rounded shape, characteristic of mature
adipocytes [10-14]. The addition of linoleic acid to the 1%, 4%, and 12% samples
appeared to induce lipid-filling within the cells, similar to the outcome observed by
Shillabeer and coworkers, where addition of fatty acid to preadipocytes resulted in
increased lipid accumulation within cells [4]. Increased amounts of fatty acid added to
the D1 cultures also correlated with increased staining of lipid within the cells.

The

exact mechanism of cellular fatty acid uptake is not clearly defined, however, it has been
suggested that intracellular diffusion of fatty acids into cells may be enhanced by
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cytosolic fatty acid binding proteins, thus explaining the rapid uptake of fatty acids from
culture medium [15].
The increase in amount of triglyceride within samples from Day 7 to Day 14
indicated that the cells were actively differentiating over time with the addition of higher
concentrations of linoleic acid added to the culture medium. In order to maximize
triglyceride production, it seems that the addition of linoleic acid, at a concentration
higher than 1%, with the adipogenic cocktail will stimulate more triglyceride production.
In order to determine the optimal concentration to be used for future studies, the results of
each assay were considered.

From the pH measurements it was determined that

concentrations of 2%, 4%, and 6% did not significantly influence the pH of the culture
medium. Concentrations higher than 6% created a more acidic environment. There was
no difference observed between the 4% and 6% pH values, so 2% and 4% were selected
as possible optimal concentrations that would allow treatment with the minimal amount
and stimulation of the desired outcome. Comparison of the DNA concentrations of the
2% and 4% samples showed that the 4% samples had significantly more DNA than the
2% samples. Likewise, measurement of the triglyceride content at the end of the study
showed that the 4% samples had significantly more triglyceride than the 2% samples. A
concentration of 4% linoleic acid was therefore identified as the optimal concentration to
be used for future studies.
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Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing
Intervals
Unsaturated fatty acids, that contain one or more carbon-carbon double bonds
within their carbon chain, may be characterized as n-3, n-6, or n-9 fatty acids, and are
more commonly referred to as omega (ω)-3, ω-6, or ω-9 fatty acids. This designation of
the fatty acids refers to the location of the double bond in proximity to the carboxyl group
of the fatty acid molecule [16]. With the exception of n-3 and n-6 fatty acids, fatty acids
may be synthesized by animal cells. The n-3 and n-6 fatty acids are therefore known as
essential fatty acids (EFAs) because they must be provided by dietary sources since they
cannot be produced within the body. The EFAs include the ω-3 fatty acid, linolenic acid,
and the ω-6 fatty acids linoleic acid and arachidonic acid. EFAs are important to cellular
processes because they are required for synthesis of other fatty acids, prostaglandins,
prostacyclins, and thromboxanes [2, 17].
The culture medium for mammalian cell culture is composed of inorganic salts,
vitamins, and amino acids. Cellular growth, however, requires additional nutrients in the
form of other proteins and lipids, which are most often supplied via serum that is added
to the culture medium. Serum derived from cattle, horses, and goats, for example, are
often used to supplement cell culture medium. Since lipids and fatty acids are insoluble
in water they are often bound to proteins, such as albumin, that facilitate their transport.
EFAs are often provided to cells as albumin-bound fatty acids within serum. Fatty acids
are also provided to cells in serum-free cultures via lipid blends consisting of nonessential fatty acids such as palmitic, oleic, and stearic acid, and EFAs such as linoleic
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and linolenic acid [16]. Early evaluation of bovine serum fatty acid components showed
that palmitic, oleic, and stearic acids account for 74% of the total fatty acids, while
linoleic acid accounts for 12% of total fatty acids [18]. In human serum, palmitic, oleic,
and stearic acids account for 59.5% of total fatty acids, while linoleic acid is 20% of total
fatty acids [19]. Fatty acids are therefore vital to cell culturing systems. Additionally,
since linoleic acid is the only EFA constituting a large part of the serum used for cell
culture, it is likely that the inclusion of linoleic acid is imperative for cell culture systems
[2, 17].
There are two proposed mechanisms by which cells uptake fatty acids. It has
been suggested that fatty acids can move unassisted across cell membranes via passive
diffusion. Alternatively, it has been suggested that proteins bound to the fatty acids (fatty
acid binding proteins) facilitate their transport into cells [20-24].

Early research

conducted by Abumrad and coworkers evaluated cultures of BFC-1 preadipocytes,
derived from brown mouse fat, to determine the uptake of fatty acids by preadipocytes
during differentiation in vitro [25].

Confluent cultures of the BFC-1 cells were

stimulated to differentiate with the addition of insulin and triiodothyronine. Preadipocyte
cells and differentiated mature cells were incubated with medium containing 80nmol of
oleate (oleic acid) and analyzed using a transport assay to observe fatty acid uptake.
Analysis of the preadipocytes and mature adipocytes showed that the most rapid uptake
of fatty acids occurred in the preadipocytes. Mature fat cells contain intracellular lipid
which serves as a source of fatty acids for the cells. The preadipocytes, meanwhile, only
had exogenous fatty acids in the medium available for use. This led Abumrad and
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coworkers to speculate that early stage differentiation cells will rapidly uptake available
lipids and ultimately produce increased levels of intracellular lipid because more fatty
acids are available for synthesis of triglycerides [25].
For the D1 cells cultured in this study, the uptake of linoleic acid is apparent from
comparisons of the fatty acid profile for each cell condition determined by gas
chromatography. Cells cultured for each specified condition commonly expressed four
fatty acids in the highest percentages: palmitic, stearic, oleic, and linoleic acid. When
linoleic acid was added to the cells at any point during culturing, whether at initial
seeding, at confluence, or post-differentiation, there was significantly more linoleic acid
within the cells than the cells cultured in normal DMEM media or when the cells were
differentiated with only the specified adipogenic cocktail. The lack of exogenous linoleic
acid in the culture medium of the DMEM and AC samples resulted in a much lower
percentage of linoleic acid within the cells. The point during cell culture at which the
linoleic acid was added to the D1 cells did appear to have some influence on the amount
of linoleic acid measured within the cells—the percentage of linoleic acid in the LA Diff
samples that were differentiated for 6 days and then supplemented with linoleic acid, had
a significantly lower percentage of linoleic acid than the cells that had linoleic added at
initial seeding or confluence. As was observed in the study conducted by Abumrad and
coworkers, however, it is possible that the differentiated cells did not take up as much of
the linoleic acid because there was already a source of intracellular fatty acids within the
cells, and the exogenous lipid was not as readily needed for triglyceride synthesis.
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The fatty acid profile for the D1 cells in the study also interestingly showed that
for samples cultured without linoleic acid, i.e. the DMEM and AC samples, oleic acid
was present in the highest percentage and linoleic acid was found in the lowest
percentage (of the four common fatty acids). The addition of linoleic acid to the D1 cells,
however, resulted in decreased percentages of oleic acid and significantly higher
percentages of linoleic acid. There appears to be an exchange of some sort occurring
between linoleic and oleic acid within the cells, whereby the influx of linoleic acid
replaces the oleic acid within the cells. This is likely due to similarities in the structure of
oleic and linoleic acids; they are both unsaturated fatty acids that are 18 carbon atoms
long, with linoleic having only one more double bond than oleic acid. Stearic acid levels
were significantly lower in all samples treated with linoleic acid, with the exception of
the LA Diff samples. Stearic acid is also 18 carbon atoms in length so there may be some
influence on its percentage by the increase in linoleic acid. The amount of palmitic acid,
within cells of each condition, was not significantly changed by the addition of linoleic
acid—palmitic acid is 16 carbon atoms in length and therefore likely not influenced by
increased linoleic acid, assuming this theory is correct.
Fatty acids have also been suggested to influence adipogenesis of fat cells. The
differentiation of fat cells from preadipocytes to mature adipocytes is characterized by
morphological and biochemical changes, where triglycerides accumulate within maturing
cells to form intracellular lipid droplets.

The relationship between fatty acids and

triglycerides is well established as it is known that triglycerides are composed of fatty
acids attached to a glycerol molecule. Fatty acids in cells also are converted to acyl
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coenzyme A molecules that are either oxidized for energy expenditure, or used to
synthesize triglycerides [2, 14]. Studies by Amri [26, 27] and coworkers and Grimaldi
and coworkers [28] evaluated the effect of derivatives of linolenic acid and palmitic acid,
respectively, on preadipocyte cell differentiation.

Both groups determined that the

addition of fatty acids, particularly long-chain fatty acids resulted in the expression of
aP2, a known marker of adipogenesis. Additionally, Hutley and coworkers evaluated the
effect of culturing human primary preadipocytes with 100µM of linoleic acid over 21
days [5] and found that linoleic acid facilitated triglyceride storage within the cells.
The results of the total triglyceride assay and Oil Red O staining here indicate that
linoleic acid does have an influence on D1 cell adipogenesis. Each sample cultured with
linoleic acid contained higher levels of triglyceride than the DMEM and AC samples,
which did not have added linoleic acid. Addition of linoleic acid also appeared to lead to
increased staining of intracellular lipid within the D1 cells; however the lipid within cells
that did not receive the adipogenic cocktail was not uniformly rounded in shape, as is
typically characteristic for maturing cells. This suggests that the linoleic acid alone may
stimulate accumulation of lipid within the cells, caused by the excess fatty acids which
are available for synthesis of triglycerides. The lowest triglyceride concentration was
measured in the LA Diff samples, likely because these samples were exposed to linoleic
acid for the shortest period of time and thus did not accumulate as much linoleic acid that
could be used for synthesis of triglyceride.
Early introduction of fatty acids to the D1 cell cultures resulted in increased
uptake of the linoleic acid by the cells. The early exposure of the cells to the fatty acids
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means that the cells were provided with a fatty acid source earlier in culture that was used
for synthesis of triglycerides within the cells.

Additionally, the addition of the

adipogenic cocktail to cells cultured with linoleic acid may have aided in the resulting
increased triglyceride accumulation.

The adipogenic cocktail contains IBMX,

dexamethasone, and insulin which all influence differentiation. Insulin is a hormone that
regulates cell growth and metabolism. In fat cells, insulin suppresses the lipolysis, or
breakdown, of stored triglycerides, facilitates the influx of glucose into the cells, and
facilitates triglyceride synthesis by stimulating the esterification of fatty acids [2, 29-35].
It is therefore likely that the combination of increased fatty acid and insulin could
together facilitate increased triglyceride production as was observed in these studies.
Evaluation of the triglyceride measurement and Oil Red O staining of the LA Begin and
LA Confl samples with and without the adipogenic cocktail suggest that combination of
the linoleic acid with the adipogenic cocktail results in higher amounts of triglyceride and
larger, more uniform lipid droplets.

4.5 Conclusions
The addition of linoleic acid to cultures of D1 stem cells was shown to influence
adipogenesis. Increased amounts of triglyceride were produced within cells cultured with
linoleic concentrations higher than 2%. The optimal concentration for treating cells to
garner increased triglyceride production without compromising the integrity of the
culture media was determined to be 4% and was used for subsequent studies.
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It can be concluded that cells grown in culture medium supplemented with
exogenous fatty acids will uptake the fatty acid that they are provided, such that increased
levels of that specific fatty acid will be found within intracellular lipid. Inclusion of
exogenous linoleic acid in D1 cell culture medium resulted in increased triglyceride
production and lipid accumulation when compared to D1 cells without any linoleic acid.
The combination of linoleic acid and an adipogenic inducing cocktail resulted in
increased triglyceride levels of triglyceride and lipid as compared with levels in cells
grown with only linoleic acid in the culture medium. This suggests that the components
of the adipogenic cocktail, most likely the insulin, and linoleic acid work together to
facilitate lipid production. The period of time at which linoleic acid is added to cell
cultures also influences the accumulation of intracellular lipid, suggesting that long-term
exposure of cells to fatty acids will result in increased intracellular lipid. This idea,
therefore, could prove useful for further development of adipose tissue engineering
strategies; supplying adipose cells with available fatty acids will likely stimulate
triglyceride production and lipid accumulation which should result in increase adipose
tissue mass in vivo.
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CHAPTER 5
EVALUATION OF FATTY ACID-SUPPLEMENTED SUBSTRATES ON
ADIPOSE CELL DIFFERENTIATION IN THREE-DIMENSIONAL (3-D)
CULTURE

5.1 Background
The injectable composite system for breast reconstruction is comprised of cells
seeded on biodegradable beads of an injectable size; these cellular constructs are then
mixed with a hydrogel delivery medium, resulting in a composite that may be injected
into a patient through a syringe at the defect site. For successful implementation of our
injectable composite system, the three-dimensional (3-D) beads must support adipose cell
attachment in vitro in order for proliferation and differentiation to occur. Preadipocytes
are anchorage-dependent cells, thus, if the cells are not attached to a scaffold or support
structure, they will not proliferate.

Additionally, the cells may potentially stop

proliferation should they become detached from the scaffold surface. Sugihara and
coworkers demonstrated that with primary adipose cells, adhesion directly influences
proliferation of cells, which in turn influences the differentiation of fat cells [1]. Previous
work has shown that for our proposed injectable composite system, culturing adipose
cells on injectable sized beads led to increased triglyceride production when compared to
cells cultured in two-dimensional (2-D) culture [2, 3].

Additionally, differences in

adipogenic genes expressed by adipose cells were observed when cells were grown in 2D versus 3-D culture [4].
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Chitosan is a natural biomaterial derived from the de-acetylation of chitin (a
copolymer of N-acetyl-glucosamine and N-glucosamine units linked by β(14)
glycosidic bonds [5-7].

Other than cellulose, chitin is the second most abundant

polysaccharide on earth and is typically found in the exoskeleton of crustaceans such as
crabs and shrimp [8-10].

Chitosan has been widely investigated for biomedical

applications such as wound healing, anti-microbial treatment of bacteria, and drug
delivery [7, 11, 12]. The use of chitosan for biomedical applications is so extensive
because it is readily available, cost-effective, biocompatible, biodegradable, and easily
processed to form structures of varied shape and porosity [6, 12, 13]. As a result of these
desirable attributes, chitosan has been investigated for engineering skin, bone, cartilage,
liver, nerve, and vascular tissues [14-17].
The use of chitosan for adipose tissue engineering has not been widely
investigated by many researchers; however, great potential for chitosan in adipose tissue
engineering applications exists. Chitosan is easily processed into scaffolds of various
shapes and sizes. Fabrication of injectable microspheres that would be well-suited for
minimally invasive applications, such as those where adipose tissue engineering would be
useful, has been reported [17, 18]. Additionally, the ease of combining growth factors
and therapeutics within chitosan, due to its cationic nature, may potentially provide
scaffolds that will facilitate adipose cell attachment and differentiation to mature fat cells
to form new tissue in vivo. To produce a bead that would more optimally support adipose
cell growth, while allowing successful delivery by injection, we opted to use beads made
of a chitosan-gelatin blend.
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The studies in Chapter 4 were performed to determine what influence exogenous
fatty acids in cell culture medium would have on adipogenic differentiation in 2-D
culture. It was determined that the addition of linoleic acid to the culture medium of D1
cells positively influenced adipogenic differentiation by facilitating increased triglyceride
production and intracellular lipid accumulation.

In order to improve the existing

injectable composite system, it was therefore suggested to incorporate fatty acids into the
microcarrier beads such that release of the fatty acids over time would ideally stimulate
increased lipid production over time. This study was performed to determine the efficacy
of producing fatty acid-loaded chitosan-gelatin beads and to determine the response of
cells to the manufactured beads in vitro.

5.2 Materials & Methods
Solution Preparation
A 1% v/v glacial acetic acid was prepared by mixing 1mL glacial acetic acid
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water. The glacial acetic acid was
filter sterilized with a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning, Corning,
NY). Chitosan (MW: 100,000-300,000, Acros Organics, Morris Plains, NJ) and gelatin
(Sigma, St. Louis, MO) powders were autoclaved at 124°C for 25 minutes to sterilize.
All other steps in the bead fabrication process were carried out in a SterilGARD III
Advance laminar flow Class II Biological Safety Cabinet (The Baker Company, Sanford,
ME) to maintain sterility. A 3% w/v chitosan-gelatin solution was prepared by dissolving
3g of chitosan and 3g of gelatin in 100mL of 1% v/v glacial acetic acid and stirring at low
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heat until completely dissolved. A 0.5N solution of sodium hydroxide (NaOH) was
prepared by dissolving 20g NaOH salt (Fisher Chemicals, Fair Lawn, NJ) in 1L of
distilled water and stirring at room temperature. The solution was filter sterilized before
use using the 0.22µm PES filters.

Bead Preparation & Characterization
The chitosan-gelatin beads were formed using an electrostatic bead generator
(Nisco, Zürich, Switzerland).

The chitosan-gelatin solution was drawn into a 20cc

syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge needle (Becton
Dickinson). The syringe was secured in place on top of a syringe pump (kdScientific,
New Hope, PA) that was set to eject the solution at a rate of 15 mL/hour. The chitosangelatin solution was ejected from the syringe and guided through plastic tubing attached
to the end of the syringe, into a metal needle of the electrostatic bead generator. The
needle was placed so that the point of ejection was approximately 4cm above the surface
of the NaOH solution below. The NaOH was pipette into a glass 80 x 40mm dish
(Pyrex®, Corning, Corning, NY) until just overflowing(>180mL) into a 100 x 20mm
glass collection dish (Pyrex) beneath. The NaOH was continuously stirred at an agitation
rate of 25%. The applied voltage potential was set at 6.5kV to obtain beads.

The

fabricated beads were collected in the 80 x40 cm dish and stirred for an additional 30
minutes post formation in the NaOH solution at the same agitation rate. The NaOH was
drained from the beads and the resulting beads were washed three times with sterile
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phosphate buffered saline (PBS) (Sigma, St. Louis, MO). The beads were then placed in
sterile DMEM until seeded into well plates.
To prepare the beads loaded with fatty acid, immediately before preparation,
10mL of the chitosan-gelatin solution was mixed with 5mL of sterile linoleic acidalbumin solution (Sigma, St. Louis, MO) in a sterile 50-mL centrifuge tube (Fisher
Scientific, Fair Lawn, NJ). The solution was pipetted up and down several times to
ensure complete mixing and then drawn into a 20cc syringe (BD, Franklin Lakes, NJ)
using a 16 gauge needle (BD, Franklin Lakes, NJ). The beads were then prepared using
the previously described settings.
To evaluate the morphology of the prepared scaffolds, images of each type were
captured using an EMZ-TR stereomicroscope (Meiji Techno, Tokyo, Japan) with a
Lumina light source (Chiu Technical Corporation, Kings Park, NY) and a SPOT
INSIGHT Color digital camera (Diagnostic Instruments, Sterling Heights, MI). The
average diameter of the scaffolds was measured using Image-Pro Plus version 4.1
software (Media Cybernetics, Inc., Silver Spring, MD).

Cell Culture
A volume of 0.6mL of plain and fatty acid loaded chitosan-gelatin beads were
placed into individual wells of 24-well ultra-low binding plates (Corning, Corning, NY).
Murine bone marrow stromal cells, D1 cells (ATCC, Manassas, VA), of passage 9 were
seeded into each well containing beads, with 4.5x105 cells added to each well. Cells were
maintained in Dulbecco’s Modified Eagle Medium (DMEM) (ATCC, Manassas, VA)
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supplemented with 10% FBS (Mediatech, Herndon, VA), 0.2% fungizone (Gibco,
Invitrogen, Carlsbad, CA) and 1% Antibiotic-Antimycotic (Gibco, Invitrogen, Carlsbad,
CA) at standard culture conditions of 37°C and 5% CO2. After 2 days of culture, upon
medium change, cells were cultured with either an adipogenic differentiation cocktail, or
with DMEM. The adipogenic cocktail consisted of 100µl insulin (Sigma, St. Louis,
MO), 2µl dexamethasone (Sigma, St. Louis, MO), and 1mL IBMX (Sigma, St. Louis,
MO) per 10mL of DMEM medium. Culture medium was changed every 2 days during
the study. Cells were then evaluated at Day 10 and Day 17 to determine the influence of
culturing cells on plain or fatty acid loaded chitosan-gelatin beads.

Fatty Acid Release Characterization
To evaluate the amount of fatty acid released from the loaded fatty-acid beads
over time, the same volume of beads used for cell culture studies, 0.6mL, was placed into
wells of a 24-well culture plate (Corning, Corning, NY) with 1mL PBS per well. The
plate containing the beads was also incubated at 37°C and 5% CO2. Aliquots of the PBS
were taken over time and evaluated using the working solution contained in the BCA
Protein Assay Kit (Pierce, Rockford, IL). Incubation of the samples with the BCA
working solution resulted in a colorimetric change that could be read using a Biotek
Synergy MX Multi-Mode Microplate Reader (BioTEK Instruments, Winooski, VT) at
562nm wavelength to determine the concentration fatty acid released from the beads.
Diluted samples of the linoleic-albumin stock solution (Stock Concentration =
850ug/mL) were prepared at concentrations ranging from 0 to 425ug/mL. Absorbance
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measurements of the diluted samples were used to prepare a standard curve that was used
for determination of the concentration of fatty acid released from beads over time.

Live/Dead Cell Viability Staining
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was
used to qualitatively assess cellular attachment to the beads and to assess cellular viability
after 10 days and 17 days of cell culture.

The LIVE/DEAD® working solution,

consisting of 10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM,
was prepared in a sterile 15mL centrifuge tube according to the manufacturer’s
instructions. Culture medium was aspirated and beads were rinsed with 1mL of sterile
PBS (Sigma). The PBS was aspirated from the scaffolds and 1mL of the working
LIVE/DEAD® solution was added to each well of the plate containing scaffolds. The
plate was allowed to incubate for 45 minutes at room temperature and protected from
light. Following the incubation period, images of each well were captured using the
Axiovert 135 fluorescence inverted microscope (Zeiss, Thornwood, NY), with color
digital camera and imaging software.

The wells were evaluated for green and red

fluorescence apparent by the activity of the calcein AM and EthD-1, respectively, present
in the working solutions. Esterase present in live cells cleaves the calcein AM, resulting
in a green fluorescence, while the red fluorescence occurs when EthD-1 enters a dead
cell.
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Metabolic Activity
Cellular metabolic activity was quantitatively assessed using alamarBlue® Cell
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).

The

alamarBlue® reagent was added to each well at 10% of the amount of culture medium in
each well. Well plates were incubated for three hours at 37°C on a shaker plate (IKA®
Works, Wilmington, NC). Following incubation, 150µl of the reaction solution was
removed from the cell culture plates to wells of a black-walled, clear-bottom 96-well
microplate to assay the fluorescence of samples resulting from the reduction of the dye by
metabolically active cells to produce a color change from blue to pink. The absorbance
was read using a Biotek Synergy MX Multi-Mode Microplate Reader (Biotek
Instruments, Winooski, VT) at wavelengths of 570nm and 600nm. The percent reduction
of alamarBlue® was calculated using Equation 5.1 shown below.

%  

Where:



!"

 !

!"

 100%

Equation 5.1

A1 = absorbance of experimental well at 570nm
A2 = absorbance of experimental well at 600nm
N1 = absorbance of negative control (media plus alamarBlue® reagent
without cells) at 570nm
N2 = absorbance of negative control (media plus alamarBlue® reagent
without cells) at 600nm

Oil Red O Staining (ORO)
Cell culture medium was aspirated from well plates and the cells were rinsed
twice with sterile PBS. The cells were fixed with 2mL 10% neutral buffered formalin
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(Fisher Chemicals, Fair Lawn, NJ) overnight. An ORO stock solution was prepared by
dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in 100mL isopropanol (Fisher
Chemicals, Fair Lawn, NJ)). An ORO working solution was prepared by mixing 60mL
of ORO stock solution with 40mL deionized water and stirring for 30 minutes. A volume
of 500µL of the working solution was added to each well and incubated for 15 minutes at
room temperature. Following incubation, the wells were rinsed three times with fresh
deionized water. After decanting of excess water, the red-stained lipid was imaged using
an inverted microscope and imaging software.

Total Triglyceride Measurement
Cell culture medium was aspirated from well plates and the cells rinsed twice
with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL of 1% Triton
X-100 (Sigma, St. Louis, MO) was added to each well and the cells were incubated for
30 minutes at room temperature. Standard glycerol solutions of concentrations ranging
from 0 to 200µM glycerol were prepared by dissolving glycerol (Sigma, St. Louis, MO)
in deionized water. Following incubation, the cells from each well were collected with
the Triton X-100 solution into microcentrifuge tubes and centrifuged for 10 minutes at
3000rpm. 100µL of each sample and standard were pipetted into the wells of a 96-well
plate (Corning, Corning, NY) in triplicate. A volume of 100µL of Infinity™ Triglyceride
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated
for 15 minutes at room temperature. The absorbance was read at 490nm on a Biotek
Synergy MX Multi-Mode Microplate Reader (Biotek Instruments, Winooski, VT).
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Statistical Analysis
Statistical analyses were performed using SAS 9.2 software (Cary, NC) to
compare the effect of each culture medium on cell behavior. The Least Squares Means
(LSMEANS) was used with a significance level of p < 0.05 (n=3). Graphical error bars
represent the standard error of the mean.

5.3 Results

Bead Characterization
Measurement of the beads revealed that each type was approximately 0.24cm in
diameter, as indicated in Table 5.1. As observed in the images of Figure 5.1, there was
no difference observed in bead color or shape due to addition of linoleic acid.

Table 5.1 Bead Size Measurements
Bead Type
(n=20)

Minimum
Value (cm)

Maximum
Value (cm)

Average Measured
Size (cm)

Chitosan-Gelatin
Fatty Acid- Loaded
Chitosan-Gelatin

0.221

0.275

0.246 ± 0.013

0.205

0.297

0.245 ± 0.022
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A

B

Figure 5.1: Both the chitosan
chitosan-gelatin beads (A) and the fatty acid-loaded
loaded chitosanchitosan
gelatin beads (B) were similar in color, shape, and size. The distance between divisions
on the ruler in each image is 1 mm.

Fatty Acid Release
The cumulative amount of fatty acid released from the chitosan
chitosan-gelatin
gelatin beads
loaded with linoleic acid was determined by comparison with a set of diluted standards
prepared from the stock linoleic acid solution. As shown in Figure 5.2, at Time 0,
immediately
ely after seeding into the well plates, there was a small quantity of linoleic acid
(3.87±0.10 µg/mL) detected in the medium. After the first hour of incubation the fatty
acid concentration increased to approximately six times more than the initial
concentration.
tration. The amount of fatty acid released from the beads steadily increased
during the incubation period until around Day 10, when minimal change in the released
concentration was observed. The cumulative quantity of fatty acid released from the
volume of beads was approximately 85.83 ± 0.09 µg/mL during the incubation period.
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Figure 5.2: Evaluation of the cumulative release of linoleic acid from the chitosangelatin beads showed a steady release of fatty acid during incubation. After Day 10,
minimal change in the amount of fatty acid released was detected.

LIVE/DEAD® Cell Viability Staining
Qualitative assessment of cell viability showed live cells attached to each type of
bead, as shown in Figure 5.3. Cells were visible on the periphery of each bead type, and
covered the surface of the beads. The cells in the Beads+AC sample (5.3C) appear to be
detaching from the surface of the cells, as evidenced by the apparent tear in the cells on
the surface of the beads. The FA-Beads+DMEM (5.3E) and FA-Beads+AC (5.3G) cells
completely covered the surface of the beads, forming multiple layers not easily imaged
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Figure 5.3: Live/Dead staining at Day 17 showed live cells attached to the surface of
each bead type. Minimal dead cells were observed for each sample; however, more dead
cells were observed in the Beads+DMEM and FABeads+DMEM samples.
magnification for all images is 50x.
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Total

with the inverted microscope. Minimal dead cells are seen for each condition. There do,
however, appear to be more dead cells in the Beads+DMEM (5.3B) and
FABeads+DMEM (5.3F) samples.

Metabolic Activity
The results of the alamarBlue® assay for metabolic activity are shown in Figure
5.4. Results of the alamarBlue® assay indicate that at Day 10, cells cultured on plain
chitosan-gelatin beads and on fatty acid loaded chitosan-gelatin beads in the presence of
the adipogenic cocktail, Beads+AC and FA-Beads+AC, respectively, were significantly
more metabolically active than cells cultured on fatty acid loaded and plain beads in
DMEM. The metabolic activity for each condition was significantly lower at Day 17
than at Day 10.

At Day 17, the metabolic activity of cells in the Beads+AC was

significantly higher than cells in the Beads+DMEM and FA-Beads+AC. Additionally, at
Day 17, the metabolic activity of cells in the FA-Beads+DMEM was significantly higher
than cells in the Beads+DMEM and FA-Beads+AC.

Oil Red O Staining
Oil Red O staining of D1 cells cultured on each type of bead shows stained
intracellular lipid present within cells on each type of bead. At Day 10, there were small
lipid droplets in the Beads+DMEM samples (Figure 5.5A). The lipid appeared to cover
the surface of the beads; however, the droplets are not large and rounded as one would
expect for differentiating cells. At Day 17 fewer stained lipid droplets were observed on
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Figure 5.4: Results of alamarBlue® assay indicate that the samples were significantly
(p<0.05) more metabolically active at Day 10 than at Day 17, denoted by asterisks (*).
Letters a and b indicate samples with statistically higher metabolic activity than other
samples at Day 10. Letters c and d indicate samples with statistically higher metabolic
activity than other samples at Day 17. Graphical error bars represent the standard error
of the mean.

the Beads+DMEM samples, although the stained droplets did appear to be larger than at
Day 10 (5.5E). The addition of the adipogenic cocktail to the plain chitosan-gelatin
beads for the Beads+AC samples appeared to stimulate differentiation, as larger clusters
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of lipid were stained at Day 10 (5.5B). At Day 17 an increased amount of lipid droplets
were stained and appeared larger in size for the Beads+AC samples (5.5F). Culture of
the D1 cells on the beads loaded with linoleic acid, FA-Beads+DMEM, showed redstained clusters of lipid on the surface of the beads at Day 10 (5.5C). The lipid droplets
were not large or uniform in shape; however, there appeared to be more lipid present on
the FA-Beads+DMEM than on the plain Beads+DMEM. By Day 17, red stained lipid
was still visible on the periphery of the FA-Beads+DMEM; however, there was not as
much lipid present on the surface of the beads (5.5G). The addition of the adipogenic
cocktail to D1 cells cultured on the fatty acid-loaded beads caused active differentiation
of the cells by Day 10, as indicated by the uniformly round, red-stained lipid droplets
seen on the surface of the beads (5.5D).

The amount of lipid stained on the FA-

Beads+AC was greater than that observed on any other beads at Day 10. By Day 17,
however, the amount of red stained lipid was decreased on the FA-Beads+AC, as smaller
and fewer lipid droplets were observed on the surface of the beads (5.5H).

Total Triglyceride Measurement
As shown in Figure 5.6, measurement of the total triglyceride content within the
D1 cells cultured on each bead type showed a significant decrease in the amount of
triglyceride measured at Day 17 than was measured at Day 10. At Day 10, the amount of
triglyceride measured in the FA-Beads+AC samples was significantly greater than all
other sample conditions.

Additionally, the amount of triglyceride produced by the

Beads+AC and FA-Beads+DMEM samples was significantly greater than that measured
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Figure 5.5: Oil Red O staining of cells on the chitosan-gelatin beads showed that
culturing of the D1 cells on fatty acid loaded beads resulted in a greater amount of
stained lipid (C) than was observed in the Beads+DMEM or Beads+AC samples. Total
magnification for all images is 200x.
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in cells cultured on Beads+DMEM alone.

At Day 17, the amount of triglyceride

measured in the FA-Beads+DMEM and FA-Beads+AC was significantly higher than that
measured in the Beads+DMEM or Beads+AC.

Figure 5.6: Measurement of total triglyceride content showed that, over time, the amount
of triglyceride measured within the cells significantly decreased over time, as noted by
asterisks (*) (p<0.05). Letter a indicates condition for which triglyceride quantity is
significantly greater than that for all other conditions at Day 10. Letter b indicates
conditions for which triglyceride quantities significantly greater than that for the
Beads+DMEM sample at Day 10. Letter c indicates conditions for which quantities are
significantly greater than that of the Beads+DMEM and Beads+AC samples at Day 17.
Graphical error bars represent the standard error of the mean.
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5.4 Discussion
The idea of delivering fatty acids and lipids to cells and tissues is not new. Early
methods to deliver lipids involved preparation of lipid microemulsions that could be used
to provide lipids to mammalian cell cultures in vitro [19, 20].

In agricultural research,

preparations of fatty acid salts encapsulated in a polymer coating have been manufactured
to deliver feed supplements to cattle [21]. Delivering fatty acids to supplement adipose
cell cultures for tissue engineering purposes, however, is novel. Here, we successfully
prepared fatty-acid loaded chitosan-gelatin beads useful for adipose tissue engineering.
Chitosan has been used in many biomedical applications, often as a mode of
delivery for other molecules. Chitosan microcapsules containing omega-3 fatty acids
eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA, were produced by
Klaypradit and Huang for potential use in food supplementation [22]. Additionally, Han
and coworkers produced alginate beads coated with chitosan to encapsulate vitamins and
other water-soluble food additives [23].
The two types of beads produced in our study were approximately 0.24cm in
diameter, which is larger than the ideal size for our injectable composite system;
however, bead size may be reduced by varying bead fabrication parameters of the
electrostatic generator. Within an hour of incubation, measurable quantities of fatty acid
were detected in the samples of PBS solution, indicating that the fatty acid was likely not
solely encapsulated in the bead, but that some fatty acid was distributed on the surface of
the beads. The amount of fatty acid released from the beads steadily increased over time
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until around Day 10, providing a steady influx of fatty acids to the D1 cells that they were
able to uptake.
The significant increase in metabolic activity observed when the adipogenic
cocktail was added to the D1 culture could indicate that initiation of adipogenesis and the
subsequent stimulation of triglyceride synthesis yields more metabolically active cells
than proliferating cultures of the D1 cells in DMEM only. The lower metabolic activity
by Day 17 could indicate that there were no longer as many cells proliferating, and that
the cells may have been actively differentiating at the end of the study. From the results
of LIVE/DEAD® staining and alamarBlue® assay, it can be determined that chitosangelatin beads may be useful as cell carriers in the injectable composite system because
they support both cellular growth and proliferation. The fatty acid loaded beads, even
when releasing fatty acid into the cell culture environment, still support cell growth and
proliferation.
Evaluation of Oil Red O staining and the total triglyceride assay showed that the
chitosan-gelatin beads not only supported cellular growth and proliferation, but they also
provided a surface that permitted cellular differentiation to occur. The larger and more
uniformly rounded lipid in the FA-Beads+AC condition at Day 10 suggests that the
addition of the fatty acid and the adipogenic cocktail facilitated more triglyceride
synthesis within the D1 cells. The presence of cells with less triglyceride and lipids at
Day 17 suggests that the cells on the beads may have either lost intracellular lipid to the
culture medium, or that they were synthesizing fewer triglycerides. The amount of fatty
acid released from the beads by Day 17 had reached its maximum, and therefore the cells
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were not receiving as much fatty acid by the end of the study as they were at earlier time
points in the study. The addition of fatty acid to the beads was therefore shown to
influence the triglyceride accumulation and differentiation of the D1 cells.

Lower

amounts of fatty acid available for the cells to use for triglyceride synthesis resulted in
decreased amounts of triglyceride, suggesting that the fatty acid concentration may need
to be increased for longer-lasting effects.
Recent studies by Rubin and coworkers were conducted to evaluate the effect of
culturing human adipose-derived stem cells with poly (lactic-co-glycolide) (PLG)
microspheres with encapsulated insulin and dexamethasone. From their studies Rubin
and coworkers were able to determine that the cells cultured with microspheres
containing only insulin produced a higher number of cells with lipid inclusions than the
cells cultured with the dexamethasone containing microspheres, or cells cultured with a
combination of insulin and dexamethasone microspheres [24]. This suggests that insulin
is an important factor in the process of adipogenesis. For our injectable composite
system, it is likely that a combination of factors may need to be included in the cellular
carriers to maximize the lipid-filling of adipose cells and sustain tissue volume over time.

5.5 Conclusions
Using the fabrication methods described here, dual purpose beads useful for tissue
engineering were created. Chitosan-gelatin beads were shown to support cellular growth
and differentiation. Meanwhile, inclusion of linoleic acid into the polymer solution to
form fatty acid-loaded chitosan-gelatin beads, allowed the delivery of linoleic acid to the
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D1 cells in culture over time. Addition of fatty acids to cells undergoing adipogenesis
facilitated increased triglyceride production and lipid-filling of the cells. This suggests
that inclusion of fatty acids into microcarrier beads for the injectable composite system
could be useful for stimulating fatty acid uptake and lipid production, which could lead to
increased adipose tissue mass and ideally sustain the tissue volume over time if the fatty
acid is provided to cells at a sufficient quantity.
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CHAPTER 6
EVALUATION OF FATTY ACID INFLUENCE ON ADIPOSE CELL-BREAST
CANCER CELL INTERACTIONS IN VITRO

6.1 Background
Fatty acids within the adipose tissue of the breast have been shown to play a key
role in the mammary microenvironment. Dietary fatty acids have been identified within
deposits of mammary tissue in the body, the measurement of which has been determined
to be useful as a biomarker of dietary fatty acid intake by individuals [1-6]. There are
conflicting reports in the literature regarding the influence of dietary fatty acids on the
behavior of breast cancer cells; for example, specific fatty acids have been shown to act
as anti-cancer agents (eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA),
while others have been considered cancer promoting agents (linoleic acid and arachidonic
acid) in certain instances [2, 3, 7-16]. Numerous epidemiological, experimental, and
ecological studies have been conducted to evaluate the relationship between dietary fatty
acids and breast cancer risks [6, 9, 15-22]. Analysis of normal breast tissue samples, i.e.
those that are identified as free of tumorigenic cells, has shown that the fatty acids found
most commonly in the highest concentrations are oleic, palmitic, linoleic, and stearic
acids [13, 23]. In the case of cancerous mammary tissue samples, investigation of fatty
acids contributing to cancer growth or inhibition has led to overall thinking that increased
levels of linoleic acid and arachidonic acid are associated with increased risk of breast
cancer [7, 8, 13, 24]; while increased levels of α-linolenic acid, EPA, DHA, and

223

conjugated linoleic acid have been associated with decreased risk of breast cancer
occurrence [7, 8, 11, 13, 25].
Breast cancers may be categorized based on hormone receptor status and
molecular subtype. Hormone receptors are proteins located on the outside surface of
cells, which bind specific circulating hormones, most often estrogen and progesterone,
ER and PR, respectively. Receptors for these hormones are often found on surfaces of
normal breast cells as well as cancerous breast cells. Breast cancer cells may contain
one, both, or neither of these receptor types. Those that have estrogen or progesterone
receptors present are known as ER+ or PR+; likewise, if the estrogen or progesterone
receptors are not present, the breast cancers are known as ER- or PR-. It has been
reported that approximately 75% of all breast cancers are ER+, and of those cases, 65%
are also PR+ [26].

The hormone receptor status is often used in assigning a course of

treatment for patients because the presence of the receptors means the cancers can be
treated with hormonal therapies, while those without receptors may not be treated with
hormones; thus giving patients with either ER+ or PR+ cancers a more positive prognosis
[27, 28].
Hormonal therapies to treat ER+ breast cancers typically function to inhibit the
effects of estrogen or to lower the levels of estrogen present in the body. Tamoxifen is
the most widely-known anti-estrogen drug that blocks the estrogen receptor of tumors
[27, 29]. It is typically taken orally daily, and has been used to treat metastatic cancers
and to help reduce the risk of tumor recurrence [30-32]. In vivo evaluation of the effects
of tamoxifen on tumors created by implantation of MCF-7 cells into the flank of athymic
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mice was performed by Haran and coworkers. Treatment of the tumors with pellets
loaded with 5mg of tamoxifen over 60 days resulted in tumor cell death, which was
attributed to an inhibition of new tumor vascularization as a result of the treatment [33].
Researchers have also investigated methods for delivering tamoxifen to tumor cells via
nanoparticles, and showed that treatment of MCF-7 cells with tamoxifen-loaded
nanoparticles resulted in uptake of the nanoparticles by the cells, which ultimately led to
apoptosis of the cells [34, 35].
From the previously described work in Chapter 5, methods to produce fatty acid
loaded chitosan-gelatin beads were developed. The beads could potentially serve two
purposes in the injectable composite system; they could function as cell carriers to
support cell growth and differentiation, and they could function as delivery devices that
could provide fatty acids to the surrounding cells. As noted in Chapter 1, fatty acids
present in the body have been shown to influence the behavior of both normal and
cancerous cells. The addition of fatty acids to the bead component of our injectable
composite systems leads one to wonder, if by chance there were residual cancer cells
within a post-surgical patient, how the implantation of this device would influence the
behavior of those cells. Additionally, fatty acids have been shown to influence the
effectiveness of cancer-treating drugs.

In a study conducted by deGraffenried and

coworkers, MCF-7 cells were transfected with Akt, a downstream mediator of PI3kinase, to induce tamoxifen resistance. The researchers were able to show that treatment
of the transfected cells with the n-3 fatty acid, EPA, not only inhibited activation of Akt,
but also led to enhanced growth inhibition of the tumor cells when treated in combination
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with the EPA and tamoxifen [36]. Additionally, studies by Chen and coworkers showed
that the growth of tumors created by injection of MCF-7 cells into athymic mice, was
inhibited in mice fed a diet high in flaxseed, which is rich in α-linolenic acid. Tumor
growth was also significantly inhibited when animals fed flaxseed were also administered
tamoxifen to treat the cancer, suggesting that the two work together to promote tumor cell
death [37].

If a patient receiving therapeutic agents underwent immediate breast

reconstruction using our injectable composite system, incorporation of fatty acids into the
implant could potentially increase the efficacy of the treatment.
The objective of this final study was to evaluate fatty acid influence on adipose
cell and breast cancer cell interactions in vitro by evaluating the influence of fatty acid
supplemented beads on breast cancer cell behavior. Chitosan-gelatin beads with and
without incorporated fatty acids were produced and cultured with human adipose cells.
These cellular microcarriers were co-cultured with breast cancer cells and then treated
with a commonly used anti-cancer drug, tamoxifen.

6.2 Materials & Methods
Solution Preparation
A 1% v/v glacial acetic acid was prepared by mixing 1mL glacial acetic acid
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water. The glacial acetic acid was
filter sterilized using a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning,
Corning, NY). Chitosan (Deacetylation Degree: ≥90%, Acros Organics, Morris Plains,
NJ) and gelatin (Sigma, St. Louis, MO) powders were autoclaved at 124°C for 25
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minutes to sterilize. All other steps in the bead fabrication process were carried out in a
SterilGARD III Advance laminar flow Class II Biological Safety Cabinet (The Baker
Company, Sanford, ME) to maintain sterility. A 3% w/v chitosan-gelatin solution was
prepared by dissolving 3g of chitosan and 3g of gelatin in 100mL of 1% v/v glacial acetic
acid and stirring at low heat until completely dissolved. A 0.5N solution of sodium
hydroxide (NaOH) was prepared by dissolving 20g NaOH salt (Fisher Chemicals, Fair
Lawn, NJ) in 1L of distilled water and stirring at room temperature. The solution was
filter sterilized before use with the 0.22µm PES filters.

Bead Preparation & Characterization
The chitosan-gelatin beads were formed using an electrostatic bead generator
(Nisco, Zürich, Switzerland).

The chitosan-gelatin solution was drawn into a 20cc

syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge needle (Becton
Dickinson). The syringe was secured in place on top of a syringe pump (kdScientific,
New Hope, PA) that was set to eject the solution at a rate of 15 mL/hour. The chitosangelatin solution was ejected from the syringe and guided through plastic tubing attached
to the end of the syringe, into a metal needle of the electrostatic bead generator. The
needle was placed so that the point of ejection was approximately 4cm above the surface
of the NaOH solution below. The NaOH was pipette into a glass 80 x 40mm dish
(Pyrex®, Corning, Corning, NY) until just overflowing(>180mL) into a 100 x 20mm
glass collection dish (Pyrex) beneath. The NaOH was continuously stirred at an agitation
rate of 25%. The applied voltage potential was set at 6.5kV to obtain beads.
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The

fabricated beads were collected in the 80 x40 cm dish and stirred for an additional 30
minutes post formation in the NaOH solution at the same agitation rate. The NaOH was
drained from the beads and the resulting beads were washed three times with sterile
phosphate buffered saline (PBS) (Sigma, St. Louis, MO). The beads were then placed in
sterile Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Invitrogen, Carlsbad, CA)
until cell seeding in well plates.
To prepare the beads loaded with fatty acid, immediately before preparation,
10mL of the chitosan-gelatin solution was mixed with 5mL of sterile linoleic acidalbumin solution (Sigma, St. Louis, MO) in a sterile 50-mL centrifuge tube (Fisher
Scientific, Fair Lawn, NJ). The solution was gently triturated to ensure complete mixing
and was then drawn into a 20cc syringe (BD, Franklin Lakes, NJ) using a 16 gauge
needle (BD, Franklin Lakes, NJ).

The beads were prepared using the previously

described settings.

Cell Isolation and Culture
Human tissue samples were obtained from Greenville Hospital System and
digested according to the protocol detailed in Appendix A. The isolated primary cells
were seeded in T-25 culture flasks (Corning, Corning, NY) with Dulbecco’s Modified
Eagle’s Medium (DMEM) (Gibco, Invitrogen, Carlsbad, CA) supplemented with 1%
antibiotic/antimycotic (AA) (Gibco) 0.2% fungizone (Gibco), 0.4% Insulin-TransferrinSodium Selenite (ITS) media supplement (Sigma), and 10% fetal bovine serum (FBS)
(Mediatech, Herndon, VA). Culture flasks were incubated at 37°C and 5% CO2. Cells
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were grown to confluence and then passaged to larger flasks until a sufficient number for
seeding on beads was obtained.
MCF-7 cells (ATCC, Manassas, VA) were cultured in T-150 flasks with 15mL of
DMEM (Gibco) until confluence. The MCF-7 culture medium consisted of 500mL
DMEM supplemented with 10% FBS, 2% AA, 0.2% fungizone, and 0.l% insulin
(Sigma).

Cell Seeding
Cells for this co-culture study were seeded according to the conditions specified
in Table 6.1.

Control samples were seeded in well plates with conditions also as

specified. Additionally, co-culture samples to evaluate the influence of culturing MCF7
cells with adipose cells grown on beads were seeded as shown in Figure 6.1. The
timeline for cell seeding is shown below in Figure 6.2.

Figure 6.1: Co-Culture Setup with Transwell Inserts
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Table 6.1: Culturing Conditions for Cell Seeding
Condition
2-D:
•
•
•

MCF-7
MCF-7 + TAM
MCF-77 + TAM + FA

Co Culture:
• MCF-7

Description
•
•
•

Cells cultured in 2-D alone
Cells cultured in 2-D with tamoxifen
Cells cultured in 2-D
D with tamoxifen and
4% linoleic acid

•

Cells cultured in 2-D
D with adipose cells
seeded on plain (Bead) or fatty acid loaded
(FA-Bead) chitosan-gelatin
gelatin beads in
transwell inserts
D with adipose cells
Cells cultured in 2-D
seeded on plain (Bead) or fatty acid loaded
(FA-Bead) chitosan-gelatin
gelatin beads in
transwell inserts and with tamoxifen

•
•

MCF-7 + TAM

Figure 6.2: Study Timeline

A volume of 0.6mL of plain and fatty acid loaded chitosan
chitosan-gelatin
gelatin beads were
placed into individual wells of 24
24-well Ultra-low Binding
g plates (Corning, Corning, NY).
NY)
Primary human adipose cells, of passage 3, were seeded into each well containing beads,
with 2.5x105 cells added to each well. Cells were maintained in DMEM at standard
culture conditions of 37°C and 5% CO2 on an orbital shaker at 50rpm (IKA® Works,
Wilmington, NC).. After two days of culture, upon medium change, cells were cultured
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with an adipogenic differentiation cocktail. The adipogenic cocktail consisted of 100µl
insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St. Louis, MO), and 1mL
IBMX (Sigma, St. Louis, MO) per 10mL of DMEM medium. Also at Day 2, 7.5x104
MCF-7 cells, of passage 10, were seeded into the wells of tissue culture treated 24-well
culture plates (Corning, Corning NY) and maintained in DMEM supplemented with 10%
FBS, 2% AA, 0.2% fungizone, and 0.l% insulin, at standard culturing conditions. At Day
5, the plain or fatty acid loaded chitosan-gelatin beads, seeded with cells, were transferred
to transwell inserts (Corning, Corning, NY), and the inserts containing cellular beads
were transferred to the well plates containing the MCF-7 cells in 2D. Additionally, at
Day 5, 4% linoleic acid-albumin (Sigma) (80µL per well) was added to the specified
MCF-7 cells in 2D. At Day 10, 10µM tamoxifen (Sigma) was added to the specified
conditions and the plates were incubated for an additional two days. At the conclusion of
the culture period at Day 12, specific assays were performed to characterize the behavior
of both the adipose cells grown on beads in the transwell inserts and the MCF-7 cells in
the co-culture system.

Atomic Force Microscopy (AFM)
Since the beads for the injectable composite system will be enclosed within a
surrounding hydrogel matrix, the properties of the matrix-bead system were characterized
using AFM. The stiffness of the following samples were evaluated: plain collagenagarose gel, collagen-agarose gel containing chitosan-gelatin bead, and collagen-agarose
gel containing fatty acid loaded chitosan-gelatin bead.
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A volume of 1mL of collagen-agarose solution was prepared by mixing 450µL of
3mg/mL PureCol® Purified Bovine Collagen (Advanced Biomatrix, San Diego, CA) with
450µL of 1% agarose solution (Type VII-A, Sigma, St. Louis, MO) and 100µL of
collagen reconstitution buffer. The collagen reconstitution buffer consisted of 0.22g
sodium bicarbonate (Fisher, Fair Lawn, NJ) and 0.48g HEPES (Fisher) in 10mL
deionized water (Millipore, Billerica, MA). The collagen-agarose gels were cast in
silicone molds. Specifically, two high-density silicone sheets (each sheet 6.5cm L x
2.5cm W, thickness per sheet = 1mm) were punched to create three 1.4-cm circular
“wells” in each sheet. The silicone sheets were placed on top of a polystyrene slide and
the collagen-agarose gel solution was distributed evenly to each circular well.

An

individual chitosan-gelatin bead or fatty acid loaded chitosan-gelatin bead was placed
into the center of an individual circular well such that the gels completely surrounded the
beads. The solutions were gelled on the slides for 10 minutes at 4○C. The elastic
modulus was tested immediately using AFM.
The MFD-3D-BIO™ AFM (Asylum Research, Santa Barbara, CA) and
borosilicate AFM tips of radius 2.5µm and spring constant 0.093N/m were used. For
AFM testing, the AFM tip approached the gel surface at a speed of 5µm/second and the
contact force was measured until an indentation depth of 10µm. Each gel was tested at
three random points in the central area of the gel, and measured three times. The gel
sample containing the chitosan-gelatin bead was tested at the interface of the gel and
bead. The gel elastic modulus was estimated by fitting a Hertz model to indentation
depths from 800 to 1000nm as shown in Equation 6.1 [38, 39].
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Where:
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Equation 6.1

F = Measured Force
υ = Poisson’s Ratio (0.5 for hydrogel)
δ = Indentation Depth
R = AFM Tip Radius

Live/Dead Cell Viability Staining
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was
used to qualitatively assess attachment of the human adipose cells to the beads and to
assess cellular viability after in vitro culture. The LIVE/DEAD® working solution,
consisting of 10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM,
was prepared in a sterile 15mL centrifuge tube according to the manufacturer’s
instructions. Transwell inserts containing beads were removed from the well plates, and
the beads were placed into fresh wells of 24-well plates. Culture medium was aspirated
and beads were rinsed with 1mL of sterile PBS (Sigma). The PBS was aspirated from the
scaffolds and 1mL of the working LIVE/DEAD® solution was added to each well of the
plate containing scaffolds. The plate was incubated for 45 minutes at room temperature
and protected from light. Following the incubation period, images of each well were
captured using the Axiovert 135 fluorescence inverted microscope (Zeiss), with color
digital camera and imaging software.

The wells were evaluated for green and red

fluorescence, as produced by the activity of the calcein AM and EthD-1, respectively,
present in the working solutions. Esterase present in live cells cleaves the calcein AM,
resulting in a green fluorescence, while the red fluorescence occurs when EthD-1 enters a
dead cell.
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Oil Red O Staining (ORO)
Transwell inserts containing beads were removed from the well plates, and the
beads were placed into fresh wells of 24-well plates. Culture medium was aspirated and
beads were rinsed with 1mL of sterile PBS (Sigma). The cells were fixed with 2mL 10%
Neutral Buffered Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight. An ORO stock
solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in 100mL
isopropanol (Fisher Chemicals, Fair Lawn, NJ)).

An ORO working solution was

prepared by mixing 60mL of ORO stock solution with 40mL deionized water and stirring
for 30 minutes. A volume of 500µL of the working solution was added to each well and
incubated for 15 minutes at room temperature. Following incubation, the wells were
rinsed three times with fresh deionized water. After decanting the excess water, the redstained lipid was imaged using an inverted microscope and imaging software. After
imaging, 500µL of isopropanol was added to each sample well and incubated for 20
minutes to extract the stained lipid.

The extraction solution was collected into

microcentrifuge tubes (Fisher Scientific, Fair Lawn, NJ) and 100µL of each sample was
pipetted into the wells of a 96-well plate (Corning, Corning, NY). The absorbance of the
samples was read at 530nm.

Total Triglyceride Measurement
Transwell inserts containing beads were removed from the well plates, and the
beads were placed into fresh wells of 24-well plates (Corning, Corning, NY). Culture
medium was aspirated and beads were rinsed with 1mL of sterile PBS (Sigma). After
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subjecting the cells to three freeze-thaw cycles, 1mL of 1% Triton X-100 (Sigma, St.
Louis, MO) was added to each well and the cells were incubated for 30 minutes at room
temperature. Standard glycerol solutions of concentrations ranging from 0 to 200µM
were prepared by dissolving glycerol (Sigma, St. Louis, MO) in deionized water.
Following incubation, the cells from each well were transferred with the Triton X-100
solution into microcentrifuge tubes and centrifuged for 10 minutes at 3000rpm.

A

volume of 100µL of each sample and standard was pipetted into the wells of a 96-well
plate (Corning, Corning, NY) in triplicate. A volume of 100µL of Infinity™ Triglyceride
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated
for 15 minutes at room temperature. The absorbance was read at 490nm on a Biotek
Synergy MX Multi-Mode Microplate Reader (Biotek Instruments, Winooski, VT).

Real-Time RT-PCR
Samples of ribonucleic acid (RNA) were isolated from the adipose cells cultured
at each condition. Transwell inserts containing beads were removed from the well plates,
and the beads were placed into fresh wells of 24-well plates. Culture medium was
aspirated and beads were rinsed with 1mL of sterile PBS (Sigma). The RNA was isolated
from the samples using the reagents and instructions supplied in an RNeasy Mini Kit
(QIAGEN, Valencia, CA) (Appendix D). The concentration and purity of the isolated
RNA samples was measured using the Agilent 2100 Bioanalyzer (Agilent Technologies,
Inc., San Jose, CA), RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000
Ladder (Ambion, Inc., Austin, TX), RNA 6000 Nano LabChip® (Caliper Technologies
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Corp., Mountain View, CA), and 2100 Expert Software (Agilent Technologies, Inc.)
(Appendix E). PPAR-γ and aP2 were selected to identify cells in the early and late stages
of adipocyte differentiation; and β-actin was chosen as the housekeeping gene. Primers
specific for the human genes and accession numbers for the mRNA sequences for each
specified gene are listed in Table 2.2. Real-time, one step RT-PCR was performed using
the Quantifast™ SYBR® Green RT-PCR kit (Qiagen) with conditions as shown in
Appendix F. The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine
the relative expression level for each gene of interest using β-actin as the reference gene.

Gas Chromatography (GC)
Culture medium was aspirated from MCF-7 cells in well plates and the cells were
rinsed with sterile PBS. Transwell inserts containing beads seeded with fat cells were
removed from the well plates, and the beads were placed into fresh wells of 24-well
plates. Culture medium was aspirated and beads were rinsed with 1mL of sterile PBS
(Sigma). The PBS was aspirated from the MCF-7 cells growing in 2D and the beads
seeded with fat cells. A volume of 1mL of PBS was added to each well and the cells
were scraped with a pipet tip and transferred to microcentrifuge tubes. Bead samples
were also transferred to the tubes since cells were attached to the beads. Tubes were
stored at -20°C until evaluation for lipid content. Detailed methods used for sample
preparation are found in Appendix D of this document. Total lipids were extracted from
the cells using organic solvents according to the procedures of Folch and coworkers [40].
The resulting lipid extracts were transmethylated according to the procedures of Park and
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coworkers [41]. Fatty acid methyl esters were analyzed using an HP6850 Series II Gas
Chromatograph fitted with an autosampler (Agilent Technologies, Santa Clara, CA).
Chemstation software was used to analyze the resulting data (Agilent Technologies).
Specific fatty acids were identified by comparing the internal standard and retention
times. The weight percentage of fatty acids was calculated using the values from the
resulting plots applied to Equation 6.2 and 6.3 shown below.
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Equation 6.3

Where: Total Area = area of entire sample plot
AreaISTD = area of the internal standard located on the resulting plot
AreaFatty Acid = area of specific fatty acids located on the resulting plot
Metabolic Activity
Metabolic activity of MCF-7 cells in culture was quantitatively assessed using
alamarBlue® Cell Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).
The alamarBlue® reagent was added to each well at 10% of the amount of culture
medium in each well. Well plates were incubated for three hours at 37°C on a shaker
plate (IKA® Works, Wilmington, NC). Following incubation, 150µl of the reaction
solution was removed from the cell culture plates to wells of a black-walled, clear-bottom
96-well microplate (Corning, Corning, NY) to assay the fluorescence of samples
resulting from the reduction of the dye by metabolically active cells to produce a color
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change from blue to pink. The absorbance was read using a Biotek Synergy MX MultiMode Microplate Reader (Biotek Instruments, Winooski, VT) at wavelengths of 570nm
and 600nm. The percent reduction of alamarBlue® was calculated using Equation 6.4
shown below.
%  
Where:



!"

 !

!"

 100%

Equation 6.4

A1 = absorbance of experimental well at 570nm
A2 = absorbance of experimental well at 600nm
N1 = absorbance of negative control (medium plus alamarBlue® reagent
without cells) at 570nm
N2 = absorbance of negative control (medium plus alamarBlue® reagent
without cells) at 600nm

PicoGreen® DNA Assay
The deoxyribonucleic acid (DNA) concentration of MCF-7 cells grown in 2D and
MCF-7 cells from the co-cultured samples was determined using the Quant-iT™
PicoGreen® dsDNA assay kit (P7589, Invitrogen, Molecular Probes, Carlsbad, CA). At
Day 12, culture medium was aspirated from the well plates and cells were rinsed with
sterile PBS. A 1X TE Buffer (10mM Tris-HCl, 1mM EDTA, pH 7.5) was prepared from
the 20X stock solution provided in the kit. A volume of 1mL of the 1X TE buffer was
added to each well of the plate. The plates were frozen and thawed three times to lyse the
cells. A pipet tip was used to scrape the cells in each well. An aqueous working solution
of the Quant-iT™ PicoGreen® reagent was prepared by making a 1:200 dilution of the
concentrated solution with 1X TE buffer. A 2µg/mL stock solution of dsDNA in 1X TE
buffer was prepared and further diluted to prepare DNA standards, ranging from 0 to
1000ng/mL, that were used to generate a standard curve. A volume of 100µL of each
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sample and standard was pipetted to wells of a black-walled 96-well plate. Working
solution in the amount of 100µL was pipetted to each well and the plate was incubated
for 5 minutes in the dark at room temperature. The fluorescence was read using a
Flouroskan Ascent® FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm
excitation and 520nm emission wavelengths.

Cell Apoptosis Assay
Apoptotic MCF-7 cells from 2D culture and from the co-culture samples with
adipose cells were stained using the Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis
Kit (V13241, Invitrogen, Molecular Probes, Carlsbad, CA). At Day 12, the culture
medium was aspirated from MCF-7 cells in the well plates and the cells were rinsed with
PBS. A 1X annexin-binding buffer was prepared from the 5X stock solution provided in
the kit. A 100µg/mL working solution of propidium iodide (PI) was prepared by diluting
the stock PI solution with 1X annexin-binding buffer. A volume of 10µL of the annexin
V conjugate provided in the kit and 2µL of the PI working solution was added to each
well containing MCF-7 cells. The well plates were incubated at room temperature for 15
minutes in the dark. Following incubation, images of each well were captured using the
Axiovert 135 fluorescence inverted microscope (Zeiss), with color digital camera and
imaging software.
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Statistical Analysis
Statistical analyses were performed using SAS 9.2 software (Cary, NC) to
compare the effect of each culture medium on cell behavior. The Least Squares Means
(LSMEANS) was used with a significance level of p < 0.05 (n=4 for PicoGreen and
Triglyceride for linoleic acid optimization studies; n=3 for all other assays). Graphical
error bars represent the standard error of the mean.

6.3 Results
Atomic Force Microscopy
After applying the Hertz model equation to the resulting AFM data, the estimated
elastic modulus, as shown in Table 6.2, for the plain collagen-agarose gel was determined
to be 22.71±1.76 kPa. The addition of the chitosan-gelatin bead to the gel resulted in a
significant increase in the gel stiffness to 33.93±3.7 kPa (p<0.05). Inclusion of the fatty
acid loaded chitosan-gelatin bead to the gel resulted in a significant increase in the gel
stiffness to 28.86±3.84 kPa (p<0.05). There was no difference in the elastic modulus of
the gels containing either the plain or fatty acid loaded bead.
Table 6.2: Estimated Elastic Modulus
Sample

Estimated Elastic Modulus
(kPA)

Gel

22.71 ± 1.76*

Gel Containing Chitosan-Gelatin
Bead
Gel Containing Fatty Acid
Loaded Chitosan-Gelatin Bead

33.93 ± 3.7
28.86 ± 3.84

* Indicates statistically different value (p<0.05)
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Live/Dead Cell Viability Staining
As shown in Figure 6.3, qualitative assessment of cell viability using the
Live/Dead stain showed a minimal number of live adipose cells attached to plain and
fatty acid loaded chitosan-gelatin beads at Day 12. Of the adipose cells grown on the two
different bead types, there appeared to be a comparable number of cells attached to the
beads. The appearance of dead cells was not apparent for the cells attached to the beads.

Figure 6.3: Live/Dead staining at Day 12 showed minimal live adipose cells attached to
the surface of the plain and fatty acid loaded chitosan-gelatin beads. Total magnification
for each image is 25x.
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Oil Red O Staining
Staining of the adipose cells seeded onto the plain and fatty acid loaded chitosangelatin beads for the co-culture system showed little to no visible lipid droplets present on
the beads. As shown in Figure 6.4, however, there did appear to be more red-stained
lipid in cells on the surface of the plain beads than those cultured on the fatty acid loaded
beads. Measurement of the absorbance of the Oil Red O extraction solution, as shown in
Figure 6.5, showed no statistically significant difference in the absorbance for adipose
cells seeded at any condition.

Figure 6.4: Oil Red O staining of human adipose cells cultured on the plain and fatty
acid loaded chitosan-gelatin beads at Day 12. Total magnification for all images is
320x.
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Figure 6.5: Measurement of the absorbance of the Oil Red O extraction solution showed
no significant difference in the amount of lipid in the human adipose cells cultured on the
plain or fatty acid loaded chitosan-gelatin beads at any condition. Graphical error bars
represent the standard error of the mean.

Total Triglyceride Measurement
As shown in Figure 6.6, there was no statistical difference in the amount of total
triglyceride measured in the human adipose cells cultured on plain or fatty acid loaded
chitosan-gelatin beads at any condition.

Comparable amounts of triglyceride were

measured in the adipose cells at all conditions.
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Figure 6.6: Measurement of total triglyceride content showed no statistical difference in
any of the concentrations measured in the human adipose cells cultured on the plain or
fatty acid loaded chitosan-gelatin beads. Graphical error bars represent the standard
error of the mean.

Real Time RT-PCR
Minimal levels of PPAR-γ and aP2 gene expression were detected in samples of
human adipose cells cultured at each condition with MCF-7 cells. As shown in Figure
6.7A, there was significantly greater PPAR-γ expression observed for adipose cells
cultured on beads with MCF-7+TAM than was observed in cells cultured on FA-Beads
with MCF-7 cells (p<0.05). There was no other statistical difference observed for PPAR-
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γ expression. Additionally, as shown in Figure 6.7B, there was no statistical difference
observed in the expression of aP2 for human adipose cells cultured at any condition.
A

B

Figure 6.7: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by the human adipose
cells seeded on the beads of the co-culture system. Asterisks (*) indicate statistically
different values for PPAR-γ expression. No statistical difference was observed in the
expression of aP2 for any culture condition. Graphical error bars represent the standard
error of the mean.
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Gas Chromatography
The fatty acid profile for both the adipose cells and the MCF-7 cells for each
condition was determined, and is shown in Figure 6.8. The percentage of each individual
fatty acid within cell samples was calculated and the sum of identifiable fatty acids was
determined. More than 75% of total fatty acids were identified for samples of each
condition. Of the identified fatty acids within the human adipose cells cultured on the
plain or fatty acid loaded chitosan-gelatin beads, four specific fatty acids were most
abundant within the cells. Myristic, palmitic, stearic, and oleic fatty acids were all found
in the highest percentages for the adipose cells of each co-culture condition.
Comparison of the percentages of the four most prevalent fatty acids in the
adipose cells is shown in Figure 6.9A. The percentage of palmitic and stearic acids were
significantly higher than myristic and oleic acids for all co-culture conditions in which
the adipose cells were evaluated (p<0.05). There was no difference observed between the
four most prevalent fatty acids in the adipose cells for any co-culture condition.
Of the identified fatty acids within the MCF-7 cells co-cultured with the adipose
cells on beads, myristic, palmitic, stearic, and oleic acids were most abundant. As shown
in Figure 6.9B, the percentage of myristic was significantly lower for each sample
condition than the other most prevalent fatty acids for that condition. For the MCF-7
cells cultured on FA-Beads, the percentage of stearic acid was significantly lower than
the percentages of palmitic and oleic acid for that condition
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Sample Condition
Average Percent (%) of Total Fatty Acid Composition (n=3 samples per condition)
MCF-7 Cells from Co-Culture
MCF-7 Cells in 2D
MCF7

MCF7+TA
M

Adipose Cells on Beads from Co-Culture

Carbon #

Common Name

Bead

Bead+TAM

FABead

FABead+TA
M

MCF7+TA
M+FA

Bead+TAM

FABead

FABead+TA
M

12

Lauric

1.21±0.21

1.19±0.29

1.50±0.15

1.71±0.21

1.43±0.19

1.16±0.09

1.20±0.46

13:0

Tridecanoic

1.80 ±0.09

2.18 ±0.51

1.88± 0.06

2.39± 0.31

2.01± 0.51

1.52± 0.21

1.49± 0.44

3.43±0.87

3.40±1.81

2.92±0.81

3.76±0.69

4.61± 0.84

4.09 ±1.84

3.79± 0.59

14

Myristic

5.69±0.37

4.78±0.07

6.89±0.82

5.84±1.07

5.18±0.90

3.98±0.38

2.89 ±0.18

4.64±0.33

3.55 ±0.86

4.20±0.55

4.24±0.51

5.61±1.36

14:1 c9

Myristoleic

0.68± 0.09

0.88± 0.34

0.55± 0.07

0.54 ±0.49

0.45± 0.40

0.39 ±0.34

0.63 ±0.13

1.44 ±1.39

1.09± 0.95

1.60± 0.44

0.00

15

Pentadecanoic

0.19± 0.32

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

16

Palmitic

19.06± 0.93*

18.35±1.72*

17.12±1.32*

17.67±1.26*

16.24±1.46

15.25±2.57

14.85±1.363

22.26±1.79*

22.05±5.50*

23.22±1.40*

20.11±3.88*

16:1 c9

Palmitoleic

4.48 ±0.24

3.42± 0.32

4.79± 0.28

3.86 ±0.69

6.08± 0.74

6.84± 0.67

1.67± 0.16

0.71± 0.64

1.07± 1.04

1.28 ±0.41

1.79± 0.10

17

Heptadecanoic

0.45± 0.08

0.34± 0.30

0.24 0.21

0.17 0.29

0.13 0.23

0.39 0.10

0.13 0.22

0.00

0.32 0.56

0.51 0.89

0.00

18

Stearic

12.94± 0.93

13.66±2.26

10.16±1.44

11.94±2.11

11.31±1.91

12.01±3.02

12.05±1.84

21.30±1.57*

22.08±5.55*

21.54±1.68*

18.78±3.36*

18:1 t11

Trans-11 vaccenic

0.71± 0.79

0.83± 0.76

0.00

0.00

0.25 ±0.44

0.49 ±0.85

0.00

0.57± 0.99

3.00 ±3.75

0.00

0.00

18:1 c9

Oleic

19.78± 0.33*

17.88±1.07*

19.82±0.30*

18.27±1.95*

24.43±1.36*

24.07±1.93*

7.83± 0.24

8.45±2.21

5.94±5.14

6.87±4.04

11.37±1.17

18:2 Omega-6

Linoleic

1.88± 0.03

1.75 0.15

2.53 0.05

2.53 0.53

0.82 0.13

1.12 0.11

34.45 3.61*

1.72 0.49

1.82 0.62

4.23 3.32

3.46 0.48

20:0

Arachidic

0.56± 0.53

1.02± 0.13

1.08± 0.07

1.21± 0.18

0.76± 0.26

1.02± 0.23

0.57 ±0.17

0.86±0.76

0.66± 0.63

1.99± 1.29

1.76± 2.49

20:1

Eicosenoic

0.62± 0.54

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

21:0

Heneicosanoic

0.68± 0.04

0.63± 0.12

0.56± 0.48

0.45± 0.77

0.75± 0.66

0.00

0.09± 0.15

0.00

0.00

0.00

0.00

18:3 Omega-3

Linolenic

0.40± 0.04

0.42± 0.07

0.57± 0.21

0.64± 0.28

0.77± 0.14

0.98± 0.22

1.57 ±2.23

0.40±0.69

1.48 ±0.32

1.86± 0.33

2.42 ±0.02

20:2

Eicosadienoic

0.66± 0.17

0.83± 0.23

0.58± 0.10

0.84± 0.22

0.56± 0.12

0.58± 0.14

3.63 ±2.40

0.33±0.58

0.45± 0.78

0.00

0.00

22:0

Behenic

0.52± 0.02

0.56± 0.06

0.49± 0.12

0.21 ±0.37

0.38± 0.36

0.52 ±0.06

0.32 ±0.27

0.00

0.00

0.00

0.00

20:3

Eicosatrienoic

0.23± 0.20

0.00

0.23± 0.20

0.14± 0.24

0.26± 0.24

0.32± 0.05

0.10 ±0.18

0.00

0.00

0.00

0.00

20:4 Omega-6

Arachidonic

2.62± 0.08

2.72± 0.20

2.92± 0.24

2.64± 0.55

1.88± 0.08

2.45± 0.37

1.01± 0.11

1.31±0.38

1.38 ±0.60

1.54± 0.77

3.08± 0.10

20:5 Omega-3

EPA

0.94± 0.27

1.18 ±0.15

0.76± 0.2

0.80± 0.08

0.80± 0.24

0.62± 0.16

0.74± 0.34

1.28±0.16

1.60± 0.32

1.14± 0.15

1.78 ±0.25

22:5 Omega-3

DPA

2.03± 0.64

2.51 ±0.33

1.13± 0.08

1.60± 0.83

1.39± 0.55

1.15 ±0.37

0.96 ±0.43

3.76±1.24

3.44 ±0.08

4.20± 1.90

2.40± 0.03

22:6 Omega-3

DHA
Total FA
Percentage (SUM)

1.54± 0.02

1.57± 0.14

1.72± 0.13

1.55± 0.36

1.20± 0.02

1.52± 0.20

1.65 ±1.57

0.31±0.53

0.00

0.00

0.00

79.68

76.68

75.52

75.01

77.08

76.37

87.81

77.41

78.05

80.93

79.87

Other (100%-SUM)

20.32

23.32

24.48

24.99

22.92

23.63

12.19

22.59

21.95

19.07

20.13

Bead

Figure 6.8: The fatty acid composition of each sample condition was determined by gas chromatography analysis. Asterisks
(*) indicate values significantly higher than all other fatty acids for that sample condition (p<0.05).
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A

Most Prevalent Fatty Acids in Co-Cultured
Adipose Cells

Most Prevalent Fatty Acids in Co-Cultured MCF-7
Cells

Most Prevalent Fatty Acids in 2-D MCF-7
Cells

C

Figure 6.9: The fatty acids found in the highest percentage for the adipose cells and
MCF-7 cells in the co-culture system were myristic, palmitic, stearic, and oleic acids (A
and B). For the MCF-7 cells in 2D culture, the most prevalent fatty acids were myristic,
palmitic, stearic, and oleic acids for the MCF-7 and MCF-7+TAM samples, while
linoleic acid was among the most prevalent found in the MCF-7+TAM+FA samples (C).
Asterisks (*) and percent symbols (%) indicate values statistically different from all other
fatty acids for that specified condition (p<0.05). Graphical error bars represent the
standard error of the mean.
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B

(p<0.05). There was no difference observed between the percentages of a specific fatty
acid for any co-culture condition, or in the percentage of linoleic acid measured for any
of co-cultured MCF-7 cells.
For the MCF-7 cells cultured in 2D, the most prevalent fatty acids identified was
not the same for all samples cultured in 2D. For the MCF-7 cells alone and the MCF-7
cells cultured with tamoxifen, the most prevalent fatty acids were myristic, palmitic,
stearic, and oleic acids. For the MCF-7 cells cultured with a combination of tamoxifen
and linoleic acid, the most prevalent fatty acids were myristic, palmitic, stearic, and
linoleic acids. As shown in Figure 6.9C, there was a significantly higher percentage of
linoleic acid in the 2D MCF-7+TAM+FA samples than was measured in the MCF-7 cells
alone and the MCF-7+TAM samples. The percentage of linoleic acid for the MCF7+TAM+FA sample in 2D was also significantly higher than the other most prevalent
fatty acids for that sample (p<0.05). For the MCF-7 and MCF-7+TAM samples in 2D,
there was a significantly higher percentage of oleic acid measured than any of the other
most prevalent fatty acids for those conditions.

Metabolic Activity
The metabolic activity of the MCF-7 cells in 2D and in the co-culture system was
evaluated with the alamarBlue® assay. As shown in Figure 6.10A, of the MCF-7 cells
cultured in 2D, the samples cultured with a combination of tamoxifen and linoleic acid
(MCF-7+TAM+FA) were significantly less metabolically active than the MCF-7 cells
cultured alone or the MCF-7 cells cultured with tamoxifen (p<0.05). For the MCF-7
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cells co-cultured with adipose cells seeded on plain or fatty acid loaded chitosan-gelatin
beads, there was no difference observed in the metabolic activity of co-cultured MCF-7
cells at any condition (Figure 6.10B).
A

B

Figure 6.10: Results of the alamarBlue assay indicate that the MCF-7+TAM+FA cells in
2D (A) were less metabolically active than the MCF-7 cells cultured alone or with
tamoxifen (p<0.05). No difference was observed among the MCF-7 cells of any coculture condition. Asterisk (*) denotes a value significantly different from the other
conditions in 2D. Graphical error bars represent the standard error of the mean.
PicoGreen® DNA Assay
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To further characterize the MCF-7 cells in this study, a PicoGreen assay to
measure the DNA concentration was performed. The DNA concentration within each
sample of MCF-7 cells is shown in Figure 6.11. For the MCF-7 cells cultured in 2D,
there was a significant difference observed among all values (Figure 6.11A). The MCF-7
cells alone had the highest concentration of DNA, while the DNA concentration of the
MCF-7+TAM cells was significantly lower (p<0.05). The DNA concentration of the
MCF-7+TAM+FA cells was significantly lower than both the MCF-7 and MCF-7+TAM
cells (p<0.05).
Of the MCF-7 cells grown in the co-culture conditions (Figure 6.11B), there was
no difference observed in the DNA concentration of the MCF-7 cells cultured with
adipose cells grown on plain chitosan-gelatin beads with or without tamoxifen treatment.
There was, however, a significantly lower DNA concentration measured in the MCF-7
cells cultured with adipose cells grown on fatty acid loaded beads and treated with
tamoxifen (FA-Bead+MCF7+TAM) than was measured in MCF-7 cells cultured with
cellular fatty acid loaded beads alone. Additionally, the DNA concentration of the MCF7 cells treated with tamoxifen was significantly lower when co-cultured with adipose
cells on fatty acid loaded beads as opposed to the plain beads (p<0.05).
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A

B

Figure 6.11: Results of the PicoGreen® assay showed that the DNA concentrations of all
samples in 2D were statistically different from each other (A) (p<0.05). For the cocultured samples, MCF-7 cells cultured with adipose cells on FA-Beads with tamoxifen
had a significantly lower DNA concentration than those co-cultured with plain beads and
without tamoxifen (B).

Asterisks (*), pound (#), and percent (%) symbols denote

statistically different values. Graphical error bars represent the standard error of the
mean.
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Cell Apoptosis Assay
Qualitative assessment of MCF-7 cell viability was performed to identify
populations of apoptotic cells, stained green by the assay, for each condition. As shown
in Figure 6.12, the resulting images of the apoptosis assay showed visible differences in
the number of apoptotic MCF-7 cells for the 2D samples.

For MCF-7 cells alone

cultured in 2-D, little to no apoptotic cells were observed (Figure 6.12B). The addition of
tamoxifen to the MCF-7 cells in 2D resulted in an increased number of apoptotic cells
than the MCF-7 cells alone, as shown in Figure 6.12D. Additionally, culturing the MCF7 cells in 2-D with tamoxifen and fatty acid resulted in what appears to be even more
apoptotic cells (Figure 6.12F).
For the MCF-7 cells co-cultured with adipose cells seeded on plain chitosangelatin beads, there were very few apoptotic cells observed with the apoptosis assay
(Figure 6.13B). With the addition of tamoxifen to the co-culture system of MFC-7 cells
adipose cells on plain beads, more apoptotic cells were observed (Figure 6.13D). For
MCF-7 cells cultured with adipose cells on fatty acid loaded beads a number of apoptotic
cells were observed, whether cells were treated with tamoxifen or not. (Figures 6.13F
and 6.13H)
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Figure 6.12: Results of the apoptosis assay for MCF-7 cells cultured in 2D showed more
apoptotic cells in samples treated with tamoxifen (D) and tamoxifen with fatty acid (F)
than MCF-7 cells cultured alone (B). Total magnification for all images is 100x.
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Figure 6.13: Results of the apoptosis assay for MCF-7 cells co-cultured with adipose
cells grown on plain beads showed very few apoptotic cells (B), while more apoptotic
MCF-7 cells were observed upon treatment with tamoxifen or culturing with adipose
cells on fatty acid loaded beads (D, F, and H). Total magnification for all images is
100x.
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6.4 Discussion
Cellular co-culture studies are often used to model in vivo cell interactions.
Culture of multiple cell types may not be advantageous in all circumstances because
many variables are introduced in the culturing system, which may result in a system that
is more complex and therefore more difficult to manage and assess. However, cocultures are necessary for better understanding cell-cell interactions. The mammary
gland largely consists of glandular tissue embedded within a stromal network consisting
of adipose tissue and fibrous connective tissue [42-46]. The most prevalent cell types
present within the breast tissue, epithelial cells, adipocytes, and fibroblasts, interact not
only through physical contacts but mainly through paracrine signaling. In particular, the
interactions between the epithelial cells and the stromal (fibroblast, adipocytes mostly)
cells within the normal mammary microenvironment modulate the effects of hormones
during mammary gland developmental processes, such as cell differentiation, ductal
elongation, and ductal branching morphogenesis [47].
Since the relationship between mammary epithelial cells and stromal cells plays a
key role during normal developmental processes, it is presumable that there will also be a
key relationship between stromal and epithelial cells in the case of a cancerous mammary
gland. Specifically, the interaction of breast cancer cells with adipose cells has been
investigated by researchers through several in vitro studies.

Johnston and coworkers

conducted a study where MCF-7 cells were cultured with conditioned medium collected
from 3T3-L1 preadipocyte cells. The influence of the preadipocyte conditioned media on
MCF-7 cell proliferation was assessed at time points ranging from 24 to 96 hours. It was
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found that MCF-7 cell growth was inhibited by 55% when compared to control samples
after 96 hours, suggesting that the 3T3-L1 preadipocyte cells secrete factors that inhibit
the growth of mammary carcinoma cells [48].
Manabe and coworkers investigated the effects of co-culturing MCF-7 cells with
either preadipocytes or mature adipocytes to determine the influence of adipose cells on
growth of the breast cancer cells. The preadipocytes or mature adipocytes from rat tissue
were seeded in a three-dimensional collagen gel system with MCF-7 cells. Evaluation of
tumor clusters that formed within the gels was performed, and it was determined that
after 7 days, the MCF-7 cells grown with the mature adipocytes formed structures
possessing characteristics of basement membranes, indicating cellular growth, while
MCF-7 cells cultured with preadipocytes retained morphology characteristic of MCF-7
cells without treatment [49].

Manabe and coworkers concluded that the mature

adipocytes promoted breast cancer cell growth, while preadipocytes inhibited growth.
Similar findings were reported by Kashani and coworkers who determined that human
preadipocytes inhibited MCF-7 cell growth, while mature human adipocytes promoted
MCF-7 cell growth in collagen gels [50].
These studies used simple co-cultures of MCF-7 cells and adipose cells to
determine how adipose cells influence breast cancer cell behavior.

There was no

attention, however, paid to the adipose cells and their behavior in the system.
Additionally, the mammary microenvironment contains other factors, such as fatty acids,
that also play a role in development. In our studies, we implemented a multi-faceted coculture system so that we could determine not only how the MCF-7 and adipose cells
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would behave in co-culture, but also determine the response of the cells to treatment with
tamoxifen if fatty acids were included in the co-culture system.
Previous studies in Chapter 5 showed that culturing of D1 mesenchymal stem
cells, differentiated to fat cells, resulted in increased triglyceride production when cells
were grown for 17 days on fatty acid loaded chitosan-gelatin beads as opposed to the
plain beads. Here, however, primary human adipose cells were used for these studies and
no differences were observed in adipose cell behavior. It is likely that no difference was
observed from any of the assays for the adipose cells because the cells were not cultured
on the beads for a similar length of time as the D1 cells in preliminary studies. From the
fatty acid release profile used to characterize the fatty acid loaded beads in Chapter 5, it
was determined that the release of fatty acids steadily increased until Day 10 when the
fatty acid concentration began to level off.

Additionally, significantly higher

concentrations of triglyceride were measured at Day 10 than at Day 17. The culture
conditions for cell seeding in this study were based on the outcome of the studies in
Chapter 5, such that human adipose cells were cultured on the fatty acid loaded beads for
a total of 10 days in an attempt to culture the cells with the highest concentrations of fatty
acids. It is likely, however, that although similar processing parameters were used for
manufacturing the beads for both studies, batch-to-batch variations may have led to an
altered release profile for the beads. Optimization of the fatty acid loading methods will
likely need to be conducted in order to better define the release properties of the beads for
future studies. More importantly, the fatty acid uptake of primary human adipose cells
likely varies from the rate of uptake by the D1 cells, suggesting that preliminary studies
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for each specific cell type should be performed to determine that cell types’ specific rate
of fatty acid uptake. It should also be pointed out, that similar to the study in Chapter 3,
the human adipose cells may require an extended culture period on the beads in order for
proliferation and ultimately differentiation to occur. Seeding more cells at the initiation
of the cultures could reduce the amount of time required for culturing.
The studies in Chapter 4, evaluating linoleic acid influence on D1 cell
differentiation to fat cells, showed that the differentiating cells readily take up exogenous
lipid from culture medium.

For the differentiating D1 cells in Chapter 4, stearic,

palmitic, oleic, and linoleic acid were the most prevalent fatty acids found within the
cells. The fatty acid profile from gas chromatography showed significant increases in
linoleic acid for D1 cells cultured with exogenous lipid when compared to control
samples in normal medium. Here, in contrast, the fatty acid profile of adipose cells
cultured on both the plain and fatty acid loaded beads was evaluated. For adipose cells
cultured on plain or fatty acid loaded beads, the most prevalent fatty acids found within
the cells were myristic, oleic, stearic, and palmitic acids.

There was no difference

observed for any sample conditions when adipose cells were co-cultured with MCF-7
cells treated with tamoxifen or not. It is interesting to note, however, the difference in the
most prevalent fatty acids observed in the differentiating D1 cells and the human adipose
cells from these co-culture studies. Both cell types contained high percentages of stearic,
oleic, and palmitic acids; however, the human adipose cells contained a high percentage
of myristic acid, while the D1 cells (even the D1 control samples not supplemented with
exogenous linoleic acid) had a high percentage of linoleic acid. Evaluation of normal
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mammary tissue samples has shown that the fatty acids found most commonly in the
highest concentrations are oleic, palmitic, linoleic, and stearic acids [13, 23].

The

difference observed with the most prevalent fatty acids within the human adipose cells
from these co-culture studies, may likely be attributed to the fact that the cells were cocultured with MCF-7 cells, which may have influenced the normal composition of the
human adipose cells.
In addition to evaluating the fatty acid profile of the adipose cells, the fatty acid
profile of the MCF-7 cells from the co-culture system and MCF-7 cells in twodimensional culture was determined. Kaur and coworkers demonstrated that the MDAMB-231 breast cancer cells were capable of taking up fatty acids, including oleic acid,
arachidonic acid, and EPA. By evaluating the MDA-MB-231 cells incubated with radiolabeled fatty acids, the rate of fatty acid uptake was measured and it was found that
arachidonic acid, in their study, was taken up faster than the EPA or oleic acid [51].
Additional studies by Evans and coworkers showed that dietary stearic acid reduced the
metastasis of MDA-MB-435 breast cancer cells in vivo. Nude mice were fed a diet
containing normal feed, safflower oil, or stearic acid in combination with safflower oil.
The mice were then injected with MDA-MB-435 breast cancer cells into the mammary
fat pad. At the conclusion of the study, metastasis of the cells to the animals’ lungs was
evaluated, and it was determined that growth and metastasis of the breast cancer cells in
mice fed stearic acid was inhibited [52]. These studies by Kaur and coworkers, and
Evans and coworkers showed that breast cancer cells are capable of taking up fatty acids,
and that fatty acids may influence the cytotoxicity of those cells. The lack of difference
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between linoleic percentages in MCF-7 cells co-cultured with adipose cells on plain
beads and MCF-7 cells co-cultured with fatty acid loaded beads suggests that perhaps the
fatty acid released from the beads may not have reached the MCF-7 cells beneath the
transwell inserts. Additionally, the release of the linoleic acid from the beads may have
been at a different rate than that measured from preliminary studies in Chapter 5—either
the linoleic acid was released quickly from the beads and was then lost by the cells over
time, or the linoleic acid was released slowly and not supplied to the cells for uptake. It
is not clear which is the case since the fatty acid released from the beads was not
measured in this particular study.
Similar to the observations of Kaur and coworkers, the MCF-7 cells cultured with
exogenous fatty acid in 2D readily took up that fatty acid such that linoleic acid made up
the largest percentage of the total fatty acids for those cells.
Fatty acids have been shown to influence the effectiveness of tamoxifen to treat
breast cancer cells. As previously described, deGraffenried and coworkers showed that
treatment of transfected MCF-7 cells that were resistant to tamoxifen with the n-3 fatty
acid, EPA, and tamoxifen led to enhanced growth inhibition of the tumor cells [36].
Additionally, as described in the background section of this chapter, Chen and coworkers
showed that the growth of tumors created by injection of MCF-7 cells into athymic mice,
was inhibited in mice fed a diet high in flaxseed, which is rich in α-linolenic acid [37].
To determine if the uptake of linoleic acid influenced the effectiveness of tamoxifen in
this study, the metabolic activity, DNA concentration and presence of apoptotic cells was
assessed.
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Based on measurement of metabolic activity, measurement of DNA
concentration, and evaluation of apoptotic MCF-7 cells within each condition, it can be
determined that tamoxifen induced death of MCF-7 cells in the co-culture with adipose
cells grown on fatty acid loaded beads. Additionally, results of MCF-7 cells cultured in
2-D at each condition, suggest that supplementation of MCF-7 culture medium with
linoleic acid positively influences the effectiveness of tamoxifen to induce death of the
MCF-7 cells. Linoleic acid, in our studies, appears to enhance the effectiveness of
tamoxifen to induce apoptosis of breast cancer cells, suggesting that the inclusion of
linoleic acid in our injectable composite system could be advantageous for post-surgical
treatment of breast cancer while also providing a stimulus for lipid formation in adipose
cells in vivo. Conflicting opinions regarding the influence of linoleic acid on breast
cancer cells exist, however. Rose and coworkers performed studies evaluating the effect
of dietary linoleic acid on MDA-MB-435 breast cancer cell metastasis. Tumors were
formed by injecting MDA-MB-435 cells into nude mice fed varying concentrations of
linoleic acid, and evaluation of the metastasis of cancer cells showed that the linoleic acid
stimulated metastasis of the breast cancer cells to the liver [53, 54].

Schley and

coworkers, meanwhile, performed a study evaluating the effect of EPA and DHA on
MDA-MB-231 breast cancer cells with and without linoleic acid included.

As an

essential fatty acid, linoleic acid was used to supplement the culture medium of MDAMB-231 cells that were treated also with EPA or DHA in vitro. It was found that
culturing the cells with EPA and DHA in the presence of linoleic acid resulted in growth
inhibition of the breast cancer cells [55]. For this reason, it is suggested that alternate
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fatty acids, or perhaps a combination of fatty acids be considered for inclusion in the
injectable composite system. It is also likely that the selection of fatty acid(s) could vary
from patient-to-patient depending on that patient’s dietary fatty acid intake which has
been shown to influence the fatty acid profile of adipose tissue deposits in the body.
Additional investigation of the literature and further studies are therefore required to
identify the optimal fatty acids for possible use in the injectable composite system.

6.5 Conclusions
From this study, it can be concluded that there is likely some batch variation in
the fatty acid loaded chitosan-gelatin bead production, indicating that further
optimization of bead processing methods is necessary to produce beads capable of
consistently releasing a desired fatty acid concentration. Because of possible limited
release of linoleic acid to the cells from beads in the co-culture system, the influence of
this co-culture system on adipose cell and breast cancer cell behavior cannot be
determined definitively. To more definitively determine the influence of fatty acids on
adipose cell-breast cancer cell interactions, the culture conditions would first need to be
optimized and the study then repeated.
The results of this study indicate that the addition of linoleic acid to MCF-7 cells
does indeed increase the effectiveness of tamoxifen in inducing apoptosis of the MCF-7
cells. These results suggest that inclusion of linoleic acid in the injectable composite
system could be used for post-surgical treatment of breast cancer while also stimulating
lipid-filling of adipose cells.
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CHAPTER 7
CONCLUSIONS

The overall goal of this work was to investigate two specific factors that influence
adipose cell differentiation. With a better understanding of how adipose cell-mammary
epithelial cell interactions and fatty acids influence adipogenesis, we hope to identify
improved culturing conditions to yield a more successful injectable composite system for
breast tissue reconstruction. Initial studies for this work allowed us to identify methods
to successfully isolate populations of primary bovine, murine, and human adipose cells
that are capable of differentiating to mature adipose cells given an appropriate stimulus.
Our studies of the relationship between mammary epithelial cells and adipose
showed that adipose cell differentiation is influenced by mammary epithelial cells.
Conditioned medium from mammary epithelial cells will either yield increased or
decreased triglyceride and lipid accumulation and adipogenic gene expression, or have no
immediate effect on adipose cell differentiation, depending on the source of conditioned
medium. Additionally, from characterization of the specific components of each type of
conditioned medium, specific factors that influence adipogenesis were identified and it
was determined that the specific concentrations of those factors, expressed in media
conditioned from mammary epithelial cells, will vary depending on the cell type.
Processing methods for preparing sterile chitosan-gelatin beads and sterile fatty
acid loaded chitosan-gelatin beads were successfully developed. It was determined that
the sterilization methods that were used for preparing beads for cell culturing did not
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significantly alter the material properties of the chitosan or gelatin. Characterization of
the mechanical properties of the components of the injectable composite system showed
that the inclusion of chitosan-gelatin beads, with or without fatty acid, within a collagenagarose gel matrix increases the stiffness of the gel matrix, however, the estimated
stiffness of the gel matrix and gel matrix containing beads was comparable to the
modulus of the normal tissue components of the mammary gland, suggesting that the
injectable composite system of these materials would be successful for restoring the
aesthetic function of the breast because of the similar material properties.
Significant differences in cell number observed between primary human adipose
cells grown in 2-D versus 3-D culture suggest that either a higher number of primary
cells should be seeded initially on the beads, or the primary cells should be cultured on
the beads for a longer period of time before differentiation is induced, particularly
because primary cells do not proliferate as quickly in culture as cell lines.
It can be concluded that the addition of linoleic acid to cultures of D1 stem cells
will influence adipogenesis. Additionally, cells grown in culture medium supplemented
with exogenous fatty acids will take up the fatty acid that they are provided, such that
increased levels of that specific fatty acid will be found within intracellular lipid, as
observed by evaluation of D1 stem cells and MCF-7 breast cancer cells. It was also
determined that long-term exposure of adipose cells to fatty acids will result in increased
intracellular lipid, which could prove useful for further development of adipose tissue
engineering strategies. The inclusion of fatty acids into microcarrier beads for the
injectable composite system could also be useful for stimulating fatty acid uptake and
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lipid production, which would lead to increased adipose tissue mass and ideally sustain
the tissue volume over time if the fatty acid is provided to cells at a sufficient quantity.
Finally, preliminary evaluation of fatty acid influence on the effectiveness of the
anti-cancer drug tamoxifen lead to the conclusion that the addition of linoleic acid to
cultures of MCF-7 cells does increase the effectiveness of tamoxifen in inducing
apoptosis of the cancer cells. This suggests that inclusion of linoleic acid in the injectable
composite system could be used for post-surgical treatment of breast cancer while also
stimulating lipid-filling of adipose cells.
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CHAPTER 8
RECOMMENDATIONS FOR FUTURE WORK

1.

For future conditioned media studies, cells of interest should be cultured in vitro
with non-conditioned medium first, possibly on chamber slides, to determine if
the non-conditioned base medium may influence cell behavior.

2.

Freshly obtained conditioned media samples should be re-analyzed with the
adipokine protein array. Subsequent quantification of specific products of interest
should be performed to determine at what concentration those factors may
influence adipogenesis.

3.

Future in vitro studies should be performed using the specific identified factors
from conditioned media characterization, e.g., TGF-β or PAI-1, to determine if
that one factor could influence adipogenesis or if there is a synergistic effect of all
conditioned media components.

4.

Studies evaluating the interaction of adipose cells and mammary epithelial cells in
three-dimensional culture should be repeated, using increased primary cell
number for seeding onto beads, and extended culture time to allow the primary
adipose cells to proliferate and differentiate on the beads.
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5.

Studies evaluating the influence of bead processing parameters on chitosangelatin bead stiffness should be performed. Follow-up studies to determine if
varied hydrogel/bead stiffness will influence adipose cell differentiation should be
performed. Additionally, in vitro analysis of the injectable composite system
(hygdrogel and multiple bead composition) with co-cultures of adipose cells and
mammary epithelial cells should be performed to determine how cell behavior
will be influenced.

6.

For future fatty acid studies, it should be determined if linoleic acid is the most
optimal fatty acid for inclusion in the injectable composite system. It should be
determined if one particular fatty acid should be use, or if a blend of multiple fatty
acids would be ideal, particularly with consideration of the ω-3/ω-6 ratio of fatty
acids in adipose tissue deposits, that has been shown to be an indicator of breast
cancer risk. Assessment of the effect of various fatty acids on normal mammary
cells should be performed.

7.

Further characterization of the fatty acid loaded chitosan beads is necessary to
determine if the fatty acid release profile will vary from batch-to-batch. Bead
fabrication methods may need to be altered if the fatty acids are to be delivered in
a specific dose-dependent manner.
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8.

Further investigation of multi-purpose beads within the injectable composite
system should be performed. Beads may potentially be used for site-specific
delivery of post-surgical treatments for tumors or for cell carriers for tissue
reconstruction.

9.

In vivo evaluation of fatty acid delivery from the microcarrier beads should be
performed within a nude mouse model to identify the influence of the fatty acids
on tumor cell viability and effectiveness of anti-cancer drugs.
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Appendix A
Digestion of Human Fat Tissue
Reagents and Medium:
• Collagenase Medium (DMEM-Incomplete)
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL
fungizone
•

Fat Growth Medium (DMEM-Fat)
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL InsulinTransferrin-Sodium Selenite Media Supplement (ITS)

•

Red Blood Cell (RBC) Lysis Buffer
Stock Solutions:
1M NH4Cl (FW=53.49) 26.75g to 500mL ddH2O
100mM KHCO3 (FW=100.1) 5.0g to 500mL ddH2O
10mM EDTA
Working Solution (500mL):
77mL 1M NH4Cl + 50mL 100mM KHCO3 + 5mL 10mM EDTA + 368mLddH2O

Tissue Retrieval Preparation:
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh
for filtering, beakers
2. Provide cooler to OR nurses station before scheduled procedure so that sample
may be placed in cooler on ice.
Collection and Isolation of Fat Cells:
1. Obtain tissue sample from the hospital OR. Transport back to the laboratory for
processing. Complete the Clemson Data Sheet for sample log.
2. Warm all media and PBS to 37°C in the water bath.
3. Open the tissue sample in the sterile hood. Cut off the desired amount of fat from
the larger sample. Place the fat tissue on a sterile disposable Petri dish and rinse
with fresh PBS. Rinse 1-2 more times to rinse away excess blood from the tissue.
4. Mince the tissue finely using disposable scalpels and scissors, carefully removing
excess connective tissue and blood vessels.
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5. Place ~5 grams of tissue into a sterile 50mL-centrifuge tube. Add filter sterilized
collagenase solution to each tube 4mL/gram tissue.
a. Prepare as much collagenase solution as needed for a given day
immediately before use. Filter sterilize before use. To prepare the
collagenase solution, add:
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL
Type II collagenase (both from Worthington Biochemical) + 2%
BSA (Sigma)
6. Incubate the tubes containing the tissue at 37°C in rotating water bath for 45
minutes at 100rpm.
7. Pipet the lysate up and down several times to break up remaining large pieces.
Filter the digested material using 1000µm nylon mesh into another sterile 50mlcentrifuge tube to remove remaining tissue fragments. Dilute the filtrate with
DMEM-Fat to minimize collagenase activity.
8. Spin the tubes for 10 minutes at 1000rpm. At the top will be an oily layer with a
fatty layer beneath. The middle is aqueous layer and the sediment is preadipocytes
and endothelial cells. Aspirate the fatty layer and liquid layer from the tube.
9.

Resuspend the cell pellet in 20mL of RBC Lysis Buffer for 10 minutes. Filter the
lysate with 100µm cell strainer into a new tube and spin for 5 minutes at
1000rpm.

10. Aspirate the top layer and aqueous layer in the tube. Resuspend the final pellet in
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium. If
there appears to be a large number of cells, perform a cell count and seed cells in
T-75 flask with 10ml fresh medium. Check cells after 24 hours to ensure no
contamination.
11. Change medium after 48hours to remove cellular debris and unattached cells.
Aspirate medium, rinse with sterile PBS, aspirate PBS, and replace culture
medium.
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Appendix B
Digestion of Bovine Fat Tissue
Reagents and Medium:
• Sterile Transport Solution
500mL Hank’s Balanced Salt Solution (HBSS) + 5mL antibiotic-antimycotic
(AA) + 1mL fungizone
•

Collagenase Medium (DMEM-Incomplete)
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL
fungizone

•

Fat Growth Medium (DMEM-Fat)
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL InsulinTransferrin-Sodium Selenite Media Supplement (ITS)

Tissue Retrieval Preparation:
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh
for filtering, beakers
2. Prepare sterile HBSS solution and aliquot to several sterile 50ml-centrifuge tubes
(30mL per tube)
3. Before going to slaughterhouse, warm tubes with HBSS in water bath to 37°C.
Also warm the Vector Travel warmer to 37°C. Place the tubes of HBSS into the
warmer and travel to the slaughterhouse.
Collection and Isolation of Fat Cells:
1. Obtain either subcutaneous or intraabdominal (from around internal organs) fatty
tissue from cow at slaughterhouse. Place tissue in tube containing sterile HBSS
solution. Place tubes back in travel warmer and transport back to the laboratory
for processing.
2. Warm all media and reagents to 37°C in the water bath.
3. Place the fat tissue on a sterile disposable Petri dish and rinse with fresh HBSS
solution. Rinse again. (Can also rinse again with sterile PBS solution.)
4. Mince the tissue finely using disposable scalpels and scissors.
5. Place ~5 grams of tissue into a sterile 50mL-centrifuge tube. Add filter sterilized
collagenase solution to each tube 4mL/gram tissue.
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a. Prepare as much collagenase solution as needed for a given day
immediately before use. Filter sterilize before use. To prepare the
collagenase solution, add:
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL
Type II collagenase (both from Worthington Biochemical) + 2%
BSA (Sigma)
6. Incubate the tubes containing the tissue at 37°C in rotating water bath for 60
minutes.
7. Filter the digested material using 1000µm nylon mesh into another sterile 50mlcentrifuge tube to remove remaining tissue fragments. Dilute the filtrate with
DMEM-Fat to minimize collagenase activity. Filter liquid through 100µm cell
strainer to another 50ml-centrifuge tube.
8. Spin the tubes for 10 minutes at 1000rpm. The thin, white layer at the top is fat
cells, middle is aqueous layer, sediment is preadipocytes and endothelial cells.
9. Aspirate the top layer and aqueous layer in the tube. Resuspend the final pellet in
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium. If
there appears to be a large amount of cellular debris in the tube, resuspend the
pellet in fresh medium and spin again. Aspirate the medium and seed cells in T25 flask.
10. Check cells after 24 hours to ensure no contamination.
11. Change medium 1-2 days following isolation to remove cellular debris and
unattached cells. Aspirate medium, rinse with sterile PBS, aspirate PBS, and
replace culture medium.
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Appendix C
Digestion of Murine Fat Tissue

Reagents and Medium:
• Collagenase Medium (DMEM-Incomplete)
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL
fungizone
•

Fat Growth Medium (DMEM-Fat)
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL InsulinTransferrin-Sodium Selenite Media Supplement (ITS)

Tissue Retrieval Preparation:
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh
for filtering, beakers
2. Prepare sterile HBSS solution and aliquot to several sterile 50ml-centrifuge tubes
(30mL per tube)
3. Before going to Godley-Snell, place the tubes into a Styrofoam cooler filled with
ice.
Collection and Isolation of Fat Cells:
1. Obtain either subcutaneous or epididymal fatty tissue from several mice at the
research facility. If mice have been used in research studies, be sure to use only
the control animals that have not been subject to experimental treatments. Place
tissue in tube containing sterile HBSS solution. Place tubes back into cooler and
transport back to the laboratory for processing.
2. Warm all media and reagents to 37°C in the water bath.
3. Place the fat tissue on a sterile disposable Petri dish and rinse with fresh HBSS
solution. Rinse again. (Can also rinse again with sterile PBS solution.)
4. Mince the tissue finely using disposable scalpels and scissors.
5. Place tissue into a sterile 50mL-centrifuge tube. Add filter sterilized collagenase
solution to each tube 4mL/gram tissue.
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a. Prepare as much collagenase solution as needed for a given day
immediately before use. Filter sterilize before use. To prepare the
collagenase solution, add:
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL
Type II collagenase (both from Worthington Biochemical) + 2%
BSA (Sigma)
6. Incubate the tubes containing the tissue at 37°C in rotating water bath for 60
minutes.
7. Filter the digested material using a 100µm cell strainer into another sterile 50mlcentrifuge tube to remove remaining tissue fragments. Dilute the filtrate with
DMEM-Fat to minimize collagenase activity.
8. Spin the tubes for 10 minutes at 1000rpm. The thin, white layer at the top is fat
cells, middle is aqueous layer, sediment is preadipocytes and endothelial cells.
9. Aspirate the top layer and aqueous layer in the tube. Resuspend the final pellet in
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium. If
there appears to be a large amount of cellular debris in the tube, resuspend the
pellet in fresh medium and spin again. Aspirate the medium and seed cells in T25 flask.
10. Check cells after 24 hours to ensure no contamination.
11. Change medium 1-2 days following isolation to remove cellular debris and
unattached cells. Aspirate medium, rinse with sterile PBS, aspirate PBS, and
replace culture medium.
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Appendix D
Purification of Total RNA from Animal Cells
Note: This protocol is adapted from Qiagen RNeasy Mini Kit Handbook and intended
for use with Qiagen RNeasy Mini Kit (Qiagen, Catalog #74106) and Qiagen
QIAshredders (Qiagen, Catalog #79656)
Reagents and Supplies
• Qiagen RNeasy Mini Kit
• Qiagen QIAshredders
• β-mercaptoethanol (β-ME)solution
• RNase/DNase-free aerosol tips
• RNase/DNase-free centrifuge tubes
• RNase/DNase-free microcentrifuge tubes
• 70% and 100% ethanol
• Micropipettors designated for RNA work
• Microcentrifuge
• Gloves and appropriate protective equipment
• Designated RNA workspace (PCR Hood)
RNA Isolation Procedure
1. Add 4 volumes of 100% ethanol to the Buffer RPE stock solution supplied in the
RNeasy Mini Kit to obtain a working solution. This is done only before using the
kit for the first time.
2. Before starting, mix 10µL β-ME per 1mL Buffer RLT in RNase free centrifuge
tube. Be sure to perform this step in the chemical fume hood.
3. For cells grown in well plates, aspirate the culture medium from the cells. Rinse
each well with 1-2mL PBS. Aspirate the PBS from the wells.
4. Lyse cells directly in the well plates by adding either 350µL or 600µL of Buffer
RLT to each well to disrupt the cells. The volume of Buffer RLT added to each
well is dependent on the size of the culture vessel, as shown in Table 6 of the
RNeasy Mini Kit Manual.
5. Incubate the cells in the lysis buffer on orbital shaker for 15 minutes.
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6. Collect the cell lysate from each well and transfer to a RNase/DNase-free
microcentrifuge tube (one tube per sample). Vortex each sample briefly.
7. Pipette the cell lysate directly into a QIAshredder spin column supplied with a
2mL collection tube. Centrifuge the samples for 2 minutes at full speed
(13,000rpm) to homogenize the samples.
8. Discard the spin column from the tube, saving the cell lysate. Add 1 volume
(either 350µL or 600µL depending on the volume of Buffer RLT added to the
samples) of 70% ethanol to the homogenized lysate, and mix well by pipetting.
Mix any precipitate that forms in the tube as well.
9. Transfer up to 700µL of the sample to and RNeasy spin column supplied in a
2mL collection tube. Centrifuge for 15s at ≥10,000rpm. Discard the sample
flow-through. If sample volume was greater than 700µl transfer up to 700µl of
sample volume again to RNeasy spin column and repeat, discarding the flowthrough after each centrifugation step.
10. Add 700µL of Buffer RW1 to the RNeasy spin column of each sample. Close the
lid and centrifuge for 15s at ≥10,000rpm to wash the spin column membrane.
Discard the flow-through.
11. Add 500µL of Buffer RPE to the RNeasy spin column of each sample. Close the
lid and centrifuge for 15s at ≥10,000rpm. Discard the flow-through.
12. Add 500µL of Buffer RPE to the RNeasy spin column of each sample. Close the
lid and centrifuge for 2 minutes at ≥10,000rpm to wash the membrane.
13. Place the RNeasy spin column into a new 1.5mL collection tube supplied in the
kit. Add 50µL of RNase-free water directly to the spin column membrane. Close
the lid and centrifuge for 1 minute at ≥10,000rpm to elute the RNA.
14. If the expected RNA yield is >30µg, repeat the elution step by adding another
50µL of RNase-free water to the RNeasy spin column.
15. Immediately store RNA samples at -80°C.
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Appendix E
Agilent Bioanalyzer RNA 6000 Nano Protocol
Note: This protocol was adapted from the Agilent RNA 6000 Nano Kit Guide and is
intended for use with the Agilent 2100 Bioanlyzer (Agilent Technologies) and
Agilent RNA 6000 Nano Kit (Catalog #5067-1511).
Reagents and Supplies
• RNA 6000 Nano Kit including Chips
• Agilent 2100 Bioanalyzer with chip priming station and IKA vortex mixer
• RNaseZap (Ambion #9780)
• RNase-free water
• RNase/DNase-free pipette tips
• Micropipettors
• RNase-free microcentrifuge tubes (1.5mL)
• Microcentrifuge
• Water bath heated to 70°C for ladder denaturation
Setup
1. Before starting, remove the RNA 6000 Nano kit from the refrigerator and allow to
equilibrate at room temperature for 30 minutes.
2. Set water bath to 70°C and allow to heat.
3. Remove RNA samples and RNA ladder supplied with RNA 6000 Nano kit from
the -80C and -20C freezers and thaw on ice. Always keep RNA samples and the
RNA ladder on ice.
Preparing the Gel
1. Pipette 550uL of RNA 6000 Nano gel matrix (red top) into the top of a spin filter
included in the kit.
2. Place the spin filter into microcentrifuge and spin for 10 minutes at 4000rpm.
3. Aliquot 65uL of filtered gel solution into 0.5mL RNase-free microcentrifuge
tubes included in the kit. Label and date the tubes. Store the aliquots at 4°C.
Aliquots must be used within one month of preparation.
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Preparing the Gel-Dye Mix
1. Vortex the RNA 6000 Nano dye concentrate (blue top) for 10 seconds and spin
down. Be sure to protect the dye from light at all times.
2. Add 1uL of RNA 6000 Nano dye concentrate to a 65uL aliquot of the filtered gel.
Close the tube and vortex until dye and gel sufficiently mixed. Return the dye to
refrigeration at 4°C in the dark.
3. Centrifuge the tube containing the gel-dye mix for 10 minutes at room
temperature at max speed (14,000rpm). Use the gel-dye mix within one day of
preparation.
Loading the Gel-Dye Mix
1. Before loading the gel-dye mix ensure that the chip priming station is set up
appropriately; priming station base plate should be in the C position (see page 7 of
the RNA 6000 Nano Kit Guide for information).
2. Remove a new RNA Nano chip from its sealed bag and place on the chip priming
station.
3. Pipette 9uL of the gel-dye mix into the bottom of the well marked G on the chip.
4. Set the timer to 30 seconds, make sure that the plunger of the syringe is positioned
at 1mL and then close the chip priming station.
5. Press the plunger of the syringe down until it is held by the clip. After 30
seconds, release the plunger. After 5 seconds, slowly pull the plunger back to the
1mL starting position.
6. Open the chip priming station and pipette 9uL of the gel dye mix into each of the
wells marked G.
Loading the RNA 6000 Nano Marker, Ladder, and Samples
1. Pipette 5uL of the RNA 6000 Nano marker (green top) into the well marked with
the ladder symbol and into each of the 12 sample wells. Add 6uL of the Nano
marker to any sample wells that will not be used for a RNA sample.
2. Pipette 1.5uL of the thawed RNA ladder to another RNase-free tube.
denature the ladder by heating in water bath at 70°C for 2 minutes.
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Heat

3. Pipette 1uL of the denatured ladder into the well marked with the ladder symbol.
4. Pipette 1uL of each sample into each of the 12 sample wells labeled #1-12.
5. Vortex the chip in the supplied IKA Vortexer for 1 minute at 2000rpm.
6. Analyze the chip within 5 minutes of preparation.
Analysis of NanoChip with Agilent 2100 Bioanalyzer
1. Start the Agilent 2100 software on the computer.
2. Decontaminate the electrodes on the Bioanalyzer before running chips.
3. Fill one of the wells of an electrode cleaner with 350uL RNaseZAP. Open the lid
and place the electrode cleaner in the Bioanalyzer. Close the lid and leave for 1
minute. Open the lid and remove the electrode cleaner.
4. Fill one of the wells of the other electrode cleaner with 350uL RNase-free water.
Place the electrode cleaner in the Bioanalyzer. Close the lid and leave for about
10 seconds. Open the lid and remove the electrode cleaner. Wait 10 seconds for
water to evaporate before closing the lid or inserting chip.
5. Once decontamination of the electrodes is completed, place the chip into the
cartridge. The chip will only fit into the instrument one way. Close the lid.
6. In the software, select Instrument. Then select Assay  Electrophoresis  RNA
 Eukaryote Total Nano
7. Click START. Data will automatically be saved to standard data folder upon
completion. Save data in a personal folder before closing software.
8. When the chip analysis has completed, open the lid and remove the chip. Discard
the chip. Repeat the decontamination procedure to clean the electrodes.
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Appendix F
Real Time RT-PCR Conditions
Note: The following RT-PCR conditions are intended for use with the Qiagen
QuantiFast™ SYBR® Green RT-PCR kit (Qiagen Catalog # 204154) for
quantitative, real-time, one-step RT-PCR.

RT-PCR Reaction Setup
Component

Volume/reaction

Final Concentration

2x QuantiFast SYBR Green RTPCR Master Mix

12.5 uL

1x

Primer A

1uL

1uM

Primer B

1uL

1uM

QuantiFast RT Mix

0.25uL

Template RNA

10ng

RNase-free water

0.25uL

Total Reaction Volume

25uL

100ng/reaction

Thermal Cycler Conditions
Step

Time

Temperature

Reverse Transcription

10 minutes

50°C

Hold

PCR Activation

5 minutes

95°C

Hold

Denaturation

10 seconds

95°C

Combined Annealing/Extension

30 seconds

60°C

Two-Step Cycling:

Number of Cycles

40 cycles
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Appendix G
Lipid Extraction and Transmethylation for Gas Chromatography Lipid Analysis
from Cell Samples
Sample Collection
• Aspirate culture medium from cells. Rinse with PBS (Sigma, St. Louis, MO).
Aspirate PBS from cells.
• Add 1mL of PBS to each well of 12-well culture plate. Scrape the cells with pipet
tip and transfer the cell/PBS solution to a microcentrifuge tube.
• Freeze sample at -20°C if not to be used immediately. If frozen, thaw samples at
room temperature before proceeding.
Lipid Extraction
• Transfer PBS and cells from microcentrifuge tube to 50mL-round bottom glass
centrifuge tube.
• Add 20mL of 2:1 Chloroform (Fisher): Methanol (VWR) solution to each tube
(13.4ml/6.6mL).
• Add 4mL of 0.58% sodium chloride solution to each tube.
• Vortex samples for 3 minutes using a multi-tube vortexer.
• Centrifuge sample tubes at 1500 rpm for 5 minutes at room temperature to
separate the solvent phases.
• Transfer the lower layer of solution to a 16 or 20-mL round bottom glass tube that
will fit on the nitrogen evaporator.
• Discard the upper layer in an appropriate waste container.

•

Evaporate the lower layer remaining in the tube under nitrogen gas (N-EVAP)
until completely dry*.
*Note: If entire sample preparation protocol cannot be finished at the allotted
time, samples may be stored after this step. Make sure the samples are
completely dry, add 100uL of methylene chloride (next step), close each tube with
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the screwtop, and store in refrigerator until the next day. Begin on the next day
by adding appropriate volume of sodium methoxide.
Transmethylation
• Add 100uL of methylene chloride (Fisher) and 1mL of 0.5N sodium methoxide in
methanol (Sigma) to each tube.
• Flush each tube with nitrogen gas, using the N-EVAP, and cap with Teflon lined
cap.
• Heat each tube on dry block heater at 90°C for 10 minutes.
• Cool each tube to room temperature.
• Add 1mL of 14% boron trifluoride (BFL3) in methanol (Sigma) to each tube.
• Flush the tubes with nitrogen gas and cap.
• Heat at 90°C for 10 minutes.
• Cool the tubes to room temperature.
• Add 500ul GC grade hexane (VWR) and 500ul GC grade hexane containing the
internal standard (ISTD) (Sigma, 1ug/ul C23:0) to each tube.
• Add 2mL deionized water to each tube.
• Vortex the tubes for 2 minutes.
• Centrifuge at 1500rpm for 5 minutes.
• Transfer the upper layer of solution (hexanes) to a disposable test tube containing
anhydrous sodium sulfate (Fisher).
• Transfer the hexane layer from the disposable test tube to an amber GC vial.
• Flush each vial carefully with nitrogen gas and cap, crimping the cap to ensure
seal.
• Run sample vials on GC for long chain fatty acids
• Calculate the weight percentages of fatty acids with the following equations:

%& '( )* 

+,-./ 01. 01.2345
01.2345 ⁄ .!78

01.=>??@ ABCD ⁄01.2345 / .!78

'( ) :;'&  <

78 E.--F GHIJ

K L 100%

Where: Total Area = area of entire sample plot
AreaISTD = area of the internal standard located on the resulting plot
AreaFatty Acid = area of specific fatty acids located on the resulting plot
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